Publication_code,Author,Year,Title,Comparison_identifier,Animal,Strain,Sex,Comorbidity,Comorbidity_induction,Age_weeks_min,Age_weeks_mean,Age_weeks_max,Weight_g_min,Weight_g_mean,Weight_g_max,N_control_groups,N_animals_control,N_treatment_groups,N_animals_treatment,N_treatment_to_control,Effective_n_control,Primary_anaesthetic,Secondary_anaesthetic,Surgical_level,Brain_area,RB_dose,RB_dose_units,RB_dose_mgkg,Light_intensity,Light_intensity_units,Light_intensity_Wcm2,Light_type,Light_source,Light_wavelength,Light_aperture,Light_time,Treatment,Treatment_class,Treatment_dose,Treatment_dose_units,Treatment_initial_hour,Treatment_time_class,Infarct_time,Infarct_measurement,Infarct_mean_control,Infarct_error_control,Infarct_mean_treatment,Infarct_error_treatment,Infarct_diff_from_control,Infarct_diff_from_control_error,Infarct_units,Infarct_error_units,Infarct_percent_control,Infarct_percent_treatment,Infarct_SD_control,Infarct_SD_control_percent,Infarct_SD_treatment,Scale_type,Scale_score_control,Scale_error_control,Scale_score_treatment,Scale_error_treatment,Scale_error_units,Scale_time,Multiple_timepoints,Multiple_doses
Aerden_2004,"Aerden, L. A.",2004,Diazepam reduces brain lesion size in a photothrombotic model of focal ischemia in rats,a,Rat,Lewis,Male,None,NA,10,11,12,210,298,320,1,12,3,8,3,4,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,10,mg/kg,10,NR,NA,NA,Fibre-optic,NR,NR,1,20,Diazepam,Excitotoxicity,10,mg/kg,NR,Before stroke,24,Other histology (ex vivo),NR,NR,NR,NR,NA,NA,NR,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Aerden_2004,"Aerden, L. A.",2004,Diazepam reduces brain lesion size in a photothrombotic model of focal ischemia in rats,b,Rat,Lewis,Male,None,NA,10,11,12,210,280,320,1,12,3,10,3,4,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,10,mg/kg,10,NR,NA,NA,Fibre-optic,NR,NR,1,20,Diazepam,Excitotoxicity,10,mg/kg,1,After stroke,24,Other histology (ex vivo),NR,NR,NR,NR,NA,NA,NR,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Aerden_2004,"Aerden, L. A.",2004,Diazepam reduces brain lesion size in a photothrombotic model of focal ischemia in rats,c,Rat,Lewis,Male,None,NA,10,11,12,210,276,320,1,12,3,9,3,4,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,10,mg/kg,10,NR,NA,NA,Fibre-optic,NR,NR,1,20,Diazepam,Excitotoxicity,10,mg/kg,4,After stroke,24,Other histology (ex vivo),NR,NR,NR,NR,NA,NA,NR,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Ahmed_2016,"Ahmed, M. E.",2016,Methylene Blue promotes cortical neurogenesis and ameliorates behavioral deficit after photothrombotic stroke in rats,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,200,225,250,1,6,1,6,1,6,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Sensorimotor cortex,0.1,mg/g,100,NR,NA,NA,Cold light,NR,NR,6,15,Methylene blue (MB),Multiple mechanisms,0.5,mg/kg,24,After stroke,288,Other histology (ex vivo),4,0.3,2.6,0.2,NA,NA,Indirect rLV % hemisphere,SE,2,1.3,0.734846923,0.367423461,0.489897949,None,NA,NA,NA,NA,NA,NA,No,No
Ahn_2016,"Ahn, S. M.",2016,Emodin from Polygonum multiflorum ameliorates oxidative toxicity in HT22 cells and deficits in photothrombotic ischemia,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,6,1,6,1,6,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,1,mg,44.44444444,NR,NA,NA,Cold light,NR,NR,4,15,Emodin,Anti-apoptosis/regeneration,3,nmol,-0.25,Before stroke,24,TTC (ex vivo),9,1.8,2.5,1.1,NA,NA,mm3,SEM,1.768485587,0.491245996,4.409081537,0.866377461,2.694438717,0-4 limb scale,0.6,0.2,0.3,0.1,SEM,24,No,No
Alaverdashvili_2018,"Alaverdashvili, M.",2018,Protein-Energy Malnutrition Exacerbates Stroke-Induced Forelimb Abnormalities and Dampens Neuroinflammation,a,Rat,Sprague-Dawley,Male,None,NA,NR,11,NR,375,426,477,1,4,1,7,1,4,Isoflurane,NA,Skull thinned,Motor cortex,10,mg/kg,10,285,mW/cm2,0.285,Diode laser,Diode laser,532,4,10,Low-protein diet,Other,0.5,% in diet,-744,Before stroke,72,NR,3015,55,3549,256,NA,NA,um,SEM,NA,NA,110,NA,677.3123356,None,NA,NA,NA,NA,NA,NA,No,No
Alaverdashvili_2008,"Alaverdashvili, M.",2008,Acute but not chronic differences in skilled reaching for food following motor cortex devascularization vs. photothrombotic stroke in the rat,a,Rat,Long Evans,Female,None,NA,13,13.5,14,NR,NR,NR,3,8,0,NA,NA,NA,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Motor cortex,10,mg/kg,10,78000,lux,0.01141998,NR,NR,NR,5,20,None,NA,NA,NA,NA,NA,NA,Other histology (ex vivo),2.84,0.58,NA,NA,NA,NA,mm3,NR,0.144089295,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Alaverdashvili_2008,"Alaverdashvili, M.",2008,Acute but not chronic differences in skilled reaching for food following motor cortex devascularization vs. photothrombotic stroke in the rat,b,Rat,Long Evans,Female,None,NA,13,13.5,14,NR,NR,NR,3,7,0,NA,NA,NA,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Motor cortex,10,mg/kg,10,140000,lux,0.0204974,NR,NR,NR,5,20,None,NA,NA,NA,NA,NA,NA,Other histology (ex vivo),6.16,1.08,NA,NA,NA,NA,mm3,NR,0.31253171,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Alaverdashvili_2008,"Alaverdashvili, M.",2008,Acute but not chronic differences in skilled reaching for food following motor cortex devascularization vs. photothrombotic stroke in the rat,c,Rat,Long Evans,Female,None,NA,13,13.5,14,NR,NR,NR,3,8,0,NA,NA,NA,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Motor cortex,10,mg/kg,10,170000,lux,0.0248897,NR,NR,NR,5,20,None,NA,NA,NA,NA,NA,NA,Other histology (ex vivo),9.86,0.89,NA,NA,NA,NA,mm3,NR,0.500253678,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Arii_2002,"Arii, K.",2002,The effect of ozagrel sodium on photochemical thrombosis in rat: therapeutic window and combined therapy with heparin sodium,a,Rat,Sprague-Dawley,Male,None,NA,NR,6,NR,152,166,185,1,9,3,9,3,3,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,540,NR,5,Ozagrel Sodium,Thrombolytics,10,mg/kg,0,During stroke,72,Other histology (ex vivo),12.92,2.99,9.02,2.774,NA,NA,Indirect rLV % hemisphere,SD,6.46,4.51,2.99,1.495,2.774,None,NA,NA,NA,NA,NA,NA,No,Yes
Arii_2002,"Arii, K.",2002,The effect of ozagrel sodium on photochemical thrombosis in rat: therapeutic window and combined therapy with heparin sodium,b,Rat,Sprague-Dawley,Male,None,NA,NR,6,NR,152,175,185,1,9,3,7,3,3,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,540,NR,5,Heparin,Thrombolytics,150,IU/kg,0,During stroke,72,Other histology (ex vivo),12.92,2.99,13.91,4.73,NA,NA,Indirect rLV % hemisphere,SD,6.46,6.955,2.99,1.495,4.73,None,NA,NA,NA,NA,NA,NA,No,No
Avraham_2011,"Avraham, Y.",2011,Leptin induces neuroprotection neurogenesis and angiogenesis after stroke,a,Mouse,Sabra,Male,None,NA,NR,NR,NR,NR,40,NR,1,18,1,20,1,18,NR,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),10,mg/kg,10,NR,NA,NA,Cold light,NR,NR,NR,20,Leptin,Energy substrates,1,mg/kg,0.5,After stroke,2160,Other histology (ex vivo),14.4,8.78,5.19,2.18,NA,NA,Indirect rLV % hemisphere,NR,7.2,2.595,NA,NA,NA,NSS,3.44,0.29,2.12,0.17,NR,264,Yes,No
Avraham_2010,"Avraham, Y.",2010,"Leptin reduces infarct size in association with enhanced expression of CB2, TRPV1, SIRT-1 and leptin receptor",a,Mouse,Sabra,Male,None,NA,NR,NR,NR,NR,50,NR,1,10,6,10,6,1.666666667,Isoflurane,NA,"Scalp retracted, skull intact",Distal middle cerebral artery (dMCA),10,mg/kg,10,NR,NA,NA,Cold light,NR,NR,NR,10,Leptin,Energy substrates,1,mg/kg,0.5,After stroke,72,TTC (ex vivo),11.14,0.78,7.65,0.86,NA,NA,Indirect rLV % hemisphere,SEM,5.57,3.825,2.466576575,1.233288287,2.719558788,NSS,2.58,0.28,1.2,0.2,SEM,504,Yes,Yes
Avraham_2013,"Avraham, Y.",2013,Delayed leptin administration after stroke induces neurogenesis and angiogenesis,a,Mouse,Sabra,Male,None,NA,NR,NR,NR,NR,40,NR,1,18,2,20,2,9,NR,NA,"Scalp retracted, skull intact",Distal middle cerebral artery (dMCA),10,mg/kg,10,NR,NA,NA,Cold light,NR,NR,NR,20,Leptin,Energy substrates,3,mg/kg,240,After stroke,2160,Other histology (ex vivo),12.47,4.28,14.75,1.32,NA,NA,Indirect rLV % hemisphere,SEM,6.235,7.375,18.15850214,9.07925107,5.903219461,NSS,4.49,0.21,3.02,0,SEM,312,Yes,Yes
Bai_2014,"Bai, Y. Y.",2014,Image-guided pro-angiogenic therapy in diabetic stroke mouse models using a multi-modal nanoprobe,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,1,6,1,6,1,6,Isoflurane,NA,Scalp and skull intact,NR,100,mg/kg,100,NR,NA,NA,Cold light,NR,NR,4,15,EPCs: endothelial progenitor cells,Anti-apoptosis/regeneration,NR,NR,NR,NR,NR,NR,NR,NR,NR,NR,NA,NA,NR,NR,NA,NA,NA,NA,NA,mNSS,4.85,0.71,4,0.9,NR,504,Yes,No
Bai_2014,"Bai, Y. Y.",2014,Image-guided pro-angiogenic therapy in diabetic stroke mouse models using a multi-modal nanoprobe,b,Mouse,db/db,Male,Diabetes,Genetic,NR,8,NR,NR,NR,NR,1,6,1,6,1,6,Isoflurane,NA,Scalp and skull intact,NR,100,mg/kg,100,NR,NA,NA,Cold light,NR,NR,4,15,EPCs: endothelial progenitor cells,Anti-apoptosis/regeneration,NR,NR,NR,NR,NR,NR,NR,NR,NR,NR,NA,NA,NR,NR,NA,NA,NA,NA,NA,mNSS,5.99,0.88,5.24,0,NR,504,Yes,No
Bailey_1995,"Bailey, S. J.",1995,"Failure of isradipine to reduce infarct size in mouse, gerbil, and rat models of cerebral ischemia",a,Rat,Lister Hooded Rat,Male,None,NA,NR,NR,NR,250,265,280,1,10,1,10,1,10,Halothane,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,300,W,NA,Xenon lamp,Xenon,NR,5,5,Isradipine,Blood flow,2.5,mg/kg,1,After stroke,168,Other histology (ex vivo),12.27,1.47,9.55,1.33,NA,NA,mm3,SEM,0.622526636,0.484525622,4.64854816,0.235847192,4.205829288,None,NA,NA,NA,NA,NA,NA,No,No
Baldwin_1994,"Baldwin, H. A.",1994,Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat,a,Rat,Lister Hooded Rat,Male,None,NA,NR,NR,NR,280,320,360,1,10,1,10,1,10,Nitrous oxide,Halothane,Other,NR,20,mg/kg,20,150,W,NA,Halogen lamp,Halogen,NR,NR,7,Chlormethiazole,Excitotoxicity,200,mg/kg,0.8,During stroke,24,TTC (ex vivo),6.81,0.73,4.79,0.83,NA,NA,mm2,SEM,NA,NA,2.308462692,NA,2.624690458,None,NA,NA,NA,NA,NA,NA,No,No
Bandla_2016,"Bandla, A.",2016,Peripheral sensory stimulation is neuroprotective in a rat photothrombotic ischemic stroke model,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,275,300,1,3,2,3,2,1.5,Sodium Pentobarbital,NA,Skull breached,Primary forelimb somatosensory cortex (S1FL),10,mg/ml,20,5,mW,NA,Continuous wave (CW) laser light,NR,532,NR,20,Peripheral sensory electrical stimulation (PSS),Other,2,Simultaneous administrations,NR,Before stroke,24,TTC (ex vivo),21.94,1.1,2.86,0.37,-75,NA,Direct rLV % hemisphere,NR,10.97,1.43,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Bandla_2018,"Bandla, A.",2018,Simultaneous functional photoacoustic microscopy and electrocorticography reveal the impact of rtPA on dynamic neurovascular functions after cerebral ischemia,a,Rat,Wistar,Male,None,NA,NR,NR,NR,250,275,300,1,8,6,8,6,1.333333333,Sodium Pentobarbital,NA,Skull breached,Primary forelimb somatosensory cortex (S1FL),10,mg/ml,20,5,mW,NA,Continuous wave (CW) laser light,NR,532,NR,20,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,10,mg/kg,1,After stroke,24,TTC (ex vivo),13,1.9,3.83,0.7,-72,5.6,Indirect rLV % hemisphere,SD,6.5,1.915,1.9,0.95,0.7,None,NA,NA,NA,NA,NA,NA,No,Yes
Baudelet_1999,"Baudelet, C.",1999,Evidence for a neuroprotective effect of pyrid-3-yl-sulphonyl-urea in photochemically induced focal ischaemia in rats: magnetic resonance imaging evaluation,a,Rat,Wistar,Male,None,NA,NR,NR,NR,250,275,300,1,5,1,6,1,5,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,2.5,mL/kg,10,NR,NA,NA,Halogen lamp,Halogen,NR,1.9,5,BM27,Other,5,mg/kg,-0.5,Before stroke,6,MRI (in vivo),140.19,12.26,100.94,9.25,NA,NA,Pixels (T2 weighted MRI),SEM,NA,NA,27.4141934,NA,22.65778012,None,NA,NA,NA,NA,NA,NA,Yes,No
Benham_1993,"Benham, C. D.",1993,"SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia",a,Rat,NR,NR,None,NA,NR,NR,NR,NR,NR,NR,1,12,1,13,1,12,NR,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,NR,NR,NR,SB 201823-A,Blood flow,40,mg/kg,0.5,After stroke,168,Other histology (ex vivo),16.57,0.97,4.1,0.62,NA,NA,mm3,SEM,0.840690005,0.208016235,3.360178567,0.170480901,2.235441791,None,NA,NA,NA,NA,NA,NA,No,No
Bierbower_2015,"Bierbower, S. M.",2015,Augmentation of M-type (KCNQ) potassium channels as a novel strategy to reduce stroke-induced brain injury,a,Mouse,C57BL/6,Male,None,NA,16,20,24,NR,25,NR,1,8,8,5,8,1,Isoflurane,NA,Skull thinned,Somatosensory cortex,20,mg/kg,20,NR,NA,NA,Diode laser,Diode laser,561,0.8,20,Retigabine (RTG),Excitotoxicity,10.5,mg/kg,3,After stroke,24,TTC (ex vivo),2,0.04,0.96,0.08,NA,NA,mm2,SEM,NA,NA,0.113137085,NA,0.178885438,None,NA,NA,NA,NA,NA,NA,No,Yes
Bierbower_2015,"Bierbower, S. M.",2015,Augmentation of M-type (KCNQ) potassium channels as a novel strategy to reduce stroke-induced brain injury,b,Mouse,C57BL/6,Male,None,NA,16,20,24,NR,25,NR,1,8,8,5,8,1,Isoflurane,NA,Skull thinned,Somatosensory cortex,20,mg/kg,20,NR,NA,NA,Diode laser,Diode laser,561,0.8,20,NH29,Excitotoxicity,10,mg/kg,0,During stroke,24,TTC (ex vivo),2,0.04,0.98,0.14,NA,NA,mm2,SEM,NA,NA,0.113137085,NA,0.313049517,None,NA,NA,NA,NA,NA,NA,No,No
Bierbower_2015,"Bierbower, S. M.",2015,Augmentation of M-type (KCNQ) potassium channels as a novel strategy to reduce stroke-induced brain injury,c,Mouse,C57BL/6,Male,None,NA,16,20,24,NR,25,NR,1,8,8,5,8,1,Isoflurane,NA,Skull thinned,Somatosensory cortex,20,mg/kg,20,NR,NA,NA,Diode laser,Diode laser,561,0.8,20,QO-58,Excitotoxicity,0.1,mg/kg,0,During stroke,24,TTC (ex vivo),2,0.04,0.98,0.23,NA,NA,mm2,SEM,NA,NA,0.113137085,NA,0.514295635,None,NA,NA,NA,NA,NA,NA,No,No
Bierbower_2015,"Bierbower, S. M.",2015,Augmentation of M-type (KCNQ) potassium channels as a novel strategy to reduce stroke-induced brain injury,d,Mouse,C57BL/6,Male,None,NA,16,20,24,NR,25,NR,1,8,8,6,8,1,Isoflurane,NA,Skull thinned,Somatosensory cortex,20,mg/kg,20,NR,NA,NA,Diode laser,Diode laser,561,0.8,20,XE991,Excitotoxicity,3,mg/kg,0,During stroke,24,TTC (ex vivo),2,0.04,3.92,0.31,NA,NA,mm2,SEM,NA,NA,0.113137085,NA,0.75934182,None,NA,NA,NA,NA,NA,NA,No,No
Bix_2013,"Bix, G. J.",2013,Perlecan domain V is neuroprotective and affords functional improvement in a photothrombotic stroke model in young and aged mice,a,Mouse,C57BL/6,Male,None,NA,8,10,12,28,30,32,1,5,4,5,4,1.25,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,g/L,66.66666667,NR,NA,NA,Cold light,NR,NR,2,15,Domain V (DV),Anti-apoptosis/regeneration,10,mg/kg,6,After stroke,168,Other histology (ex vivo),2.36,0.08,1.66,0.04,NA,NA,mm3,SEM,0.463736221,0.326187342,0.178885438,0.035150702,0.089442719,None,NA,NA,NA,NA,NA,NA,No,Yes
Bix_2013,"Bix, G. J.",2013,Perlecan domain V is neuroprotective and affords functional improvement in a photothrombotic stroke model in young and aged mice,b,Mouse,C57BL/6,Male,Aged,NA,NR,104,NR,28,30,32,1,7,2,7,2,3.5,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,g/L,66.66666667,NR,NA,NA,Cold light,NR,NR,2,15,Domain V (DV),Anti-apoptosis/regeneration,10,mg/kg,3,After stroke,168,Other histology (ex vivo),2.61,0.21,1.99,0.12,NA,NA,mm3,SEM,0.51286082,0.391031813,0.555607775,0.109176038,0.317490157,None,NA,NA,NA,NA,NA,NA,No,Yes
Brown_2004,"Brown, A. W.",2004,"Motor response to amphetamine treatment, task-specific training, and limited motor experience in a postacute animal stroke model",a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,245,282.5,320,1,5,1,5,1,5,Halothane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,80,mg/kg,80,150,W,NA,Halogen lamp,Halogen,NR,8,15,D-amphetamine,Nootropics/cognition,2,mg/kg,24,After stroke,48,Other histology (ex vivo),23.3,1.857,27.6,2.675,NA,NA,mm3,SEM,1.182141045,1.400304414,4.152378234,0.21067368,5.98148184,BWS - Feeney Beam Walking Score,21.875,4.79,32.25,9.02,SD,48,Yes,Yes
Buccellati_1998,"Buccellati, C.",1998,Inhibition of prostanoid synthesis protects against neuronal damage induced by focal ischemia in rat brain,a,Rat,Wistar,Male,None,NA,NR,NR,NR,200,225,250,1,NR,1,NR,1,NA,Equitensine,NA,"Scalp retracted, skull intact",Fronto-parietal cerebral cortex,1.7,mg/100g,17,150,W,NA,Halogen lamp,Halogen,NR,NR,30,Indomethacin,Anti-inflammation,20,mg/kg,-1,Before stroke,NR,Other histology (ex vivo),5.6,0.5,3.2,0.2,-43,NA,mm2,SEM,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Buchkremer-Ratzmann_1997_a,"Buchkremer-Ratzmann, I.",1997,Pharmacological reduction of electrophysiological diaschisis after photothrombotic ischemia in rat neocortex,a,Rat,Wistar,Male,None,NA,13,19.5,26,290,300,310,1,18,1,11,1,18,Halothane,NA,"Scalp retracted, skull intact",Motor cortex,1.3,mg/100g,13,15,W/cm2,15,Cold light,NR,NR,1.5,20,MK-801 (dizocilpine maleate),Excitotoxicity,0.5,mg/kg,-0.5,Before stroke,168,Other histology (ex vivo),2.3,0.3,2.4,0.2,NA,NA,mm (diameter),SD,NA,NA,0.3,NA,0.2,None,NA,NA,NA,NA,NA,NA,No,No
Buchkremer-Ratzmann_1997_a,"Buchkremer-Ratzmann, I.",1997,Pharmacological reduction of electrophysiological diaschisis after photothrombotic ischemia in rat neocortex,b,Rat,Wistar,Male,None,NA,13,19.5,26,290,300,310,1,6,2,8,2,3,Halothane,NA,"Scalp retracted, skull intact",Motor cortex,1.3,mg/100g,13,15,W/cm2,15,Cold light,NR,NR,1.5,20,Lubeluzole,Excitotoxicity,0.62,mg/kg,0.42,After stroke,168,Other histology (ex vivo),2.4,0.2,2.2,0.2,NA,NA,mm (diameter),SD,NA,NA,0.2,NA,0.2,None,NA,NA,NA,NA,NA,NA,No,No
Buchkremer-Ratzmann_1997_a,"Buchkremer-Ratzmann, I.",1997,Pharmacological reduction of electrophysiological diaschisis after photothrombotic ischemia in rat neocortex,c,Rat,Wistar,Male,None,NA,13,19.5,26,290,300,310,1,6,2,5,2,3,Halothane,NA,"Scalp retracted, skull intact",Motor cortex,1.3,mg/100g,13,15,W/cm2,15,Cold light,NR,NR,1.5,20,Lubeluzole R-isomer,Excitotoxicity,0.62,mg/kg,0.42,After stroke,168,Other histology (ex vivo),2.4,0.2,2.1,0.3,NA,NA,mm (diameter),SD,NA,NA,0.2,NA,0.3,None,NA,NA,NA,NA,NA,NA,No,No
Cai_2018,"Cai, Y.",2018,"Diffusion Tensor Imaging Evaluation of Axonal/White Matter Remodeling in a Mouse Model of Diabetic Stroke Treated with Novel p38 MAPK Inhibitor, VCP979",a,Mouse,C57BL/6,Male,None,NA,NR,4,NR,NR,NR,NR,1,6,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),0.025,mmol/kg,24.34175,NR,NA,NA,NR,NR,532,NR,2,None,NA,NA,NA,NA,NA,168,MRI (in vivo),15.81,8.55,NA,NA,NA,NA,Indirect rLV % whole brain,SD,15.81,NA,8.55,8.55,NA,mNSS,3.67,1.62,NA,NA,SD,168,Yes,NA
Cai_2018,"Cai, Y.",2018,"Diffusion Tensor Imaging Evaluation of Axonal/White Matter Remodeling in a Mouse Model of Diabetic Stroke Treated with Novel p38 MAPK Inhibitor, VCP979",b,Mouse,C57BL/6,Male,Diabetes,High-fat diet + streptozotocin,NR,4,NR,NR,NR,NR,1,6,2,6,2,3,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),0.025,mmol/kg,24.34175,NR,NA,NA,NR,NR,532,NR,2,RWJ67657,Anti-inflammation,648,mg/kg,24,After stroke,168,MRI (in vivo),35.79,5.93,28.39,5.74,NA,NA,Indirect rLV % whole brain,SD,35.79,28.39,5.93,5.93,5.74,mNSS,4.4,0.89,4.2,1.29,SD,168,Yes,No
Cai_2018,"Cai, Y.",2018,"Diffusion Tensor Imaging Evaluation of Axonal/White Matter Remodeling in a Mouse Model of Diabetic Stroke Treated with Novel p38 MAPK Inhibitor, VCP979",c,Mouse,C57BL/6,Male,Diabetes,High-fat diet + streptozotocin,NR,4,NR,NR,NR,NR,1,6,2,6,2,3,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),0.025,mmol/kg,24.34175,NR,NA,NA,NR,NR,532,NR,2,VCP979,Multiple mechanisms,504,mg/kg,24,After stroke,168,MRI (in vivo),35.79,5.93,13.7,4.63,NA,NA,Indirect rLV % whole brain,SD,35.79,13.7,5.93,5.93,4.63,mNSS,4.4,0.89,2.2,1.3,SD,168,Yes,No
Cecatto_2014,"Cecatto, R. B.",2014,Motor recovery and cortical plasticity after functional electrical stimulation in a rat model of focal stroke,a,Rat,Wistar,Male,None,NA,NR,NR,NR,200,250,300,1,8,1,8,1,8,Ketamine,Xylazine,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,30,mg/kg,30,150,W,NA,Halogen lamp,Halogen,500-600,5,30,FES - Functional electrical stimulation,Other,2,mA,96,After stroke,456,Other histology (ex vivo),4.7,0.9,4.8,0.2,NA,NA,mm (craniocaudal extent of lesion),SD,NA,NA,0.9,NA,0.2,None,NA,NA,NA,NA,NA,NA,No,No
Cekanaviciute_2014,"Cekanaviciute, E.",2014,Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice,a,Mouse,Wild type (WT),Female,None,NA,NR,8,NR,NR,NR,NR,1,8,0,NA,NA,NA,NR,NA,Skull thinned,Motor cortex,40,mg/kg,40,NR,NA,NA,Metal-halide lamp,Metal-halide,NR,5,30,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),5.13,0.69,NA,NA,NA,NA,Direct rLV % hemisphere,SEM,2.565,NA,1.951614716,0.975807358,NA,Modified Garcia Score,9.26,0.49,NA,NA,SEM,672,Yes,No
Cekanaviciute_2014,"Cekanaviciute, E.",2014,Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice,b,Mouse,Ast-Tbr2DN,Female,None,NA,NR,8,NR,NR,NR,NR,1,8,0,NA,NA,NA,NR,NA,Skull thinned,Motor cortex,40,mg/kg,40,NR,NA,NA,Metal-halide lamp,Metal-halide,NR,5,30,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),4.32,0.41,NA,NA,NA,NA,Direct rLV % hemisphere,SEM,2.16,NA,1.159655121,0.579827561,NA,Modified Garcia Score,6.96,0.55,NA,NA,SEM,672,Yes,No
Chang_2015_a,"Chang, D.",2015,Role of P38 MAPK on MMP Activity in Photothrombotic Stroke Mice as Measured using an Ultrafast MMP Activatable Probe,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,1,6,1,6,1,6,Isoflurane,NA,Scalp and skull intact,NR,100,mg/kg,100,NR,NA,NA,LCD,NR,NR,4,15,RWJ67657,Anti-inflammation,700,mg/kg,0.1,After stroke,168,MRI (in vivo),17.81,2.94,10.48,1.83,NA,NA,Direct rLV % whole brain,SD,17.81,10.48,2.94,2.94,1.83,mNSS,7.96,0.72,6.29,1.03,SD,336,Yes,No
Chang_2015_b,"Chang, W. H.",2015,Effects of extradural cortical stimulation on motor recovery in a rat model of subacute stroke,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,275,300,1,14,1,15,1,14,Ketamine,Xylazine,Other,Primary forelimb somatosensory cortex (S1FL),20,mg/kg,20,NR,NR,NA,Cold light,NR,NR,5,20,ECS: extradural cortical stimulation,Other,3.1,Volts,120,After stroke,NR,Other histology (ex vivo),15.59,3.73,13.62,3.92,NA,NA,mm3,NR,0.790969051,0.691019787,NA,NA,NA,Garcia Score,NR,NR,NR,NR,NR,NR,No,No
Chang_1999,"Chang, Y. Y.",1999,Neuroprotective effects of an antioxidant in cortical cerebral ischemia: prevention of early reduction of the apurinic/apyrimidinic endonuclease DNA repair enzyme,a,Mouse,CD-1,Male,None,NA,NR,12,NR,35,37.5,40,1,5,1,5,1,5,Chloral hydrate,Xylazine,"Scalp retracted, skull intact",NR,1,mg/100g,10,150,W,NA,Fibre-optic,NR,NR,1.4,15,21-Aminosteroid,Anti-oxidants,20,mg/kg,-0.5,Before stroke,72,NR,7.07,1.21,3.02,0.65,NA,NA,mm3,NR,1.389243678,0.593425164,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Chen_2007_a,"Chen, F.",2007,Rodent stroke induced by photochemical occlusion of proximal middle cerebral artery: evolution monitored with MR imaging and histopathology,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,230,290,350,1,4,0,NA,NA,NA,Isoflurane,NA,Skull breached,Proximal middle cerebral artery (pMCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,12,TTC (ex vivo),26.4,9.6,NA,NA,NA,NA,Direct rLV % whole brain,SD,26.4,NA,9.6,9.6,NA,None,NA,NA,NA,NA,NA,NA,Yes,NA
Chen_2007_b,"Chen, F.",2007,Microplasmin and tissue plasminogen activator: comparison of therapeutic effects in rat stroke model at multiparametric MR imaging,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,220,285,350,1,13,3,9,3,4.333333333,Halothane,Isoflurane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,Microplasmin,Thrombolytics,10,mg/kg,1.5,After stroke,24,MRI (in vivo),27,3,20,4,NA,NA,Direct rLV % whole brain,SD,27,20,3,3,4,Bederson Scale,7, 4-9,4, 3-6,Range,24,No,Yes
Chen_2007_b,"Chen, F.",2007,Microplasmin and tissue plasminogen activator: comparison of therapeutic effects in rat stroke model at multiparametric MR imaging,b,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,220,285,350,1,13,3,14,3,4.333333333,Halothane,Isoflurane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,TPA (tissue plasminogen activator),Thrombolytics,10,mg/kg,1.5,After stroke,24,MRI (in vivo),27,3,21,6,NA,NA,Direct rLV % whole brain,SD,27,21,3,3,6,Bederson Scale,7, 4-9,4, 3-7,Range,24,No,No
Chen_2006,"Chen, T. Y.",2006,Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice,a,Mouse,ICR,Male,None,NA,NR,NR,NR,30,32.5,35,1,8,3,8,3,2.666666667,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Distal middle cerebral artery (dMCA),10,mg/kg,10,10,mW,NA,Argon laser,Argon laser,514.5,NR,0.67,Melatonin,Anti-oxidants,5,mg/kg,6,After stroke,24,TTC (ex vivo),17.61,1.44,14.94,1.65,NA,NA,Indirect rLV % hemisphere,SEM,8.805,7.47,4.07293506,2.03646753,4.666904756,Clark 28 point scale,12, 9.3-14.4,10, 8.1-12.2,CI range,24,No,Yes
Chen_2006,"Chen, T. Y.",2006,Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice,b,Mouse,ICR,Male,None,NA,NR,NR,NR,30,32.5,35,1,8,3,8,3,2.666666667,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Distal middle cerebral artery (dMCA),10,mg/kg,10,10,mW,NA,Argon laser,Argon laser,514.5,NR,0.67,TPA (tissue plasminogen activator),Thrombolytics,10,mg/kg,6,After stroke,24,TTC (ex vivo),17.61,1.44,18.53,0.99,NA,NA,Indirect rLV % hemisphere,SEM,8.805,9.265,4.07293506,2.03646753,2.800142853,Clark 28 point scale,12, 9.3-14.4,12, 10.2-13.5,CI range,24,No,Yes
Chen_2016,"Chen, Y.",2016,Calcineurin beta protects brain after injury by activating the unfolded protein response,a,Mouse,C57BL/6,Male,None,NA,8,9,10,NR,NR,NR,1,5,1,5,1,5,Isoflurane,NA,Skull breached,NR,NR,NA,NA,NR,NA,NA,NR,NR,543,NR,5,PERK inhibitor (PI),Anti-apoptosis/regeneration,NR,NA,-12,Before stroke,24,TTC (ex vivo),3.64,0.85,12.29,1.41,NA,NA,mm3,SEM,0.715254171,2.414965318,1.900657781,0.37347621,3.152855848,None,NA,NA,NA,NA,NA,NA,No,No
Chen_2016,"Chen, Y.",2016,Calcineurin beta protects brain after injury by activating the unfolded protein response,b,Mouse,CN? knockout,Male,None,NA,8,9,10,NR,NR,NR,1,5,1,5,1,5,Isoflurane,NA,Skull breached,NR,NR,NA,NA,NR,NA,NA,NR,NR,543,NR,5,PERK inhibitor (PI),Anti-apoptosis/regeneration,NR,NA,-12,Before stroke,24,TTC (ex vivo),10.73,2.01,12.14,1.93,NA,NA,mm3,SEM,2.108427816,2.385490558,4.494496635,0.883161391,4.315611197,None,NA,NA,NA,NA,NA,NA,No,No
Cho_2016_a,"Cho, J.",2016,Remodeling of Neuronal Circuits After Reach Training in Chronic Capsular Stroke,a,Rat,Sprague-Dawley,Male,None,NA,NR,9,NR,NR,300,NR,2,16,0,NA,NA,NA,NR,NA,Skull breached,Posterior Limb of the Internal Capsule,20,mg/kg,20,3.7,mW,NA,Green laser,Diode-pumped solid state laser,NR,0.125,1.5,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),0.59,0.36,NA,NA,NA,NA,mm3,SD,0.029934044,NA,0.36,0.01826484,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Cho_2016_a,"Cho, J.",2016,Remodeling of Neuronal Circuits After Reach Training in Chronic Capsular Stroke,b,Rat,Sprague-Dawley,Male,None,NA,NR,9,NR,NR,300,NR,2,18,0,NA,NA,NA,NR,NA,Skull breached,Posterior Limb of the Internal Capsule,20,mg/kg,20,3.7,mW,NA,Green laser,Diode-pumped solid state laser,NR,0.125,1.5,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),0.63,0.37,NA,NA,NA,NA,mm3,SD,0.03196347,NA,0.37,0.018772197,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Cho_2016_b,"Cho, S. E.",2016,The effect of ultrasound for increasing neural differentiation in hBM-MSCs and inducing neurogenesis in ischemic stroke model,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,1,8,2,8,2,4,Zoletil,Xylazine,"Scalp retracted, skull intact",NR,10,mg/ml,NA,150,W,NA,Cold light,NR,NR,NR,15,hBMSC (human bone marrow mesenchymal stem cell),Multiple mechanisms,1 x 10^5,Cells,NR,After stroke,NR,Other histology (ex vivo),1,0.2,0.8,0.15,NA,NA,% (not specified percentage of),SD,NA,NA,0.2,NA,0.15,None,NA,NA,NA,NA,NA,NA,No,Yes
Choi_2018,"Choi, I. A.",2018,Effect of Inhibition of DNA Methylation Combined with Task-Specific Training on Chronic Stroke Recovery,a,Rat,Wistar,Male,None,NA,NR,8,NR,NR,283.88,NR,1,10,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,LCD,NR,NR,4,30,None,NA,NA,NA,NA,NA,1008,NR,94.05,12.13,NA,NA,NA,NA,mm3,SE,4.771689498,NA,38.35842802,1.946140437,NA,mNSS,10.64,0.55,NA,NA,SE,1344,Yes,No
Choi_2018,"Choi, I. A.",2018,Effect of Inhibition of DNA Methylation Combined with Task-Specific Training on Chronic Stroke Recovery,b,Rat,Wistar,Male,None,NA,NR,8,NR,NR,283.88,NR,1,12,3,6,3,4,Ketamine,Xylazine,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,LCD,NR,NR,4,30,Task-specific training (TST),Other,NA,NA,1584,After stroke,2184,NR,76.68,5.56,67.61,3.22,NA,NA,mm3,SE,3.890410959,3.430238458,19.26040498,0.977189497,7.887356972,mNSS,10.92,NR,9.2,0.8,SE,2184,Yes,Yes
Choi_2018,"Choi, I. A.",2018,Effect of Inhibition of DNA Methylation Combined with Task-Specific Training on Chronic Stroke Recovery,c,Rat,Wistar,Male,None,NA,NR,8,NR,NR,283.88,NR,1,12,3,6,3,4,Ketamine,Xylazine,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,LCD,NR,NR,4,30,5-Aza-dC,Other,280,ug,1584,After stroke,2184,NR,76.68,5.56,94.54,8.78,NA,NA,mm3,SE,3.890410959,4.796549975,19.26040498,0.977189497,21.50651994,mNSS,10.92,NR,9.65,NR,SE,2184,Yes,Yes
Choi_2016_a,"Choi, Y. K.",2016,Effect of human mesenchymal stem cell transplantation on cerebral ischemic volume-controlled photothrombotic mouse model,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,3,5,0,NA,NA,NA,Tiletamine-Zolazepam,Xylazine,Skull breached,Frontal cortex,10,mg/ml,NA,3200,K,NA,Halogen lamp,Halogen,560,5,15,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),2.11,0.46,NA,NA,NA,NA,mm3,SD,0.414611621,NA,0.46,0.090389263,NA,None,NA,NA,NA,NA,NA,NA,No,No
Choi_2016_a,"Choi, Y. K.",2016,Effect of human mesenchymal stem cell transplantation on cerebral ischemic volume-controlled photothrombotic mouse model,b,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,3,5,0,NA,NA,NA,Tiletamine-Zolazepam,Xylazine,Skull breached,Frontal cortex,10,mg/ml,NA,3250,K,NA,Halogen lamp,Halogen,560,5,15,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),2.6,0.59,NA,NA,NA,NA,mm3,SD,0.510895836,NA,0.59,0.115934055,NA,None,NA,NA,NA,NA,NA,NA,No,No
Choi_2016_a,"Choi, Y. K.",2016,Effect of human mesenchymal stem cell transplantation on cerebral ischemic volume-controlled photothrombotic mouse model,c,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,3,5,0,NA,NA,NA,Tiletamine-Zolazepam,Xylazine,Skull breached,Frontal cortex,10,mg/ml,NA,3300,K,NA,Halogen lamp,Halogen,560,5,15,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),3.13,0.34,NA,NA,NA,NA,mm3,SD,0.615039987,NA,0.34,0.066809456,NA,None,NA,NA,NA,NA,NA,NA,No,No
Choy_2016,"Choy, F. C.",2016,"Reduction of the neuroprotective transcription factor Npas4 results in increased neuronal necrosis, inflammation and brain lesion size following ischaemia",a,Mouse,C57BL/6,Male,None,NA,14,14.5,15,NR,NR,NR,2,9,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Forelimb motor cortex,100,mg/kg,100,240,lumens,NA,LED,LED,500-570,2.5,10,None,NA,NA,NA,NA,NA,96,Other histology (ex vivo),14.38,4.43,NA,NA,NA,NA,Direct rLV % hemisphere,SD,7.19,NA,4.43,2.215,NA,None,NA,NA,NA,NA,NA,NA,No,No
Choy_2016,"Choy, F. C.",2016,"Reduction of the neuroprotective transcription factor Npas4 results in increased neuronal necrosis, inflammation and brain lesion size following ischaemia",b,Mouse,Npas4 knockout,Male,None,NA,14,14.5,15,NR,NR,NR,2,8,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Forelimb motor cortex,100,mg/kg,100,240,lumens,NA,LED,LED,500-570,2.5,10,None,NA,NA,NA,NA,NA,96,Other histology (ex vivo),20.9,4.26,NA,NA,NA,NA,Direct rLV % hemisphere,SD,10.45,NA,4.26,2.13,NA,None,NA,NA,NA,NA,NA,NA,No,No
Clarkson_2018,"Clarkson, A. N.",2018,"The flavonoid, 2'-methoxy-6-methylflavone, affords neuroprotection following focal cerebral ischaemia",a,Mouse,C57BL/6,Male,None,NA,8,10,12,25,26,27,1,5,3,5,3,1.666666667,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,g/L,76.92307692,NR,NA,NA,LCD,NR,NR,2,15,2'MeO6MF,Anti-inflammation,60,mg/kg,1,After stroke,168,Other histology (ex vivo),2.23,0.26,0.89,0.54,NA,NA,mm3,SD,0.438191429,0.174883575,0.26,0.051089584,0.54,None,NA,NA,NA,NA,NA,NA,No,Yes
Comelli_1993,"Comelli, M. C.",1993,"Time course, localization and pharmacological modulation of immediate early inducible genes, brain-derived neurotrophic factor and trkB messenger RNAs in the rat brain following photochemical stroke",a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,275,300,1,9,1,10,1,9,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,80,mg/kg/ml,NA,NR,NA,NA,NR,NR,NR,5,60,MK-801 (dizocilpine maleate),Excitotoxicity,1,mg/kg,-1,Before stroke,24,NR,36.62,3.58,33.92,2.82,NA,NA,mm3,NR,1.857940132,1.720953831,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Cruz_2017,"Cruz, S. A.",2017,Loss of IRF2BP2 in Microglia Increases Inflammation and Functional Deficits after Focal Ischemic Brain Injury,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,1,12.5,1,12.5,1,12.5,Isoflurane,NA,"Scalp retracted, skull intact",NR,100,mg/kg,100,20,mW,NA,Green laser,Diode-pumped solid state laser,532,NR,10,IFN? (Interferon beta),Anti-inflammation,10000,"""units""",0.5,After stroke,NR,NR,2.59,0.22,1.9,0.11,NA,NA,mm3,SEM,0.508930852,0.373346957,0.777817459,0.152839885,0.38890873,None,NA,NA,NA,NA,NA,NA,No,No
Cruz_2017,"Cruz, S. A.",2017,Loss of IRF2BP2 in Microglia Increases Inflammation and Functional Deficits after Focal Ischemic Brain Injury,b,Mouse,IRF2BP2 knockout,Male,None,NA,NR,8,NR,NR,NR,NR,1,12.5,1,12.5,1,12.5,Isoflurane,NA,"Scalp retracted, skull intact",NR,100,mg/kg,100,20,mW,NA,Green laser,Diode-pumped solid state laser,532,NR,10,IFN? (Interferon beta),Anti-inflammation,10000,"""units""",0.5,After stroke,NR,NR,3.23,0.22,2.89,0.68,NA,NA,mm3,SEM,0.634689827,0.567880372,0.777817459,0.152839885,2.404163056,None,NA,NA,NA,NA,NA,NA,No,No
Cruz_2018,"Cruz, S. A.",2018,"Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury",a,Mouse,C57BL/6,Male,None,NA,8,10,12,NR,33,NR,1,8,1,8,1,8,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,100,mg/kg,100,20,mW,NA,Green laser,Diode-pumped solid state laser,532,NR,10,Dabrafenib,Anti-apoptosis/regeneration,25,mg/kg,1,After stroke,24,Other histology (ex vivo),6.77,0.43,5.01,0.51,NA,NA,Indirect rLV % whole brain,SEM,6.77,5.01,1.216223664,1.216223664,1.442497834,None,NA,NA,NA,NA,NA,NA,Yes,No
Cybulska-Klosowicz_2011,"Cybulska-Klosowicz, A.",2011,Matrix metalloproteinase inhibition counteracts impairment of cortical experience-dependent plasticity after photothrombotic stroke,a,Mouse,C57BL/6,NR,None,NA,NR,8,NR,NR,NR,NR,1,3,1,3,1,3,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mg/ml,NA,2750,K,NA,LCD,NR,560,1.5,20,FN-439 (tetrapeptidyl hydroxamic acid),Anti-inflammation,10,mg/kg,0,During stroke,168,Other histology (ex vivo),2.23,0.9,2.11,0.5,NA,NA,mm3,SD,0.438191429,0.414611621,0.9,0.176848559,0.5,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1990,"De Ryck, M.",1990,Animal models of cerebral stroke: pharmacological protection of function,a,Rat,NR,NR,None,NA,NR,NR,NR,NR,NR,NR,1,NR,1,NR,1,NA,NR,NA,NR,Hindlimb sensorimotor cortex,NR,NA,NA,NR,NA,NA,NR,NR,NR,NR,NR,Flunarizine,Blood flow,1.25,mg/kg,0.5,After stroke,4,NR,7.01,0.71,4.81,0.74,NA,NA,mm3,NR,0.355657027,0.244038559,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
De Ryck_1996,"De Ryck, M.",1996,Lubeluzole protects sensorimotor function and reduces infarct size in a photochemical stroke model in rats,a,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,12,3,12,3,4,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,30,mg/kg,30,35,klux,0.00512435,Halogen lamp,Halogen,NR,1.3,5,Lubeluzole,Excitotoxicity,0.94,mg/kg,0.08,After stroke,4,Other histology (ex vivo),27.1,6.2,20.7,4.2,-24,NA,mm3,SD,1.37493658,1.050228311,6.2,0.314561136,4.2,None,NA,NA,NA,NA,NA,NA,Yes,Yes
De Ryck_1996,"De Ryck, M.",1996,Lubeluzole protects sensorimotor function and reduces infarct size in a photochemical stroke model in rats,b,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,12,3,12,3,4,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,30,mg/kg,30,35,klux,0.00512435,Halogen lamp,Halogen,NR,1.3,5,Lubeluzole R-isomer,Excitotoxicity,0.94,mg/kg,0.08,After stroke,4,Other histology (ex vivo),27.1,6.2,29.2,3.6,8,NA,mm3,SD,1.37493658,1.481481481,6.2,0.314561136,3.6,None,NA,NA,NA,NA,NA,NA,Yes,No
De Ryck_2000,"De Ryck, M.",2000,Diffusion-weighted MRI of infarct growth in a rat photochemical stroke model: effect of lubeluzole,a,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,10,1,11,1,10,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,30,mg/kg,30,35,klux,0.00512435,Halogen lamp,Halogen,NR,1.3,5,Lubeluzole,Excitotoxicity,0.62,mg/kg,1,After stroke,6,MRI (in vivo),27.2,5.7,30.5,7.1,-18.4,NA,mm3,SEM,1.380010147,1.547437849,18.02498266,0.914509521,23.54803601,None,NA,NA,NA,NA,NA,NA,Yes,No
De Ryck_1989,"De Ryck, M.",1989,Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats,a,Rat,Wistar,Male,None,NA,NR,NR,NR,270,295,320,3,8,3,8,1,8,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,20,mg/kg,20,90,W,NA,Halogen lamp,Halogen,NR,1,20,Flunarizine,Blood flow,1.25,mg/kg,0.5,After stroke,4,Other histology (ex vivo),7.01,0.71,4.81,0.74,NA,NA,mm3,SEM,0.355657027,0.244038559,2.008183259,0.101886517,2.093036072,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Demougeot_2004_a,"Demougeot, C.",2004,Effect of diets with different magnesium content in ischemic stroke rats,a,Rat,Wistar,Male,None,NA,NR,NR,NR,NR,100,NR,1,8,2,7,2,4,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,10,mg/kg,10,NR,NA,NA,Argon laser,Argon laser,570,2,3,Magnesium,Multiple mechanisms,0.015,% in diet,-924,Before stroke,24,Other histology (ex vivo),20.2,2,29.3,2.3,NA,NA,mm3,SEM,1.024860477,1.486555048,5.656854249,0.287004274,6.085228015,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Abo_2003,"Abo, M.",2003,Behavioural recovery correlated with MRI in a rat experimental stroke model,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,200,220,240,1,6,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,80,mg/kg,80,150,W,NA,Halogen lamp,Halogen,NR,8,15,None,NA,NA,NA,NA,NA,12,MRI (in vivo),13.71,0.42,NA,NA,NA,NA,Direct rLV % whole brain,SEM,13.71,NA,1.028785692,1.028785692,NA,None,NA,NA,NA,NA,NA,NA,Yes,NA
Alamri_2018,"Alamri, F. F.",2018,Applicability of the grip strength and automated von Frey tactile sensitivity tests in the mouse photothrombotic model of stroke,a,Mouse,CD-1,Male,None,NA,NR,12,NR,NR,NR,NR,1,10,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mL/kg,80,NR,NR,NA,Halogen lamp,Halogen,NR,2,15,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),1.73,0.45,NA,NA,NA,NA,mm3,SD,0.339942229,NA,0.45,0.088424279,NA,None,NA,NA,NA,NA,NA,NA,No,NA
Alaverdashvili_2015,"Alaverdashvili, M.",2015,Laser system refinements to reduce variability in infarct size in the rat photothrombotic stroke model,a,Rat,Sprague-Dawley,Male,None,NA,13,13.5,14,NR,NR,NR,1,5,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull thinned,Motor cortex,10,mg/kg,10,36,mW,NA,NR,NR,532,3,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),17.51,1.44,NA,NA,NA,NA,mm2,SD,NA,NA,1.44,NA,NA,None,NA,NA,NA,NA,NA,NA,No,NA
Balbi_2017,"Balbi, M.",2017,Targeted ischemic stroke induction and mesoscopic imaging assessment of blood flow and ischemic depolarization in awake mice,a,Mouse,GCaMP3,Mixed,None,NA,16,18,20,NR,NR,NR,1,12,0,NA,NA,NA,Isoflurane,NA,Cranial window (awake induction),Sensorimotor cortex,0.1,cc/10g,NA,11,mW,NA,NR,NR,532,1.2,13,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),NR,NR,NA,NA,NA,NA,mm3,NR,NA,NA,NA,NA,NA,NDS (Neurodeficit Score Evaluation),NR,NR,NR,NR,NR,NR,Yes,NA
Becker_2016,"Becker, A. M.",2016,An automated task for the training and assessment of distal forelimb function in a mouse model of ischemic stroke,a,Mouse,C57BL/6,Mixed,None,NA,25,30,35,20,25,30,1,13,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Forelimb motor cortex,1.5,mg,60,55,mW,NA,NR,NR,561,3,15,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),12.29,5.36,NA,NA,NA,NA,mm3,NR,2.414965318,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,NA
Brima_2013,"Brima, T.",2013,Impacts of perinatal induced photothrombotic stroke on sensorimotor performance in adult rats,a,Rat,Wistar,Male,None,NA,NR,NR,NR,NR,NR,NR,2,7,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,10,mg/ml,NA,50,mW,NA,Green laser,Diode-pumped solid state laser,NR,NR,0.5,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),0.94,0.02,NA,NA,NA,NA,ratio of hemisphere volumes (intact hemisphere/stroke hemisphere) ,SEM,NA,NA,0.052915026,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Brima_2013,"Brima, T.",2013,Impacts of perinatal induced photothrombotic stroke on sensorimotor performance in adult rats,b,Rat,Wistar,Male,None,NA,NR,NR,NR,NR,NR,NR,2,7,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,10,mg/ml,NA,50,mW,NA,Green laser,Diode-pumped solid state laser,NR,NR,5,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),0.79,0.07,NA,NA,NA,NA,ratio of hemisphere volumes (intact hemisphere/stroke hemisphere) ,SEM,NA,NA,0.185202592,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Brown_2003,"Brown, A. W.",2003,Age effect on motor recovery in a post-acute animal stroke model,a,Rat,Fischer 344,Male,None,NA,NR,12,NR,NR,NR,NR,5,7,0,NA,NA,NA,Halothane,NA,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,80,mg/kg,80,150,W,NA,Halogen lamp,Halogen,NR,8,15,None,NA,NA,NA,NA,NA,96,Other histology (ex vivo),43.6,10.3,NA,NA,NA,NA,mm3,SD,2.212075089,NA,10.3,0.522577372,NA,BWS - Feeney Beam Walking Score,19,8.6,NA,NA,SD,720,Yes,No
Brown_2003,"Brown, A. W.",2003,Age effect on motor recovery in a post-acute animal stroke model,b,Rat,Fischer 344,Male,None,NA,NR,24,NR,NR,NR,NR,5,8,0,NA,NA,NA,Halothane,NA,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,80,mg/kg,80,150,W,NA,Halogen lamp,Halogen,NR,8,15,None,NA,NA,NA,NA,NA,96,Other histology (ex vivo),51.3,7.9,NA,NA,NA,NA,mm3,SD,2.602739726,NA,7.9,0.400811771,NA,BWS - Feeney Beam Walking Score,34,15.4,NA,NA,SD,720,Yes,No
Brown_2003,"Brown, A. W.",2003,Age effect on motor recovery in a post-acute animal stroke model,c,Rat,Fischer 344,Male,Aged,NA,NR,52,NR,NR,NR,NR,5,11,0,NA,NA,NA,Halothane,NA,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,80,mg/kg,80,150,W,NA,Halogen lamp,Halogen,NR,8,15,None,NA,NA,NA,NA,NA,96,Other histology (ex vivo),50.6,4.9,NA,NA,NA,NA,mm3,SD,2.567224759,NA,4.9,0.248604769,NA,BWS - Feeney Beam Walking Score,57,12.5,NA,NA,SD,720,Yes,No
Brown_2003,"Brown, A. W.",2003,Age effect on motor recovery in a post-acute animal stroke model,d,Rat,Fischer 344,Male,Aged,NA,NR,78,NR,NR,NR,NR,5,12,0,NA,NA,NA,Halothane,NA,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,80,mg/kg,80,150,W,NA,Halogen lamp,Halogen,NR,8,15,None,NA,NA,NA,NA,NA,96,Other histology (ex vivo),46.2,5.3,NA,NA,NA,NA,mm3,SD,2.343987823,NA,5.3,0.268899036,NA,BWS - Feeney Beam Walking Score,86,30.9,NA,NA,SD,720,Yes,No
Brown_2003,"Brown, A. W.",2003,Age effect on motor recovery in a post-acute animal stroke model,e,Rat,Fischer 344,Male,Aged,NA,NR,104,NR,NR,NR,NR,5,10,0,NA,NA,NA,Halothane,NA,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,80,mg/kg,80,150,W,NA,Halogen lamp,Halogen,NR,8,15,None,NA,NA,NA,NA,NA,96,Other histology (ex vivo),47.1,2.7,NA,NA,NA,NA,mm3,SD,2.389649924,NA,2.7,0.136986301,NA,BWS - Feeney Beam Walking Score,87,NR,NA,NA,SD,720,Yes,No
Buchkremer-Ratzmann_1996,"Buchkremer-Ratzmann, I.",1996,Electrophysiological transcortical diaschisis after cortical photothrombosis in rat brain,a,Rat,Wistar,Male,None,NA,NR,NR,NR,290,300,310,1,35,0,NA,NA,NA,Halothane,NA,"Scalp retracted, skull intact",Sensory cortex,1.3,mg/100g,13,300,W,NA,Fibre-optic,NR,NR,1.5,20,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),2.3,0.3,NA,NA,NA,NA,mm (diameter),SD,NA,NA,0.3,NA,NA,None,NA,NA,NA,NA,NA,NA,No,NA
Buchkremer-Ratzmann_1997_b,"Buchkremer-Ratzmann, I.",1997,Extended brain disinhibition following small photothrombotic lesions in rat frontal cortex,a,Rat,Wistar,NR,None,NA,NR,NR,NR,290,300,310,2,5,0,NA,NA,NA,Nitrous oxide,Enflurane,Skull thinned,NR,1.3,mg/100g,13,NR,NA,NA,Cold light,NR,NR,1.5,20,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),1.6,0.1,NA,NA,NA,NA,mm (rostrocaudal extent of lesion),SD,NA,NA,0.1,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Buchkremer-Ratzmann_1997_b,"Buchkremer-Ratzmann, I.",1997,Extended brain disinhibition following small photothrombotic lesions in rat frontal cortex,b,Rat,Wistar,NR,None,NA,NR,NR,NR,290,300,310,2,5,0,NA,NA,NA,Nitrous oxide,Enflurane,Skull thinned,NR,1.3,mg/100g,13,NR,NA,NA,Cold light,NR,NR,3,20,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),2.6,0.44,NA,NA,NA,NA,mm (rostrocaudal extent of lesion),SD,NA,NA,0.44,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Cai_1998,"Cai, H.",1998,"Photothrombotic middle cerebral artery occlusion in spontaneously hypertensive rats: influence of substrain, gender, and distal middle cerebral artery patterns on infarct size",a,Rat,SHR/Kyushu,Male,None,NA,20,24,28,NR,NR,NR,4,24,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,NR,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),83.8,11.7,NA,NA,NA,NA,mm3,SD,4.251648909,NA,11.7,0.593607306,NA,None,NA,NA,NA,NA,NA,NA,No,No
Cai_1998,"Cai, H.",1998,"Photothrombotic middle cerebral artery occlusion in spontaneously hypertensive rats: influence of substrain, gender, and distal middle cerebral artery patterns on infarct size",b,Rat,SHR/Izm,Male,None,NA,20,24,28,NR,NR,NR,4,15,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,NR,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),61.5,10.7,NA,NA,NA,NA,mm3,SD,3.120243531,NA,10.7,0.542871639,NA,None,NA,NA,NA,NA,NA,NA,No,No
Cai_1998,"Cai, H.",1998,"Photothrombotic middle cerebral artery occlusion in spontaneously hypertensive rats: influence of substrain, gender, and distal middle cerebral artery patterns on infarct size",c,Rat,SHR/Kyushu,Female,None,NA,20,24,28,NR,NR,NR,4,8,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,NR,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),58.5,9.2,NA,NA,NA,NA,mm3,SD,2.96803653,NA,9.2,0.466768138,NA,None,NA,NA,NA,NA,NA,NA,No,No
Cai_1998,"Cai, H.",1998,"Photothrombotic middle cerebral artery occlusion in spontaneously hypertensive rats: influence of substrain, gender, and distal middle cerebral artery patterns on infarct size",d,Rat,SHR/Izm,Female,None,NA,20,24,28,NR,NR,NR,4,5,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,NR,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),34.8,7.9,NA,NA,NA,NA,mm3,SD,1.765601218,NA,7.9,0.400811771,NA,None,NA,NA,NA,NA,NA,NA,No,No
Chen_2008,"Chen, F.",2008,Comparing two methods for assessment of perfusion-diffusion mismatch in a rodent model of ischaemic stroke: a pilot study,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,NR,350,NR,1,8,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),20.5,5.7,NA,NA,NA,NA,Direct rLV % whole brain,SD,20.5,NA,5.7,5.7,NA,None,NA,NA,NA,NA,NA,NA,Yes,NA
Chen_2004_a,"Chen, F.",2004,Rat cerebral ischemia induced with photochemical occlusion of proximal middle cerebral artery: a stroke model for MR imaging research,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,NR,350,NR,1,37,0,NA,NA,NA,Isoflurane,NA,Skull breached,Proximal middle cerebral artery (pMCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),25,3.4,NA,NA,NA,NA,Direct rLV % whole brain,SD,25,NA,3.4,3.4,NA,Bederson Scale,NR,NR,NA,NA,NR,NR,Yes,NA
Chen_2004_b,"Chen, F.",2004,Visualization of stroke with clinical MR imagers in rats: a feasibility study,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,280,335,390,1,12,0,NA,NA,NA,Isoflurane,NA,Skull breached,Proximal middle cerebral artery (pMCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),24.2,3.1,NA,NA,NA,NA,Direct rLV % whole brain,SD,24.2,NA,3.1,3.1,NA,Bederson Scale,NR,NR,NA,NA,NR,NR,Yes,NA
Chen_2005,"Chen, F.",2005,Dynamic susceptibility contrast-enhanced perfusion MR imaging at 1.5 T predicts final infarct size in a rat stroke model,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,NR,350,NR,1,15,0,NA,NA,NA,Isoflurane,NA,Skull breached,Proximal middle cerebral artery (pMCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),25.1,3.5,NA,NA,NA,NA,Direct rLV % whole brain,SD,25.1,NA,3.5,3.5,NA,Bederson Scale,NR,NR,NA,NA,NR,NR,Yes,NA
Chen_2007_c,"Chen, F.",2007,Delayed perfusion phenomenon in a rat stroke model at 1.5 T MR: an imaging sign parallel to spontaneous reperfusion and ischemic penumbra?,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,NR,350,NR,1,8,0,NA,NA,NA,Isoflurane,NA,Skull breached,Proximal middle cerebral artery (pMCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),33,4.1,NA,NA,NA,NA,Direct rLV % whole brain,SD,33,NA,4.1,4.1,NA,Bederson Scale,3.75,1.4,NA,NA,SD,72,Yes,NA
Choi_2012,"Choi, B. I.",2012,Neurobehavioural deficits correlate with the cerebral infarction volume of stroke animals: a comparative study on ischaemia-reperfusion and photothrombosis models,a,Rat,Sprague-Dawley,Male,None,NA,NR,9,NR,300,325,350,3,15,0,NA,NA,NA,Zoletil,Tiletamine-Zolazepam,"Scalp retracted, skull intact",Parietal sensorimotor neocortex,30,mg/kg,30,10000,lux,0.0014641,Halogen lamp,Halogen,NR,6,5,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),69.95,11.73,NA,NA,NA,NA,mm3,SEM,3.548959919,NA,45.43009465,2.304926162,NA,Modified Garcia Score,NR,NR,NR,NR,NR,NR,No,No
Choi_2012,"Choi, B. I.",2012,Neurobehavioural deficits correlate with the cerebral infarction volume of stroke animals: a comparative study on ischaemia-reperfusion and photothrombosis models,b,Rat,Sprague-Dawley,Male,None,NA,NR,9,NR,300,325,350,3,15,0,NA,NA,NA,Zoletil,Tiletamine-Zolazepam,"Scalp retracted, skull intact",Parietal sensorimotor neocortex,30,mg/kg,30,10000,lux,0.0014641,Halogen lamp,Halogen,NR,6,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),134.53,12.15,NA,NA,NA,NA,mm3,SEM,6.825469305,NA,47.05674766,2.387455487,NA,Modified Garcia Score,NR,NR,NR,NR,NR,NR,No,No
Choi_2012,"Choi, B. I.",2012,Neurobehavioural deficits correlate with the cerebral infarction volume of stroke animals: a comparative study on ischaemia-reperfusion and photothrombosis models,c,Rat,Sprague-Dawley,Male,None,NA,NR,9,NR,300,325,350,3,15,0,NA,NA,NA,Zoletil,Tiletamine-Zolazepam,"Scalp retracted, skull intact",Parietal sensorimotor neocortex,30,mg/kg,30,10000,lux,0.0014641,Halogen lamp,Halogen,NR,6,20,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),153.94,13.88,NA,NA,NA,NA,mm3,SEM,7.810248605,NA,53.75700885,2.727397709,NA,Modified Garcia Score,NR,NR,NR,NR,NR,NR,No,No
Choi_2016_b,"Choi, Yun-Kyong",2016,Human mesenchymal stem cell transplantation promote neural differentiation and behavioral performance in the photothrombotic mouse model,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,3,5,0,NA,NA,NA,Tiletamine-Zolazepam,Xylazine,Skull breached,Frontal cortex,10,mg/ml,NA,3200,K,NA,Cold light,NR,560,5,15,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),2.11,0.46,NA,NA,NA,NA,mm3,SD,0.414611621,NA,0.46,0.090389263,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Choi_2016_b,"Choi, Yun-Kyong",2016,Human mesenchymal stem cell transplantation promote neural differentiation and behavioral performance in the photothrombotic mouse model,b,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,3,5,0,NA,NA,NA,Tiletamine-Zolazepam,Xylazine,Skull breached,Frontal cortex,10,mg/ml,NA,3250,K,NA,Cold light,NR,560,5,15,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),2.225,0.975,NA,NA,NA,NA,mm3,SD,0.437208937,NA,0.975,0.191585939,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Choi_2016_b,"Choi, Yun-Kyong",2016,Human mesenchymal stem cell transplantation promote neural differentiation and behavioral performance in the photothrombotic mouse model,c,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,3,5,0,NA,NA,NA,Tiletamine-Zolazepam,Xylazine,Skull breached,Frontal cortex,10,mg/ml,NA,3300,K,NA,Cold light,NR,560,5,15,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),3.128,0.342,NA,NA,NA,NA,mm3,SD,0.614646991,NA,0.342,0.067202452,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Clarkson_2010,"Clarkson, A. N.",2010,Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke,a,Mouse,C57BL/6,Male,None,NA,8,10,12,NR,NR,NR,1,4,2,4,2,2,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mg/ml,NA,NR,NA,NA,Cold light,NR,NR,4.5,15,"L655,708",Nootropics/cognition,0.8,mg/kg,0,During stroke,168,NR,0.99,0.12,1.61,0.08,NA,NA,mm3,SEM,0.194533415,0.316362422,0.24,0.047159616,0.16,None,NA,NA,NA,NA,NA,NA,No,Yes
Clarkson_2013,"Clarkson, A. N.",2013,Multimodal examination of structural and functional remapping in the mouse photothrombotic stroke model,a,Mouse,C57BL/6,Male,None,NA,8,10,12,28,30,32,2,4,0,NA,NA,NA,NR,NA,"Scalp retracted, skull intact",NR,NR,NA,NA,NR,NA,NA,Cold light,NR,NR,NR,15,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),0.983,0.129,NA,NA,NA,NA,mm3,SEM,0.193157926,NA,0.258,0.050696587,NA,None,NA,NA,NA,NA,NA,NA,No,No
Clarkson_2013,"Clarkson, A. N.",2013,Multimodal examination of structural and functional remapping in the mouse photothrombotic stroke model,b,Mouse,C57BL/6,Male,None,NA,8,10,12,28,30,32,2,4,0,NA,NA,NA,NR,NA,"Scalp retracted, skull intact",NR,NR,NA,NA,NR,NA,NA,Cold light,NR,NR,NR,18,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),1.514,0.155,NA,NA,NA,NA,mm3,SEM,0.297498575,NA,0.31,0.060914504,NA,None,NA,NA,NA,NA,NA,NA,No,No
Clarkson_2011,"Clarkson, Andrew N.",2011,AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,4,2,4,2,2,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,Cold light,NR,NR,4.5,15,CX1837,Nootropics/cognition,168,mg/kg,4,During stroke,168,NR,0.98,0.13,1.89,0.38,NA,NA,mm3,SEM,0.192568431,0.371381973,0.26,0.051089584,0.76,None,NA,NA,NA,NA,NA,NA,No,Yes
Cotrina_2017,"Cotrina, M. L.",2017,Direct comparison of microglial dynamics and inflammatory profile in photothrombotic and arterial occlusion evoked stroke,a,Mouse,Cx3CR1-GFP,Mixed,None,NA,NR,8,NR,NR,NR,NR,1,4,0,NA,NA,NA,NR,NA,Skull thinned,Middle cerebral artery (MCA),10,g/L,NA,0.01,mW,NA,Green laser,Diode-pumped solid state laser,NR,NR,15,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),27.06,6.95,NA,NA,NA,NA,Direct rLV % hemisphere,SEM,13.53,NA,13.9,6.95,NA,None,NA,NA,NA,NA,NA,NA,Yes,NA
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,a,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,6,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Primary forelimb somatosensory cortex (S1FL),35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,2,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),9.78,0.33,NA,NA,NA,NA,mm3,SEM,0.496194825,NA,0.808331615,0.041011244,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,b,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,6,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Primary forelimb somatosensory cortex (S1FL),35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,2,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),11.5,0.62,NA,NA,NA,NA,mm3,SEM,0.583460173,NA,1.518683641,0.077051428,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,c,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,6,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Primary forelimb somatosensory cortex (S1FL),35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,2,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),11.98,1.09,NA,NA,NA,NA,mm3,SEM,0.607813293,NA,2.66994382,0.135461381,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,d,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,6,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Primary forelimb somatosensory cortex (S1FL),35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,2,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),8.72,0.77,NA,NA,NA,NA,mm3,SEM,0.442415018,NA,1.886107102,0.095692902,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,e,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,6,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Primary forelimb somatosensory cortex (S1FL),35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,2,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),8.74,1.2,NA,NA,NA,NA,mm3,SEM,0.443429731,NA,2.939387691,0.149131796,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,f,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,6,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Primary forelimb somatosensory cortex (S1FL),35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,2,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),8.72,0.77,NA,NA,NA,NA,mm3,SEM,0.442415018,NA,1.886107102,0.095692902,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,g,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,12,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Primary forelimb somatosensory cortex (S1FL),35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,2,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),28.19,3.41,NA,NA,NA,NA,mm3,SEM,1.430238458,NA,11.81258651,0.599319458,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,h,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,8,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,1,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),7.8,0.42,NA,NA,NA,NA,mm3,SEM,0.395738204,NA,1.187939392,0.060270898,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,i,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,6,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Medical agranular neocortex parietal forelimb,35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,1,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),3.71,0.57,NA,NA,NA,NA,mm3,SEM,0.188229325,NA,1.396209153,0.070837603,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,j,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,10,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Medical agranular neocortex parietal hindlimb,35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,1,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),4.84,0.85,NA,NA,NA,NA,mm3,SEM,0.245560629,NA,2.687936011,0.136374227,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,k,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,12,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Primary somatosensory neocortex,35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,2,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),11.3,2.6,NA,NA,NA,NA,mm3,SEM,0.573313039,NA,9.006664199,0.456959117,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,l,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,12,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Primary somatosensory neocortex,35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,2,5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),11.4,1.1,NA,NA,NA,NA,mm3,SEM,0.578386606,NA,3.810511777,0.193328857,NA,None,NA,NA,NA,NA,NA,NA,No,No
De Ryck_1992,"De Ryck, M.",1992,Neocortical localization of tactile/proprioceptive limb placing reactions in the rat,m,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,6,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Occipital neocortex,35,mg/kg,35,NR,NA,NA,Cold light,NR,NR,2,10,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),29.1,4.1,NA,NA,NA,NA,mm3,SEM,1.476407915,NA,10.04290795,0.509533635,NA,None,NA,NA,NA,NA,NA,NA,No,No
Demougeot_2003,"Demougeot, C.",2003,Reversible loss of N-acetyl-aspartate in rats subjected to long-term focal cerebral ischemia,a,Rat,Wistar,Male,None,NA,NR,NR,NR,300,310,320,1,5,0,NA,NA,NA,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,90,mW,NA,Diode-pumped solid state laser,Diode-pumped solid state laser,532,1,5,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),73.4,6.1,NA,NA,NA,NA,mm3,SD,3.723997971,NA,6.1,0.30948757,NA,None,NA,NA,NA,NA,NA,NA,yes,NA
Demougeot_2004_b,"Demougeot, C.",2004,"Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model",a,Rat,Wistar,Male,None,NA,NR,NR,NR,350,400,450,1,5.5,1,5.5,1,5.5,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,90,mW,NA,Diode-pumped solid state laser,Diode-pumped solid state laser,532,1,5,"2,2'-Dipyridyl (2,2'-Bipyridine)",Anti-oxidants,40,mg/kg,-0.25,Before stroke,24,Other histology (ex vivo),70.55,2.09,39.4,3.78,NA,NA,mm3,SEM,3.579401319,1.998985287,4.901484469,0.248680085,8.864885786,None,NA,NA,NA,NA,NA,NA,Yes,No
Demyanenko_2018_a,"Demyanenko, S.",2018,Expression of Class I Histone Deacetylases in Ipsilateral and Contralateral Hemispheres after the Focal Photothrombotic Infarction in the Mouse Brain,a,Mouse,CD-1,Male,None,NA,14,14.5,15,20,22.5,25,1,5,0,NA,NA,NA,Chloral hydrate,NA,"Scalp retracted, skull intact",Sensorimotor cortex,10,ug/g,10,0.2,W/cm2,0.2,Diode laser,Diode laser,532,1,15,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),17.93,3.23,NA,NA,NA,NA,Indirect rLV % hemisphere,SEM,8.965,NA,7.222499567,3.611249784,NA,None,NA,NA,NA,NA,NA,NA,Yes,NA
Demyanenko_2017,"Demyanenko, S.",2017,Profiling of Signaling Proteins in Penumbra After Focal Photothrombotic Infarct in the Rat Brain Cortex,a,Rat,Wistar,Male,None,NA,NR,NR,NR,200,225,250,1,3,0,NA,NA,NA,Chloral hydrate,NA,"Scalp retracted, skull intact",Somatosensory cortex,20,mg/kg,20,64,mW/cm2,0.064,Diode laser,Diode laser,532,3,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),31,2,NA,NA,NA,NA,mm3,SEM,1.572805682,NA,3.464101615,0.175753507,NA,None,NA,NA,NA,NA,NA,NA,Yes,NA
Demyanenko_2018_b,"Demyanenko, S. V.",2018,The Focal-Focal Preconditioning Effect of Photothrombotic Impact on the Signaling Protein Profile in the Penumbra Surrounding the Ischemic Core Induced by Another Photothrombotic Impact,a,Rat,Wistar,Male,None,NA,NR,NR,NR,200,225,250,1,6,0,NA,NA,NA,Chloral hydrate,NA,"Scalp retracted, skull intact",Somatosensory cortex,20,mg/kg,20,64,mW/cm2,0.064,Diode laser,Diode laser,532,3,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),27.8,1.3,NA,NA,NA,NA,mm3,SEM,1.410451547,NA,3.184336666,0.161559445,NA,None,NA,NA,NA,NA,NA,NA,Yes,NA
Deng_2017,"Deng, G.",2017,Delayed administration of guanosine improves longterm functional recovery and enhances neurogenesis and angiogenesis in a mouse model of photothrombotic stroke,a,Mouse,C57BL/6,Male,None,NA,8,9,10,20,22.5,25,1,8,1,8,1,8,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,Cold light,NR,NR,4,15,Guanosine (GUO),Multiple mechanisms,56,mg/kg,24,After stroke,168,Other histology (ex vivo),1.22,0.11,1.125,0.12,NA,NA,mm3,SEM,0.239728046,0.221060698,0.311126984,0.061135954,0.339411255,mNSS,7.88,0.7,6.29,1.21,SEM,336,Yes,No
Diederich_2012_a,"Diederich, K.",2012,Citicoline enhances neuroregenerative processes after experimental stroke in rats,a,Rat,Wistar,Male,None,NA,NR,NR,NR,270,290,310,1,9,1,10,1,9,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,10,mg/ml,1.33,NR,NA,NA,NR,NR,NR,8,20,Citicoline,Other,1000,mg/kg,24,After stroke,672,Other histology (ex vivo),8.15,2.38,10.78,4.76,NA,NA,mm3,SEM,0.413495687,0.546930492,7.14,0.362252664,15.05244166,None,NA,NA,NA,NA,NA,NA,No,No
Diederich_2012_b,"Diederich, K.",2012,Successful regeneration after experimental stroke by granulocyte-colony stimulating factor is not further enhanced by constraint-induced movement therapy either in concurrent or in sequential combination therapy,a,Rat,Wistar,Male,None,NA,NR,NR,NR,280,300,320,1,20,4,20,4,5,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,10,mg/ml,3,NR,NA,NA,NR,NR,NR,8,20,CIMT (Constraint-induced movement therapy),Other,NA,NA,48,After stroke,672,Other histology (ex vivo),3.63,1.24,4.57,1.09,NA,NA,mm2,SEM,NA,NA,5.545448584,NA,4.874628191,None,NA,NA,NA,NA,NA,NA,No,Yes
Diederich_2012_b,"Diederich, K.",2012,Successful regeneration after experimental stroke by granulocyte-colony stimulating factor is not further enhanced by constraint-induced movement therapy either in concurrent or in sequential combination therapy,b,Rat,Wistar,Male,None,NA,NR,NR,NR,280,300,320,1,20,4,20,4,5,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,10,mg/ml,3,NR,NA,NA,NR,NR,NR,8,20,G-CSF (Granulocyte-colony stimulating factor),Blood flow,110,ug/kg,48,After stroke,672,Other histology (ex vivo),3.63,1.24,4.76,1.89,NA,NA,mm2,SEM,NA,NA,5.545448584,NA,8.452336955,None,NA,NA,NA,NA,NA,NA,No,Yes
Diederich_2014_a,"Diederich, K.",2014,Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,12,12.5,13,260,275,290,1,13,3,14,3,4.333333333,Ketamine,Xylazine,"Scalp retracted, skull intact",Frontal cortex,10,mg/ml,1.33,NR,NA,NA,NR,NR,NR,8,20,G-CSF (Granulocyte-colony stimulating factor),Blood flow,250,ug/kg,1,After stroke,672,Other histology (ex vivo),4.03,0.21,4.25,0.23,NA,NA,mm3,SEM,0.204464739,0.215626585,0.757165768,0.03841531,0.860581199,None,NA,NA,NA,NA,NA,NA,No,Yes
Diederich_2014_a,"Diederich, K.",2014,Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats,b,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,12,12.5,13,260,275,290,1,13,3,14,3,4.333333333,Ketamine,Xylazine,"Scalp retracted, skull intact",Frontal cortex,10,mg/ml,1.33,NR,NA,NA,NR,NR,NR,8,20,BM-MNCs (bone marrow derived mononuclear cells),Blood flow,25,Million,1,After stroke,672,Other histology (ex vivo),4.03,0.21,4,0.24,NA,NA,mm3,SEM,0.204464739,0.202942669,0.757165768,0.03841531,0.897997773,None,NA,NA,NA,NA,NA,NA,No,Yes
Diederich_2014_b,"Diederich, K.",2014,Cortical photothrombotic infarcts impair the recall of previously acquired memories but spare the formation of new ones,a,Rat,Wistar,Male,None,NA,NR,NR,NR,NR,NR,NR,1,19,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,10,mg/ml,1.33,NR,NA,NA,NR,NR,NR,8,20,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),12.92,1.72,NA,NA,NA,NA,mm3,SEM,0.65550482,NA,7.497306183,0.380380831,NA,None,NA,NA,NA,NA,NA,NA,No,NA
Dietrich_1989,"Dietrich, W. D.",1989,Effect of the serotonin antagonist ketanserin on the hemodynamic and morphological consequences of thrombotic infarction,a,Rat,Wistar,Male,None,NA,NR,NR,NR,250,275,300,1,5,1,5,1,5,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,7.5,mg/ml,NA,NR,NA,NA,Xenon lamp,Xenon,560,NR,4,Ketanserin,Blood flow,2,mg/kg,-0.5,Before stroke,120,Other histology (ex vivo),27,6,27,3,NA,NA,mm3,SD,1.369863014,1.369863014,6,0.304414003,3,None,NA,NA,NA,NA,NA,NA,No,No
Ding_2016,"Ding, J.",2016,Bioluminescence imaging of transplanted human endothelial colony-forming cells in an ischemic mouse model,a,Mouse,BALB/c-nu,Male,None,NA,NR,NR,NR,18,20,22,1,NR,1,NR,1,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,100,mg/kg,100,NR,NA,NA,LCD,NR,NR,4,15,ECFCs (Endothelial colony-forming cells),Anti-apoptosis/regeneration,1000000,Cells,24,After stroke,24,MRI (in vivo),14.58,0.99,10.15,0.5,NA,NA,Indirect rLV % hemisphere,SD,7.29,5.075,NA,NA,NA,mNSS,8.46,1.02,5.08,0.98,SD,168,Yes,No
Ding_2009,"Ding, S.",2009,Photothrombosis ischemia stimulates a sustained astrocytic Ca2+ signaling in vivo,a,Mouse,FVB/NJ,Male,None,NA,5,6,7,NR,NR,NR,1,6,1,6,1,6,Urethane,NA,Skull breached,Somatosensory cortex,0.03,mg/g,30,NR,NA,NA,Mercury lamp,Mercury,534,1,2,BAPTA,Excitotoxicity,200,uM,0,During stroke,24,Other histology (ex vivo),NR,NR,NR,NR,-47,NA,NR,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Egea_2014,"Egea, J.",2014,Small synthetic hyaluronan disaccharides afford neuroprotection in brain ischemia-related models,a,Mouse,Swiss,Male,None,NA,12,13,14,35,37.5,40,1,19,2,9,2,9.5,Isoflurane,NA,"Scalp retracted, skull intact",Somatosensory cortex,0.1,mL,NA,NR,NA,NA,LCD,NR,NR,2,20,"High molecular weight (HMW) glycosaminoglycanes (di4,6S)",Anti-oxidants,10,mg/kg,1,After stroke,24,TTC (ex vivo),19.1,1.7,14.27,1.24,-25,NA,% (not specified percentage of),SEM,NA,NA,7.410128204,NA,3.72,None,NA,NA,NA,NA,NA,NA,No,Yes
Elger_1997,"Elger, B.",1997,Magnetic resonance imaging studies on the effect of the fibrinogen-lowering agent ancrod on cerebral lesions in two rat models of acute stroke,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,NR,NR,NR,170,285,400,1,10,2,11,2,5,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",NR,10,mg/kg,10,150,W,NA,Other,Other,NR,3,20,Ancrod,Thrombolytics,30,IU/kg,0.5,After stroke,24,MRI (in vivo),142,28,111,20,NA,NA,mm3,SD,7.204464739,5.631659056,28,1.420598681,20,None,NA,NA,NA,NA,NA,NA,No,Yes
Erdo_2005,"Erdo, F.",2005,The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia,c,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,340,360,380,3,10.5,3,10.5,1,10.5,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,150,W,NA,Halogen lamp,Halogen,NR,4,20,Talampanel,Excitotoxicity,36,mg/kg,0.5,After stroke,24,TTC (ex vivo),20.84,1.68,13.65,1.41,NA,NA,mm2,SEM,NA,NA,5.443822187,NA,4.568922192,None,NA,NA,NA,NA,NA,NA,No,Yes
Feng_2018,"Feng, Y.",2018,"Chronic colitis induces meninges traffic of gut-derived T cells, unbalances M1 and M2 microglia/macrophage and increases ischemic brain injury in mice",a,Mouse,C57BL/6,Female,None,NA,NR,NR,NR,18,19.5,21,1,4.5,0,NA,NA,NA,Sodium Pentobarbital,NA,Cranial window (asleep induction),NR,NR,NA,NA,NR,NA,NA,Cold light,NR,NR,NR,10,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),1.35,0.08,NA,NA,NA,NA,mm3,SEM,0.265272838,NA,0.169705627,0.033346884,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Feng_2018,"Feng, Y.",2018,"Chronic colitis induces meninges traffic of gut-derived T cells, unbalances M1 and M2 microglia/macrophage and increases ischemic brain injury in mice",b,Mouse,C57BL/6,Female,Chronic colitis,DSS (dextran sodium sulfate),NR,NR,NR,18,19.5,21,1,4.5,0,NA,NA,NA,Sodium Pentobarbital,NA,Cranial window (asleep induction),NR,NR,NA,NA,NR,NA,NA,Cold light,NR,NR,NR,10,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),2.4,0.4,NA,NA,NA,NA,mm3,SEM,0.471596156,NA,0.848528137,0.16673442,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Feng_2017,"Feng, Y.",2017,Infiltration and persistence of lymphocytes during late-stage cerebral ischemia in middle cerebral artery occlusion and photothrombotic stroke models,a,Mouse,C57BL/6,Male,None,NA,10,11,12,NR,NR,NR,1,10,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,150,mg/kg,150,NR,NA,NA,LED,LED,NR,4,20,None,NA,NA,NA,NA,NA,24,MRI (in vivo),32.37,2.81,NA,NA,NA,NA,mm3,SEM,6.360653161,NA,8.886000225,1.746084814,NA,mNSS,10.03,1.01,NA,NA,SEM,24,Yes,NA
Fluri_2017,"Fluri, F.",2017,Stimulation of the mesencephalic locomotor region for gait recovery after stroke,a,Rat,Wistar,Male,None,NA,6,7,8,250,262.5,275,1,9,1,9,1,9,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,10,mg/ml,19.04761905,NR,NA,NA,NR,NR,NR,5,15,DBS (Deep brain stimulation),Other,40,uA,72,After stroke,96,MRI (in vivo),72.8,6.4,84.9,9.6,NA,NA,mm3,SD,3.69355657,4.307458143,6.4,0.32470827,9.6,None,NA,NA,NA,NA,NA,NA,No,No
Frieler_2012,"Frieler, R. A.",2012,Myeloid mineralocorticoid receptor during experimental ischemic stroke: effects of model and sex,a,Mouse,Floxed controls (FC),Male,None,NA,NR,NR,NR,25,27.5,30,4,5.5,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),50,mg/kg,50,3.5,mW,NA,Green laser,Diode-pumped solid state laser,540,1,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),50.02,5.459,NA,NA,NA,NA,mm3,SD,9.828849895,NA,5.459259259,1.072735702,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Frieler_2012,"Frieler, R. A.",2012,Myeloid mineralocorticoid receptor during experimental ischemic stroke: effects of model and sex,b,Mouse,MyMRKO,Male,None,NA,NR,NR,NR,25,27.5,30,4,5.5,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),50,mg/kg,50,3.5,mW,NA,Green laser,Diode-pumped solid state laser,540,1,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),54.69,3.637,NA,NA,NA,NA,mm3,SD,10.74649742,NA,3.637037037,0.714671953,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Frieler_2012,"Frieler, R. A.",2012,Myeloid mineralocorticoid receptor during experimental ischemic stroke: effects of model and sex,c,Mouse,Floxed controls (FC),Female,None,NA,NR,NR,NR,25,27.5,30,4,5.5,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),50,mg/kg,50,3.5,mW,NA,Green laser,Diode-pumped solid state laser,540,1,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),42.87,3.467,NA,NA,NA,NA,mm3,SD,8.423886345,NA,3.466666667,0.681194448,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Frieler_2012,"Frieler, R. A.",2012,Myeloid mineralocorticoid receptor during experimental ischemic stroke: effects of model and sex,d,Mouse,MyMRKO,Female,None,NA,NR,NR,NR,25,27.5,30,4,5.5,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),50,mg/kg,50,3.5,mW,NA,Green laser,Diode-pumped solid state laser,540,1,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),42.87,4.704,NA,NA,NA,NA,mm3,SD,8.423886345,NA,4.703703704,0.924270245,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Fukuda_2000,"Fukuda, K.",2000,Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Female,Hypertension,Genetic,NR,20,NR,190,210,230,1,8,2,8,2,4,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,3,4,Ovariectomy (OVX),Harm induction,NA,NA,-672,Before stroke,72,TTC (ex vivo),49.9,19.8,78.5,21,NA,NA,mm3,SD,2.531709792,3.982749873,19.8,1.00456621,21,None,NA,NA,NA,NA,NA,NA,No,Yes
Fukumoto_2009,"Fukumoto, D.",2009,Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in rats: effect of oxygen affinity,a,Rat,Sprague-Dawley,Male,None,NA,10,11,12,270,285,300,1,23,6,7,6,3.833333333,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,NR,3,10,LEH (TRM-645),Energy substrates,120,mg/kg,0,After stroke,24,TTC (ex vivo),10.59,4.23,6.8,0.91,NA,NA,% (not specified percentage of),NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Fukuta_2017,"Fukuta, T.",2017,Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke,a,Rat,Wistar,Male,None,NA,NR,8,NR,180,195,210,1,7,4,7,4,1.75,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),12,mg/kg,12,NR,NA,NA,Green laser,Diode-pumped solid state laser,540,3,10,TPA (tissue plasminogen activator),Thrombolytics,3,mg/kg,0,After stroke,24,TTC (ex vivo),0.31,0.05,0.18,0.02,NA,NA,cm3,SD,15.72805682,9.132420091,0.05,2.536783359,0.02,None,NA,NA,NA,NA,NA,NA,No,Yes
Fukuta_2017,"Fukuta, T.",2017,Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke,b,Rat,Wistar,Male,None,NA,NR,8,NR,180,195,210,1,7.5,5,7.5,5,1.5,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),12,mg/kg,12,NR,NA,NA,Green laser,Diode-pumped solid state laser,540,3,10,Fasudil,Blood flow,5,mg/kg,1,After stroke,24,TTC (ex vivo),0.31,0.03,0.25,0.03,NA,NA,cm3,SD,15.72805682,12.68391679,0.03,1.522070015,0.03,Other,7.54,1.16,10.54,0.84,SD,24,No,Yes
Fukuta_2018,"Fukuta, T.",2018,Co-administration of liposomal fasudil and tissue plasminogen activator ameliorated ischemic brain damage in occlusion model rats prepared by photochemically induced thrombosis,a,Rat,Wistar,Male,None,NA,NR,8,NR,180,195,210,1,6,3,6,3,2,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),12,mg/kg,12,NR,NA,NA,Green laser,Diode-pumped solid state laser,540,NR,10,TPA (tissue plasminogen activator),Thrombolytics,3,mg/kg,3,After stroke,24,TTC (ex vivo),0.31,0.03,0.29,0.04,NA,NA,cm3,SD,15.72805682,14.71334348,0.03,1.522070015,0.04,Other,7.65,1.04,9.17,1.56,SD,24,No,Yes
Fukuta_2018,"Fukuta, T.",2018,Co-administration of liposomal fasudil and tissue plasminogen activator ameliorated ischemic brain damage in occlusion model rats prepared by photochemically induced thrombosis,b,Rat,Wistar,Male,None,NA,NR,8,NR,180,195,210,1,6,3,6,3,2,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),12,mg/kg,12,NR,NA,NA,Green laser,Diode-pumped solid state laser,540,NR,10,Fasudil,Blood flow,2.5,mg/kg,3,After stroke,24,TTC (ex vivo),0.31,0.03,0.28,0.04,NA,NA,cm3,SD,15.72805682,14.20598681,0.03,1.522070015,0.04,Other,7.65,1.04,9,0.88,SD,24,No,Yes
Furuichi_2003,"Furuichi, Y.",2003,"Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primates",a,Primate,"Cynomolgus monkey (Macaca fascicularis, crab-eating macaque)",Male,None,NA,156,208,260,3100,4300,5500,1,6,4,6,4,1.5,Nitrous oxide,Ketamine,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,4000000,lux,0.58564,Xenon lamp,Xenon,540,NR,20,FK506 (Tacrolimus),Other,0.1,mg/kg,0,During stroke,24,Other histology (ex vivo),6281,2166,1994,1032,NA,NA,mm3,SD,NA,NA,2166,NA,1032,Other,58.59,19.56,29.02,14.35,SD,22,Yes,Yes
Furuichi_2007,"Furuichi, Y.",2007,Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator,a,Primate,"Cynomolgus monkey (Macaca fascicularis, crab-eating macaque)",Male,None,NA,156,208,260,3100,4300,5500,1,8,3,8,3,2.666666667,Nitrous oxide,Ketamine,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,4000000,lux,0.58564,Xenon lamp,Xenon,540,NR,20,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,1,mg/kg,2,After stroke,672,Other histology (ex vivo),4625,481,4298,865,NA,NA,mm3,SE,NA,NA,1360.473447,NA,2446.589463,Other,NR,NR,NR,NR,SE,NR,Yes,Yes
Furuichi_2007,"Furuichi, Y.",2007,Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator,b,Primate,"Cynomolgus monkey (Macaca fascicularis, crab-eating macaque)",Male,None,NA,156,208,260,3100,4300,5500,1,8,3,8,3,2.666666667,Nitrous oxide,Ketamine,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,4000000,lux,0.58564,Xenon lamp,Xenon,540,NR,20,FK506 (Tacrolimus),Other,0.2,mg/kg,2,After stroke,672,Other histology (ex vivo),4625,481,1952,173,NA,NA,mm3,SE,NA,NA,1360.473447,NA,489.3178926,Other,NR,NR,NR,NR,SE,NR,Yes,Yes
Gaser_2012,"Gaser, C.",2012,Deformation-based brain morphometry in rats,a,Rat,HanWist,Male,None,NA,NR,12,NR,NR,NR,NR,1,10,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Motor cortex,1.3,mg/100mg,NA,NR,NA,NA,Halogen lamp,Halogen,NR,3,20,None,NA,NA,NA,NA,NA,NR,MRI (in vivo),NR,NR,NA,NA,NA,NA,NR,SEM,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Gaser_2012,"Gaser, C.",2012,Deformation-based brain morphometry in rats,b,Rat,HanWist,Male,Aged,NA,NR,104,NR,NR,NR,NR,1,15,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Motor cortex,1.3,mg/100mg,NA,NR,NA,NA,Halogen lamp,Halogen,NR,3,20,None,NA,NA,NA,NA,NA,NR,MRI (in vivo),NR,NR,NA,NA,NA,NA,NR,SEM,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Geibig_2012,"Geibig, C. S.",2012,Functional recruitment of newborn hippocampal neurons after experimental stroke,a,Mouse,C57BL/6,Male,None,NA,11,12,13,20,25,30,1,7,2,6,2,3.5,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,10,mg/ml,120,NR,NA,NA,Cold light,NR,NR,1.8,15,Enriched cage environment,Other,NA,NA,NA,NA,1344,Other histology (ex vivo),0.65,0.11,0.87,0.21,NA,NA,mm3,SEM,0.127723959,0.170953607,0.291032644,0.057187449,0.514392846,None,NA,NA,NA,NA,NA,NA,No,Yes
Geibig_2012,"Geibig, C. S.",2012,Functional recruitment of newborn hippocampal neurons after experimental stroke,b,Mouse,C57BL/6,Male,None,NA,11,12,13,20,25,30,1,7,2,4,2,3.5,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,10,mg/ml,120,NR,NA,NA,Cold light,NR,NR,1.8,15,Exercise cage environment,Other,NA,NA,NA,NA,1344,Other histology (ex vivo),0.65,0.11,0.73,0.11,NA,NA,mm3,SEM,0.127723959,0.143443831,0.291032644,0.057187449,0.22,None,NA,NA,NA,NA,NA,NA,No,Yes
Ginsberg_1989,"Ginsberg, M. D.",1989,Acute thrombotic infarction suppresses metabolic activation of ipsilateral somatosensory cortex: evidence for functional diaschisis,a,Rat,Wistar,Male,None,NA,NR,NR,NR,255,300,345,1,5,1,5,1,5,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Frontal cortex,7.5,mg/ml,9.975,NR,NA,NA,Xenon lamp,Xenon,560,NR,2,Vibrissae-barrel-field stimulation,Other,NA,NA,NR,NR,120,Other histology (ex vivo),2.8,0.5,3.6,1.3,NA,NA,mm2,SD,NA,NA,0.5,NA,1.3,None,NA,NA,NA,NA,NA,NA,No,No
Ginsberg_1987,"Ginsberg, M. D.",1987,Hyperglycemia reduces the extent of cerebral infarction in rats,a,Rat,Wistar,Male,Hyperglycemia,Dextrose treatment,NR,NR,NR,275,312.5,350,1,5,2,13,2,2.5,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,1,mg/100g,10,0.58,W/cm2,0.58,Xenon lamp,Xenon,560,NR,2,Dextrose,Energy substrates,1.5,ml,NR,Before stroke,168,Other histology (ex vivo),10.2,2.2,9.3,3.3,NA,NA,mm3,SD,0.517503805,0.471841705,2.2,0.111618468,3.3,None,NA,NA,NA,NA,NA,NA,No,No
Ginsberg_1987,"Ginsberg, M. D.",1987,Hyperglycemia reduces the extent of cerebral infarction in rats,b,Rat,Wistar,Male,None,NA,NR,NR,NR,275,312.5,350,1,5,2,7,2,2.5,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,1,mg/100g,10,0.58,W/cm2,0.58,Xenon lamp,Xenon,560,NR,2,Mannitol,Other,2.8,ml,NR,Before stroke,168,Other histology (ex vivo),10.2,2.2,18.3,2.5,NA,NA,mm3,SD,0.517503805,0.928462709,2.2,0.111618468,2.5,None,NA,NA,NA,NA,NA,NA,No,No
Gorlamandala_2018,"Gorlamandala, N.",2018,Focal Ischaemic Infarcts Expand Faster in Cerebellar Cortex than Cerebral Cortex in a Mouse Photothrombotic Stroke Model,a,Mouse,129/SvEv,Mixed,None,NA,5,7,9,18,21.5,25,2,3,0,NA,NA,NA,Isoflurane,NA,Skull thinned,Cerebral cortex,50,mg/kg,50,3,mW,NA,NR,NR,532,2,6,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),6.29,1.95,NA,NA,NA,NA,mm3,SEM,1.235974927,NA,3.377499075,0.663673159,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Gorlamandala_2018,"Gorlamandala, N.",2018,Focal Ischaemic Infarcts Expand Faster in Cerebellar Cortex than Cerebral Cortex in a Mouse Photothrombotic Stroke Model,b,Mouse,129/SvEv,Mixed,None,NA,5,7,9,18,21.5,25,2,3,0,NA,NA,NA,Isoflurane,NA,Skull thinned,Cerebellum,50,mg/kg,50,3,mW,NA,NR,NR,532,2,6,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),18.85,3.92,NA,NA,NA,NA,mm3,SEM,3.703994812,NA,6.789639166,1.334153223,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Grome_1988,"Grome, J. J.",1988,Quantitation of photochemically induced focal cerebral ischemia in the rat,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,300,325,350,5,10,0,NA,NA,NA,Halothane,NA,"Scalp retracted, skull intact",NR,5,mg/ml,15.38461538,NR,NA,NA,Xenon lamp,Xenon,570,3,15,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),50,16,NA,NA,NA,NA,ul,SD,2.536783359,NA,16,0.811770675,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Guan_2001,"Guan, X.",2001,"Metabolic changes in rats with photochemically induced cerebral infarction and the effects of batroxobin: a study by magnetic resonance imaging, 1H- and 31P-magnetic resonance spectroscopy",a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,180,200,220,1,6,1,6,1,6,Chloral hydrate,NA,"Scalp retracted, skull intact",Temporal neocortex,20,mg/kg,20,120,W,NA,Halogen lamp,Halogen,NR,3,20,Batroxobin,Thrombolytics,8,BU/kg,-0.17,Before stroke,24,MRI (in vivo),158.3,27.9,107.5,24.2,NA,NA,mm3,SD,8.031456114,5.454084221,27.9,1.415525114,24.2,None,NA,NA,NA,NA,NA,NA,Yes,No
Guo_2016,"Guo, X.",2016,Plastic Change along the Intact Crossed Pathway in Acute Phase of Cerebral Ischemia Revealed by Optical Intrinsic Signal Imaging,a,Rat,Sprague-Dawley,Male,None,NA,NR,14,NR,300,350,400,1,6,0,NA,NA,NA,Isoflurane,NA,Cranial window (asleep induction),NR,80,mg/kg,80,20,mW,NA,Green laser,Diode-pumped solid state laser,532,2,15,None,NA,NA,NA,NA,NA,48,TTC (ex vivo),41.45,3.74,NA,NA,NA,NA,mm3,SD,2.102993404,NA,3.74,0.189751395,NA,None,NA,NA,NA,NA,NA,NA,No,No
Hakon_2018,"Hakon, J.",2018,Multisensory stimulation improves functional recovery and resting-state functional connectivity in the mouse brain after stroke,a,Mouse,C57BL/6,NR,None,NA,8,9,10,NR,NR,NR,1,15,1,15,1,15,Isoflurane,NA,"Scalp retracted, skull intact",NR,0.1,mg/kg,0.1,NR,NA,NA,Halogen lamp,Halogen,NR,4,20,Enriched cage environment,Other,NA,NA,48,After stroke,336,Other histology (ex vivo),4,0.5,4.3,0.4,NA,NA,mm3,SEM,0.785993594,0.844943114,1.936491673,0.380517513,1.549193338,None,NA,NA,NA,NA,NA,NA,No,No
Halder_2013,"Halder, S. K.",2013,Novel neuroprotective action of prothymosin alpha-derived peptide against retinal and brain ischemic damages,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,6,1,6,1,6,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),3,mg/kg,3,NR,NA,NA,Xenon lamp,Xenon,540,1,10,"P30, Prothymosin alpha (ProT-alpha)",Anti-apoptosis/regeneration,1,mg/kg,1,After stroke,24,TTC (ex vivo),48.39,2.44,30,2.29,NA,NA,Direct rLV % hemisphere,SEM,24.195,15,5.976754972,2.988377486,5.609331511,"""Clinical score""",3.46,0.24,0.99,0.36,SEM,24,No,No
Han_2017,"Han, C. W.",2017,An Experimental Infarct Targeting the Internal Capsule: Histopathological and Ultrastructural Changes,a,Rat,Sprague-Dawley,Male,None,NA,8,8.5,9,200,220,240,1,7,0,NA,NA,NA,NR,NA,Skull breached,NR,NR,NA,NA,2.5,mW,NA,NR,NR,NR,0.0625,1.5,None,NA,NA,NA,NA,NA,336,Other histology (ex vivo),0.6,0.2,NA,NA,NA,NA,mm3,SEM,0.0304414,NA,0.529150262,0.026846792,NA,None,NA,NA,NA,NA,NA,NA,No,No
Harrison_2013,"Harrison, T. C.",2013,Displacement of sensory maps and disorganization of motor cortex after targeted stroke in mice,a,Mouse,Thy1-ChR2-YFP,Mixed,None,NA,20,20.5,21,NR,NR,NR,2,6.5,0,NA,NA,NA,Isoflurane,NA,Cranial window (awake induction),Sensory cortex,100,mg/kg,100,10,mW,NA,Other,Other,NR,1,13,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),0.18,0.07,NA,NA,NA,NA,mm3,SEM,0.035369712,NA,0.178465683,0.035068221,NA,None,NA,NA,NA,NA,NA,NA,No,No
Harrison_2013,"Harrison, T. C.",2013,Displacement of sensory maps and disorganization of motor cortex after targeted stroke in mice,b,Mouse,Thy1-ChR2-YFP,Mixed,None,NA,20,20.5,21,NR,NR,NR,2,6.5,0,NA,NA,NA,Isoflurane,NA,Cranial window (awake induction),Motor cortex,100,mg/kg,100,10,mW,NA,Other,Other,NR,1,13,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),0.23,0.06,NA,NA,NA,NA,mm3,SEM,0.045194632,NA,0.152970585,0.030058475,NA,None,NA,NA,NA,NA,NA,NA,No,No
Haupt_2007,"Haupt, C.",2007,Temporal profile of connexin 43 expression after photothrombotic lesion in rat brain,a,Rat,Wistar,Male,None,NA,NR,NR,NR,280,300,320,1,10,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,1.3,mg/100mg,NA,NR,NA,NA,Fibre-optic,NR,NR,1.5,NR,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),1.9,0.1,NA,NA,NA,NA,mm (diameter),NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
He_2013,"He, Y.",2013,Neuroprotective effects of focal brain cooling on photochemically-induced cerebral infarction in rats: analysis from a neurophysiological perspective,a,Rat,Wistar,Male,None,NA,NR,NR,NR,300,350,400,1,6,1,6,1,6,Sevoflurane,NA,Skull breached,Sensorimotor cortex,1.3,mg/100g,13,NR,NA,NA,Fibre-optic,NR,NR,3,20,Hypothermia,Multiple mechanisms,15,Degrees C,0,During stroke,8,TTC (ex vivo),1.71,0.54,0.99,0.3,NA,NA,mm2,SD,NA,NA,0.54,NA,0.3,None,NA,NA,NA,NA,NA,NA,No,No
He_2013,"He, Y.",2013,Neuroprotective effects of focal brain cooling on photochemically-induced cerebral infarction in rats: analysis from a neurophysiological perspective,b,Rat,Wistar,Male,None,NA,NR,NR,NR,300,350,400,1,9,1,9,1,9,Sevoflurane,NA,Skull breached,Sensorimotor cortex,1.3,mg/100g,13,NR,NA,NA,Fibre-optic,NR,NR,3,20,Hypothermia,Multiple mechanisms,15,Degrees C,0,During stroke,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,1.56,1.26,0.33,0.67,SD,24,No,No
Heimann_1999,"Heimann, A.",1999,C1-esterase inhibitor reduces infarct volume after cortical vein occlusion,a,Rat,Wistar,Male,None,NA,NR,NR,NR,273,317,361,1,8,1,8,1,8,Chloral hydrate,Atropine,Skull breached,Parietal cortex,50,mg/kg,50,5500,lux,0.000805255,Other,Other,540,0.2,10,C1-INH,Anti-inflammation,20,IU/kg,0,During stroke,120,Other histology (ex vivo),3.09,0.62,0.86,0.23,NA,NA,mm3,SEM,0.156773212,0.043632674,1.753624817,0.088971325,0.650538239,None,NA,NA,NA,NA,NA,NA,No,No
Heimann_2003,"Heimann, A.",2003,Effects of hypertonic/hyperoncotic treatment after rat cortical vein occlusion,a,Rat,Wistar,Male,None,NA,NR,NR,NR,305,359,413,1,10,2,9,2,5,Chloral hydrate,NA,Skull breached,Parietal cortex,50,mg/kg,50,5500,lux,0.000805255,NR,NR,540,0.2,10,Hydroxyethyl starch,Blood flow,2567,mOsm/kg,0.5,After stroke,48,Other histology (ex vivo),4.8,0.6,1.5,0.1,NA,NA,mm2,SE,NA,NA,1.897366596,NA,0.3,None,NA,NA,NA,NA,NA,NA,No,Yes
Hernandez-Jimenez_2017,"Hernandez-Jimenez, M.",2017,Test repositioning for functional assessment of neurological outcome after experimental stroke in mice,a,Mouse,CD-1,Male,None,NA,8,9,10,25,27.5,30,1,25,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Anterior cerebral artery,10,mg/kg,10,NR,NA,NA,Cold light,NR,549,NR,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),23.53,8.91,NA,NA,NA,NA,Indirect rLV % hemisphere,SD,11.765,NA,8.91,4.455,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Hernandez-Jimenez_2017,"Hernandez-Jimenez, M.",2017,Test repositioning for functional assessment of neurological outcome after experimental stroke in mice,b,Mouse,CD-1,Male,None,NA,8,9,10,25,27.5,30,1,9,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Anterior cerebral artery,10,mg/kg,10,NR,NA,NA,Cold light,NR,549,NR,10,None,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Modified Garcia Score,95.22,6.04,NA,NA,SD,24,Yes,No
Hines_2013,"Hines, D. J.",2013,Inhibition of a SNARE-sensitive pathway in astrocytes attenuates damage following stroke,a,Mouse,C57BL/6,Male,None,NA,12,14,16,NR,NR,NR,2,NR,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Forelimb sensorimotor cortex,100,mg/kg,100,NR,NA,NA,Other,Other,NR,NR,12,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),1.8,0.22,NA,NA,NA,NA,mm3,NR,0.353697117,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Hines_2013,"Hines, D. J.",2013,Inhibition of a SNARE-sensitive pathway in astrocytes attenuates damage following stroke,b,Mouse,dnSNARE,Male,None,NA,12,14,16,NR,NR,NR,2,NR,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Forelimb sensorimotor cortex,100,mg/kg,100,NR,NA,NA,Other,Other,NR,NR,12,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),0.93,0.17,NA,NA,NA,NA,mm3,NR,0.182743511,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Hirono_2018,"Hirono, J.",2018,Expression of tissue inhibitor of metalloproteinases and matrix metalloproteinases in the ischemic brain of photothrombosis model mice,a,Mouse,C57BL/6,Male,None,NA,8,10,12,NR,NR,NR,1,NR,2,NR,2,NA,Tribromoethanol,NA,"Scalp retracted, skull intact",Visual cortex,15,mg/ml,NA,50,mW,NA,NR,NR,532,NR,5,Aspirin,Thrombolytics,5,mg/kg,0,During stroke,72,Other histology (ex vivo),NR,NR,NR,NR,NR,NR,NR,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Hirono_2018,"Hirono, J.",2018,Expression of tissue inhibitor of metalloproteinases and matrix metalloproteinases in the ischemic brain of photothrombosis model mice,b,Mouse,C57BL/6,Male,None,NA,8,10,12,NR,NR,NR,1,NR,2,NR,2,NA,Tribromoethanol,NA,"Scalp retracted, skull intact",Visual cortex,15,mg/ml,NA,50,mW,NA,NR,NR,532,NR,5,Etodolac,Anti-inflammation,1,mg/kg,0,During stroke,72,Other histology (ex vivo),NR,NR,NR,NR,NR,NR,NR,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Hosseini_2018_a,"Hosseini, S. M.",2018,Photothrombotically induced unilateral selective hippocampal ischemia in rat,a,Rat,Wistar,Male,None,NA,NR,NR,NR,225,250,275,1,6,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Hippocampus,20,mg/ml,40,NR,NA,NA,Diode laser,Diode laser,523,0.2,25,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),6.55,0.44,NA,NA,NA,NA,Indirect rLV % hemisphere,SEM,3.275,NA,1.077775487,0.538887743,NA,None,NA,NA,NA,NA,NA,NA,No,No
Hosseini_2018_b,"Hosseini, S. M.",2018,"Neuroprotective effect of monophosphoryl lipid A, a detoxified lipid A derivative, in photothrombotic model of unilateral selective hippocampal ischemia in rat",a,Rat,Wistar,Male,None,NA,6,7,8,225,250,275,1,6,4,6,4,1.5,Ketamine,Xylazine,Skull breached,Hippocampus,20,mg/ml,40,NR,NA,NA,NR,NR,523,0.2,25,MPL (Monophosphoryl lipid A),Anti-inflammation,5,ug,-48,Before stroke,24,TTC (ex vivo),6.55,0.45,1.91,0.32,NA,NA,Indirect rLV % hemisphere,SEM,3.275,0.955,1.102270384,0.551135192,0.783836718,None,NA,NA,NA,NA,NA,NA,No,Yes
Hosseini_2018_b,"Hosseini, S. M.",2018,"Neuroprotective effect of monophosphoryl lipid A, a detoxified lipid A derivative, in photothrombotic model of unilateral selective hippocampal ischemia in rat",b,Rat,Wistar,Male,None,NA,6,7,8,225,250,275,1,6,4,6,4,1.5,Ketamine,Xylazine,Skull breached,Hippocampus,20,mg/ml,40,NR,NA,NA,NR,NR,523,0.2,25,LPS (Lipopolysaccharide),Anti-inflammation,5,ug,-48,Before stroke,24,TTC (ex vivo),6.55,0.45,2.47,0.4,NA,NA,Indirect rLV % hemisphere,SEM,3.275,1.235,1.102270384,0.551135192,0.979795897,None,NA,NA,NA,NA,NA,NA,No,No
Hou_2017,"Hou, B.",2017,Exogenous Neural Stem Cells Transplantation as a Potential Therapy for Photothrombotic Ischemia Stroke in Kunming Mice Model,a,Mouse,Kunming,Mixed,None,NA,NR,12,NR,22,23.5,25,1,18,1,20,1,18,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Sensorimotor cortex,40,uL,NA,150,W,NA,Cold light,NR,NR,NR,2,NSC (neural stem cell) transplantation,Anti-apoptosis/regeneration,10000,Cells/uL,NR,After stroke,168,Other histology (ex vivo),31.6,2.24,23.88,2.1,NA,NA,mm3,SEM,6.209349394,4.692381757,9.503515139,1.867425505,9.391485505,None,NA,NA,NA,NA,NA,NA,No,No
Hurwitz_1991,"Hurwitz, B. E.",1991,Amphetamine promotes recovery from sensory-motor integration deficit after thrombotic infarction of the primary somatosensory rat cortex,a,Rat,Wistar,Male,None,NA,NR,NR,NR,250,325,400,1,9,2,10,2,4.5,Halothane,NA,NR,Primary somatosensory neocortex,20,mg/kg,20,NR,NA,NA,NR,NR,NR,NR,7,D-amphetamine,Nootropics/cognition,2,mg/kg,NR,After stroke,960,Other histology (ex vivo),2.5,0.2,2,0.2,NA,NA,mm2,SEM,NA,NA,0.6,NA,0.632455532,None,NA,NA,NA,NA,NA,NA,No,Yes
Hwang_2018,"Hwang, S. A.",2018,Caffeic acid phenethyl ester protects against photothrombotic cortical ischemic injury in mice,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,4,4,4,4,1,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,LCD,NR,NR,4,15,CAPE (caffeic acid phenethyl ester),Anti-inflammation,10,mg/kg,1,After stroke,24,TTC (ex vivo),63.15,4.67,17.26,6.7,NA,NA,mm3,SEM,12.40887387,3.391562359,9.34,1.835295042,13.4,None,NA,NA,NA,NA,NA,NA,No,Yes
Igarashi_2011,"Igarashi, K.",2011,Use of polyamine metabolites as markers for stroke and renal failure,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,1,10,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),23.3,1.4,NA,NA,NA,NA,mm3,SD,4.578412686,NA,1.4,0.275097758,NA,None,NA,NA,NA,NA,NA,NA,No,No
Ikeda_2013_a,"Ikeda, S.",2013,"Effects of edaravone, a free radical scavenger, on photochemically induced cerebral infarction in a rat hemiplegic model",a,Rat,Wistar,NR,None,NA,NR,NR,NR,250,275,300,1,18,1,18,1,18,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,NR,NR,533,10,NR,Edaravone (MCI-186),Anti-oxidants,3,mg/kg,NR,After stroke,168,Other histology (ex vivo),33.3,2.66,17.4,1.39,NA,NA,mm2,SEM,NA,NA,11.28542423,NA,5.897270555,BWS - Feeney Beam Walking Score,2.45,0.32,4.2,0.29,SEM,24,Yes,No
Ikeda_2013_b,"Ikeda, S.",2013,Contralateral cortical role on functional recovery in a rat model of hemiplegia,a,Rat,Wistar,Male,None,NA,NR,8,NR,250,275,300,1,10,0,NA,NA,NA,NR,NA,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,NR,NR,533,10,20,None,NA,NA,NA,NA,NA,672,Other histology (ex vivo),39.9,3.3,NA,NA,NA,NA,mm2,SEM,NA,NA,10.43551628,NA,NA,BWS - Feeney Beam Walking Score,1.69,0.24,NA,NA,SEM,120,Yes,No
Ikeda_2013_c,"Ikeda, S.",2013,Expected for acquisition movement exercise is more effective for functional recovery than simple exercise in a rat model of hemiplegia,a,Rat,Wistar,Male,None,NA,NR,8,NR,NR,NR,NR,1,8,2,8,2,4,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,Fibre-optic,NR,533,10,20,Beam walking exercise,Other,20,minutes/day,NR,After stroke,336,Other histology (ex vivo),35.1,2.12,37.1,3.16,NA,NA,mm2,SD,NA,NA,2.12,NA,3.16,BWS - Feeney Beam Walking Score,2.38,0.26,6.51,0.19,SD,120,Yes,Yes
Ikeda_2005,"Ikeda, Y.",2005,"Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model",a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,260,290,320,1,8,6,5,6,1.333333333,NR,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,10,KCL-440,Anti-inflammation,3,mg/kg/h,0,After stroke,24,TTC (ex vivo),44.76,3.12,31.17,1.87,NA,NA,Direct rLV % hemisphere,SE,22.38,15.585,8.824692629,4.412346315,4.181447118,Bederson Scale,0.5,0.5,1,0,SD,24,Yes,Yes
Imura_1995,"Imura, Y.",1995,"Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model",a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,300,350,400,1,5,1,5,1,5,Sodium Pentobarbital,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,500000,lux,0.073205,Xenon lamp,Xenon,540,3,4,CV-4151,Thrombolytics,10,mg/kg,-1.5,Before stroke,24,MRI (in vivo),308,19,192,12,NA,NA,mm3,SEM,15.62658549,9.741248097,42.48529157,2.155519613,26.83281573,None,NA,NA,NA,NA,NA,NA,No,Yes
Inui_2013,"Inui, T.",2013,Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model,a,Rat,Wistar,Male,None,NA,NR,NR,NR,260,300,340,1,9,4,10,4,2.25,Chloral hydrate,NA,Skull breached,Cerebral cortex,50,mg/kg,50,50,W,NA,Mercury lamp,Mercury,540,0.1,NR,CTX (Ceftriaxone antibiotic),Energy substrates,200,mg/kg,-120,Before stroke,48,Other histology (ex vivo),8.84,1.94,6.44,0.95,NA,NA,mm3,SEM,0.448503298,0.326737697,5.82,0.295281583,3.004163777,None,NA,NA,NA,NA,NA,NA,No,Yes
Ishikawa_2009,"Ishikawa, E.",2009,Midkine gene transfer protects against focal brain ischemia and augments neurogenesis,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,20,26,32,360,400,440,1,6,1,6,1,6,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,3,4,AdMK (Adenovirus vectors encoding mouse midkine),Anti-apoptosis/regeneration,30,uL,90,After stroke,168,Other histology (ex vivo),87.8,23.8,58.5,18,NA,NA,mm3,SD,4.454591578,2.96803653,23.8,1.207508879,18,None,NA,NA,NA,NA,NA,NA,No,No
Ito_2010,"Ito, H.",2010,"Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats",a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,NR,20,NR,313,346,379,2,13,6,13,3,4.333333333,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,3,4,Cilostazol,Thrombolytics,100,mg/kg,0.5,After stroke,24,TTC (ex vivo),102,28,67,33,NA,NA,mm3,SD,5.175038052,3.399289701,28,1.420598681,33,None,NA,NA,NA,NA,NA,NA,No,Yes
Ito_2010,"Ito, H.",2010,"Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats",b,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,NR,20,NR,313,346,379,2,10,6,10,3,3.333333333,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,3,4,Aspirin,Thrombolytics,10,mg/kg,-2,Before stroke,24,TTC (ex vivo),17.09,3.01,16.26,3.54,NA,NA,mm2,SD,NA,NA,3.01,NA,3.54,None,NA,NA,NA,NA,NA,NA,No,Yes
Ito_2010,"Ito, H.",2010,"Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats",c,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,NR,20,NR,313,346,379,2,10,6,10,3,3.333333333,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,3,4,Clopidogrel,Thrombolytics,3,mg/kg,-2,Before stroke,24,TTC (ex vivo),17.09,3.01,15.58,4.56,NA,NA,mm2,SD,NA,NA,3.01,NA,4.56,None,NA,NA,NA,NA,NA,NA,No,Yes
Iwashita_2003,"Iwashita, A.",2003,"A novel potent radical scavenger, 8-(4-fluorophenyl)-2-((2E)-3-phenyl-2-propenoyl)-1,2,3,4-tetrahydropyrazolo[5,1-c ] [1,2,4]triazine (FR210575), prevents neuronal cell death in cultured primary neurons and attenuates brain injury after focal ischemia in rats",a,Rat,Wistar,Male,None,NA,8,9,10,274,327,380,1,9,2,7,2,4.5,Halothane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,540,3,10,FR210575,Anti-oxidants,1.07,mg/kg/h,0,During stroke,24,TTC (ex vivo),15.793,4.46,10.78,1.11,-36,NA,mm3,SEM,0.801268392,0.546930492,13.38,0.678843227,2.936783955,None,NA,NA,NA,NA,NA,NA,No,Yes
Jablonka_2012,"Jablonka, J. A.",2012,Experience-dependent brain plasticity after stroke: effect of ibuprofen and poststroke delay,a,Rat,Wistar,Male,None,NA,NR,NR,NR,NR,230,NR,1,7,NR,NR,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mg/kg,10,NR,NA,NA,Cold light,NR,NR,1.5,20,Ibuprofen,Anti-inflammation,NR,NA,NR,NA,720,Other histology (ex vivo),0.8,0.3,0.6,0.3,NA,NA,mm3,SD,0.040588534,0.0304414,0.3,0.0152207,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Jablonka_2006,"Jablonka, J.",2006,Focal stroke in the barrel cortex of rats enhances ipsilateral response to vibrissal input,a,Rat,Wistar,Male,None,NA,NR,NR,NR,NR,230,NR,1,5,0,NA,NA,NA,Isoflurane,NA,Skull thinned,Barrel field,10,mg/ml,NA,NR,NA,NA,Fibre-optic,NR,NR,3,20,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),3.5,NR,NA,NA,NA,NA,mm2,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Jadavji_2018,"Jadavji, N. M.",2018,A genetic deficiency in folic acid metabolism impairs recovery after ischemic stroke,a,Mouse,Mthfr+/+ (C57BL/6 variant),Male,None,NA,NR,84,NR,NR,NR,NR,2,17,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Sensorimotor cortex,10,mg/kg,10,NR,NA,NA,NR,NR,532,NR,15,None,NA,NA,NA,NA,NA,1344,Other histology (ex vivo),0.21,0.09,NA,NA,NA,NA,mm3,SEM,0.041264664,NA,0.371079506,0.072916529,NA,None,NA,NA,NA,NA,NA,NA,No,No
Jadavji_2018,"Jadavji, N. M.",2018,A genetic deficiency in folic acid metabolism impairs recovery after ischemic stroke,b,Mouse,Mthfr+/- (C57BL/6 variant),Male,None,NA,NR,84,NR,NR,NR,NR,2,16,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Sensorimotor cortex,10,mg/kg,10,NR,NA,NA,NR,NR,532,NR,15,None,NA,NA,NA,NA,NA,1344,Other histology (ex vivo),0.29,0.15,NA,NA,NA,NA,mm3,SEM,0.056984536,NA,0.6,0.117899039,NA,None,NA,NA,NA,NA,NA,NA,No,No
Jang_2014,"Jang, J. Y.",2014,Neuroprotective effects of a novel single compound 1-methoxyoctadecan-1-ol isolated from Uncaria sinensis in primary cortical neurons and a photothrombotic ischemia model,a,Mouse,C57BL/6,Male,None,NA,NR,6,NR,20,22.5,25,1,9,2,9,2,4.5,Isoflurane,NA,"Scalp retracted, skull intact",NR,1,mg,44.44444444,75,NR,NA,LED,LED,NR,4,15,1-methoxyoctadecan-1-ol,Anti-apoptosis/regeneration,3,mg/kg,-0.5,Before stroke,24,TTC (ex vivo),55.6,5.36,31.13,7.08,NA,NA,mm3,SEM,10.92531096,6.116995146,16.08,3.159694248,21.24,0-4 limb scale,1.22,0.15,0.1,0.1,SEM,24,No,Yes
Jiao_2017,"Jiao, C. X.",2017,Protective efficacy of a single salvianolic acid A treatment on photothrombosis-induced sustained spatial memory impairments,a,Rat,Sprague-Dawley,Male,None,NA,12,13,14,300,325,350,2,9,2,9,1,9,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Frontal cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,4,15,SAA (Salvianolic acid A),Nootropics/cognition,2,mg/kg,0.17,After stroke,240,Other histology (ex vivo),23.56,2.14,15.7,2.91,NA,NA,mm3,SEM,1.195332319,0.796549975,6.42,0.325722983,8.73,None,NA,NA,NA,NA,NA,NA,Yes,No
Jin_2017,"Jin, H. J.",2017,Alleviative effects of fluoxetine on depressive-like behaviors by epigenetic regulation of BDNF gene transcription in mouse model of post-stroke depression,a,Mouse,C57BL/6,Male,None,NA,NR,12,NR,NR,NR,NR,1,18,0,NA,NA,NA,Chloral hydrate,NA,"Scalp retracted, skull intact",Anterior cerebral cortex,150,mg/kg,150,150,W,NA,LCD,NR,560,1.5,15,None,NA,NA,NA,NA,NA,1344,TTC (ex vivo),4.22,0.41,NA,NA,NA,NA,mm3,SEM,0.829223242,NA,1.739482682,0.341805561,NA,mNSS,5.06,0.92,NA,NA,SEM,24,Yes,No
Jin_2010,"Jin, Z.",2010,The effect of stress on stroke recovery in a photothrombotic stroke animal model,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,200,225,250,1,15,1,15,1,15,Ketamine,Xylazine,"Scalp retracted, skull intact",Motor cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,4,20,Stress (restraint),Other,10,Hours,24,After stroke,144,TTC (ex vivo),6.8,1,12.6,2,NA,NA,Indirect rLV % hemisphere,SD,3.4,6.3,1,0.5,2,None,NA,NA,NA,NA,NA,NA,No,No
Jolkkonen_2007,"Jolkkonen, J.",2007,Subacute hemorrhage and resolution of edema in Rose Bengal stroke model in rats coincides with improved sensorimotor functions,a,Rat,Wistar,Male,None,NA,12,14,16,NR,NR,NR,1,16,0,NA,NA,NA,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Motor cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,4,10,None,NA,NA,NA,NA,NA,48,MRI (in vivo),49.97,2.83,NA,NA,NA,NA,mm3,NR,2.535261289,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kaido_2003,"Kaido, T.",2003,Novel complement C1 inhibitor BSF468248 does not improve brain damage after cortical vein occlusion,a,Rat,Wistar,Male,None,NA,NR,NR,NR,278,345.7,430,2,5,2,5,1,5,Ether,Atropine,Skull breached,Cerebral cortex,50,mg/kg,50,50,W,NA,Mercury lamp,Mercury,540,NR,10,BSF468248,Anti-inflammation,12,mg/g,0,During stroke,168,Other histology (ex vivo),1.76,0.31,2.27,0.43,NA,NA,mm3,SEM,0.089294774,0.115169964,0.693181073,0.035169004,0.96150923,None,NA,NA,NA,NA,NA,NA,No,Yes
Kaku_1997,"Kaku, S.",1997,"Evaluation of the disintegrin, triflavin, in a rat middle cerebral artery thrombosis model",a,Rat,Wistar,Male,None,NA,NR,NR,NR,220,245,270,1,8,3,8,3,2.666666667,Halothane,NA,Skull breached,Middle cerebral artery (MCA),7.5,mg/kg,7.5,NR,NA,NA,Xenon lamp,Xenon,540,3,10,Triflavin,Thrombolytics,1,mg/kg,0,During stroke,24,TTC (ex vivo),12.6,1.68,3.58,2.08,NA,NA,Direct rLV % hemisphere,SEM,6.3,1.79,4.75175757,2.375878785,5.883128419,None,NA,NA,NA,NA,NA,NA,No,Yes
Kaku_1998,"Kaku, S.",1998,Evaluation of a GPIIb/IIIa antagonist YM337 in a primate model of middle cerebral artery thrombosis,a,Primate,Squirrel monkey (Saimiri sciureus),NR,None,NA,NR,NR,NR,535,725,915,1,5,4,5,4,1.25,Ketamine,Halothane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,20,YM337,Thrombolytics,1,mg/kg,-0.25,Before stroke,24,Other histology (ex vivo),23.44,4.88,9.82,1.65,NA,NA,Direct rLV % hemisphere,SEM,11.72,4.91,10.91201173,5.456005865,3.689512163,Five-point scale (Crowell et al. 1970),2.2,0.98,0.2,0.4,SD,24,No,Yes
Kaku_1998,"Kaku, S.",1998,Evaluation of a GPIIb/IIIa antagonist YM337 in a primate model of middle cerebral artery thrombosis,b,Primate,Squirrel monkey (Saimiri sciureus),NR,None,NA,NR,NR,NR,535,725,915,1,5,4,5,4,1.25,Ketamine,Halothane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,20,Ozagrel Sodium,Thrombolytics,10,mg/kg,-0.25,Before stroke,24,Other histology (ex vivo),23.44,4.88,14.59,2.89,NA,NA,Direct rLV % hemisphere,SEM,11.72,7.295,10.91201173,5.456005865,6.462236455,Five-point scale (Crowell et al. 1970),2.2,0.98,0.8,0.4,SD,24,No,Yes
Kang_2015_a,"Kang, B. K.",2015,Anti-Neuroinflammatory Effects of Uncaria sinensis in LPS-Stimulated BV2 Microglia Cells and Focal Cerebral Ischemic Mice,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,9,2,9,2,4.5,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,LCD,NR,NR,4,15,HEUS (Hexane extracts of Uncaria sinensis),Blood flow,100,mg/kg,-0.5,Before stroke,48,TTC (ex vivo),61.23,6.14,41.5,2.65,NA,NA,mm3,SEM,12.03159694,8.154683539,18.42,3.619500501,7.95,0-4 limb scale,0.83,0.17,0.17,0.17,SEM,48,No,Yes
Kang_2013,"Kang, C.",2013,The effect of continuous epidural electrical stimulation on neuronal proliferation in cerebral ischemic rats,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,275,300,1,9,1,10,1,6,Ketamine,Xylazine,Other,Motor cortex,20,mg/kg,20,1,W/cm2,1,Halogen lamp,Halogen,NR,4,16,ES (electrical stimulation),Other,50,Hz,NR,NR,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0-4 limb scale,3.27,NR,3.81,NR,NR,48,Yes,No
Kang_2015_b,"Kang, H. M.",2015,Use of indocyanine green for optical analysis of cortical infarcts in photothrombotic ischemic brains,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,NR,NR,NR,3,4,0,NA,NA,NA,Zoletil,Xylazine,"Scalp retracted, skull intact",NR,0.1,mL/25g,NA,150,W,NA,LCD,NR,NR,3,3,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),16.18,1.24,NA,NA,NA,NA,mm2,SEM,NA,NA,2.48,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kao_2014,"Kao, Y. C",2014,Dynamic perfusion and diffusion MRI of cortical spreading depolarization in photothrombotic ischemia,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,325,400,5,6,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Primary forelimb somatosensory cortex (S1FL),10,mg/kg,10,10,mW,NA,Green laser,Diode-pumped solid state laser,532,0.2,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),13.5,2.08,NA,NA,NA,NA,mm3,SD,0.684931507,NA,2.08,0.105530188,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kao_2014,"Kao, Y. C",2014,Dynamic perfusion and diffusion MRI of cortical spreading depolarization in photothrombotic ischemia,b,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,325,400,5,6,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Primary forelimb somatosensory cortex (S1FL),20,mg/kg,20,10,mW,NA,Green laser,Diode-pumped solid state laser,532,0.2,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),38.97,6.16,NA,NA,NA,NA,mm3,SD,1.97716895,NA,6.16,0.31253171,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kao_2014,"Kao, Y. C",2014,Dynamic perfusion and diffusion MRI of cortical spreading depolarization in photothrombotic ischemia,c,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,325,400,5,5,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Primary forelimb somatosensory cortex (S1FL),10,mg/kg,10,20,mW,NA,Green laser,Diode-pumped solid state laser,532,0.2,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),36.32,8.34,NA,NA,NA,NA,mm3,SD,1.842719432,NA,8.34,0.423135464,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kao_2014,"Kao, Y. C",2014,Dynamic perfusion and diffusion MRI of cortical spreading depolarization in photothrombotic ischemia,d,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,325,400,5,5,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Primary forelimb somatosensory cortex (S1FL),10,mg/kg,10,30,mW,NA,Green laser,Diode-pumped solid state laser,532,0.2,10,None,NA,NA,NA,NA,NA,24,MRI (in vivo),47.59,5.78,NA,NA,NA,NA,mm3,SD,2.414510401,NA,5.78,0.293252156,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kao_2014,"Kao, Y. C",2014,Dynamic perfusion and diffusion MRI of cortical spreading depolarization in photothrombotic ischemia,e,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,325,400,5,6,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Primary forelimb somatosensory cortex (S1FL),10,mg/kg,10,10,mW,NA,Green laser,Diode-pumped solid state laser,532,0.2,20,None,NA,NA,NA,NA,NA,24,MRI (in vivo),16.81,2.65,NA,NA,NA,NA,mm3,SD,0.852866565,NA,2.65,0.134449518,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Karasawa_2002,"Karasawa, Y.",2002,Effect of TTC-909 in a middle cerebral artery thrombosis model in stroke-prone spontaneously hypertensive rats,a,Rat,Wistar,Male,None,NA,NR,11,NR,NR,NR,NR,2,10,0,NA,NA,NA,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),51.3,5.2,NA,NA,NA,NA,mm3,NR,2.602739726,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Karasawa_2002,"Karasawa, Y.",2002,Effect of TTC-909 in a middle cerebral artery thrombosis model in stroke-prone spontaneously hypertensive rats,b,Rat,Stroke-prone SHR (Spontaneously Hypertensive Rat),Male,Hypertension,Genetic,10,11,12,NR,NR,NR,2,10,0,NA,NA,NA,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),136,7.8,NA,NA,NA,NA,mm3,NR,6.900050736,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Karasawa_2002,"Karasawa, Y.",2002,Effect of TTC-909 in a middle cerebral artery thrombosis model in stroke-prone spontaneously hypertensive rats,c,Rat,Stroke-prone SHR (Spontaneously Hypertensive Rat),Male,Hypertension,Genetic,10,11,12,NR,NR,NR,1,13,3,13,3,4.333333333,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,TTC-909,Thrombolytics,2700,ng/kg,0,During stroke,24,Other histology (ex vivo),116.2,7.8,88.6,8.6,NA,NA,mm3,NR,5.895484526,4.495180112,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Karasawa_2002,"Karasawa, Y.",2002,Effect of TTC-909 in a middle cerebral artery thrombosis model in stroke-prone spontaneously hypertensive rats,d,Rat,Stroke-prone SHR (Spontaneously Hypertensive Rat),Male,Hypertension,Genetic,10,11,12,NR,NR,NR,1,15,3,15,3,5,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,Ozagrel Sodium,Thrombolytics,27,mg/kg,0,During stroke,24,Other histology (ex vivo),114.4,6,67.9,10.2,NA,NA,mm3,NR,5.804160325,3.444951801,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Karetko-Sysa_2011,"Karetko-Sysa, M.",2011,Disturbance of perineuronal nets in the perilesional area after photothrombosis is not associated with neuronal death,a,Rat,Wistar,Male,None,NA,NR,12,NR,260,270,280,5,5,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mg/ml,14.81481481,2750,K,NA,LCD,NR,560,1.5,20,None,NA,NA,NA,NA,NA,1,Other histology (ex vivo),17.98,1.27,NA,NA,NA,NA,mm3,NR,0.912227296,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Karlsson_2018,"Karlsson, L.",2018,Constitutive PGC-1alpha Overexpression in Skeletal Muscle Does Not Improve Morphological Outcome in Mouse Models of Brain Irradiation or Cortical Stroke,a,Mouse,C57BL/6,Male,None,NA,NR,12,NR,NR,NR,NR,2,7,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Cerebral cortex,10,mg/ml,NA,50,mW,NA,NR,NR,561,NR,10,None,NA,NA,NA,NA,NA,96,Other histology (ex vivo),0.61,0.1,NA,NA,NA,NA,mm3,SEM,0.119864023,NA,0.264575131,0.05198859,NA,None,NA,NA,NA,NA,NA,NA,No,No
Karlsson_2018,"Karlsson, L.",2018,Constitutive PGC-1alpha Overexpression in Skeletal Muscle Does Not Improve Morphological Outcome in Mouse Models of Brain Irradiation or Cortical Stroke,b,Mouse,MCK-PGC-1alpha,Male,None,NA,NR,12,NR,NR,NR,NR,2,6,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Cerebral cortex,10,mg/ml,NA,50,mW,NA,NR,NR,561,NR,10,None,NA,NA,NA,NA,NA,96,Other histology (ex vivo),0.96,0.07,NA,NA,NA,NA,mm3,SEM,0.188638463,NA,0.171464282,0.033692457,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kawaguchi_2007,"Kawaguchi, A. T.",2007,Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral artery,a,Rat,Sprague-Dawley,Male,None,NA,10,11,12,270,283,300,2,6,2,7,1,6,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,10,LEH (TRM-645),Energy substrates,10,ml/kg,0,During stroke,24,TTC (ex vivo),12.91,2.35,10,1.35,NA,NA,Direct rLV % whole brain,NR,12.91,10,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Kawaguchi_2007,"Kawaguchi, A. T.",2007,Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral artery,b,Rat,Sprague-Dawley,Male,None,NA,10,11,12,270,283,300,2,5,2,6,1,5,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,10,Blood transfusion,Multiple mechanisms,10,ml/kg,0,During stroke,24,TTC (ex vivo),12.01,0.3,13.01,2.2,NA,NA,Direct rLV % whole brain,NR,12.01,13.01,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kawaguchi_2009,"Kawaguchi, A. T.",2009,S-nitrosylated pegylated hemoglobin reduces the size of cerebral infarction in rats,a,Rat,Sprague-Dawley,Male,None,NA,10,10.5,11,270,285,300,1,15,3,7,3,5,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,10,SNO-PEG-Hb (S-nitrosylated pegylated hemoglobin),Energy substrates,0.4,ml/kg,0,During stroke,24,TTC (ex vivo),10.34,2.73,7.58,1.55,NA,NA,Direct rLV % whole brain,SD,10.34,7.58,2.73,2.73,1.55,0-3 scale,2,0.19,2,0,NR,24,No,Yes
Kawaguchi_2009,"Kawaguchi, A. T.",2009,S-nitrosylated pegylated hemoglobin reduces the size of cerebral infarction in rats,b,Rat,Sprague-Dawley,Male,None,NA,10,10.5,11,270,285,300,1,10,3,8,3,3.333333333,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,10,PEG-Hb (Pegylated hemoglobin),Energy substrates,0.4,ml/kg,0,During stroke,24,TTC (ex vivo),9.55,2.29,11.38,3.59,NA,NA,Direct rLV % whole brain,SD,9.55,11.38,2.29,2.29,3.59,0-3 scale,2,0.19,2.25,0.38,NR,24,No,Yes
Kawai_1995,"Kawai, H.",1995,Effect of argatroban on microthrombi formation and brain damage in the rat middle cerebral artery thrombosis model,a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,250,260,2,6,2,6,1,6,Sodium Pentobarbital,NA,Skull breached,Lenticulostriate branch of MCA,20,mg/kg,20,0.62,W/cm2,0.62,Xenon lamp,Xenon,540,3,10,Argatroban,Thrombolytics,40,mg/kg,3,After stroke,6,Other histology (ex vivo),13.78,1.95,6.96,0.33,NA,NA,Direct rLV % whole brain,SEM,13.78,6.96,4.776504998,4.776504998,0.808331615,None,NA,NA,NA,NA,NA,NA,Yes,No
Kawano_1998,"Kawano, K.",1998,Increased cerebral infarction by cyclic flow reductions: studies in the guinea pig MCA thrombosis model,a,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,300,375,450,4,6,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull breached,Lenticulostriate branch of MCA,20,mg/kg,20,0.636,J/cm2,NA,Xenon lamp,Xenon,570,3,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),124.9,11.8,NA,NA,NA,NA,mm3,SE,NA,NA,28.90397896,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kawano_1998,"Kawano, K.",1998,Increased cerebral infarction by cyclic flow reductions: studies in the guinea pig MCA thrombosis model,b,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,300,375,450,4,6,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull breached,Lenticulostriate branch of MCA,20,mg/kg,20,0.636,J/cm2,NA,Xenon lamp,Xenon,570,3,15,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),158.3,10.8,NA,NA,NA,NA,mm3,SE,NA,NA,26.45448922,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kawano_1998,"Kawano, K.",1998,Increased cerebral infarction by cyclic flow reductions: studies in the guinea pig MCA thrombosis model,c,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,300,375,450,4,6,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull breached,Lenticulostriate branch of MCA,20,mg/kg,20,0.636,J/cm2,NA,Xenon lamp,Xenon,570,3,20,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),174.3,17.7,NA,NA,NA,NA,mm3,SE,NA,NA,43.35596845,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kawano_1998,"Kawano, K.",1998,Increased cerebral infarction by cyclic flow reductions: studies in the guinea pig MCA thrombosis model,d,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,300,375,450,4,6,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull breached,Lenticulostriate branch of MCA,20,mg/kg,20,0.636,J/cm2,NA,Xenon lamp,Xenon,570,3,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),205.3,4.7,NA,NA,NA,NA,mm3,SE,NA,NA,11.51260179,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kawano_1999,"Kawano, K.",1999,Superiority of platelet integrin GPIIb-IIIa receptor antagonist over aspirin in preventing cyclic flow reductions in the guinea pig middle cerebral artery,a,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,300,375,450,1,10,6,10,6,1.666666667,Nitrous oxide,Isoflurane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.636,J/cm2,NA,Xenon lamp,Xenon,570,3,10,ME3277,Thrombolytics,3,mg/kg,-0.17,Before stroke,24,Other histology (ex vivo),16.63,1.43,7.03,1.9,NA,NA,Direct rLV % whole brain,SE,16.63,7.03,4.522057054,4.522057054,6.008327554,Other,NR,NR,NR,NR,NR,24,No,Yes
Kawano_1999,"Kawano, K.",1999,Superiority of platelet integrin GPIIb-IIIa receptor antagonist over aspirin in preventing cyclic flow reductions in the guinea pig middle cerebral artery,b,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,300,375,450,1,10,6,10,6,1.666666667,Nitrous oxide,Isoflurane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.636,J/cm2,NA,Xenon lamp,Xenon,570,3,10,Ozagrel Sodium,Thrombolytics,30,mg/kg,-0.17,Before stroke,24,Other histology (ex vivo),16.63,1.43,12.2,1.1,NA,NA,Direct rLV % whole brain,SE,16.63,12.2,4.522057054,4.522057054,3.478505426,Other,NR,NR,NR,NR,NR,24,No,Yes
Kawano_1999,"Kawano, K.",1999,Superiority of platelet integrin GPIIb-IIIa receptor antagonist over aspirin in preventing cyclic flow reductions in the guinea pig middle cerebral artery,c,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,300,375,450,1,10,6,10,6,1.666666667,Nitrous oxide,Isoflurane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.636,J/cm2,NA,Xenon lamp,Xenon,570,3,10,Aspirin,Thrombolytics,30,mg/kg,-0.17,Before stroke,24,Other histology (ex vivo),16.63,1.43,15.46,1.79,NA,NA,Direct rLV % whole brain,SE,16.63,15.46,4.522057054,4.522057054,5.660477012,Other,NR,NR,NR,NR,NR,24,No,No
Kawano_2000,"Kawano, K. I.",2000,"ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery",a,Rabbit,Japanese White,Male,None,NA,NR,NR,NR,2000,2500,3000,1,10,5,11,5,2,Nitrous oxide,Isoflurane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.636,W/cm2,0.636,Xenon lamp,Xenon,570,3,20,ME3277,Thrombolytics,12.6,mg/kg,0.5,After stroke,24,TTC (ex vivo),23.6,8.09,12.9,6.63,NA,NA,Direct rLV % whole brain,SD,23.6,12.9,8.09,8.09,6.63,Other,8,2.38,4,3,SD,24,No,Yes
Kawano_2000,"Kawano, K. I.",2000,"ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery",b,Rabbit,Japanese White,Male,None,NA,NR,NR,NR,2000,2500,3000,1,10,5,12,5,2,Nitrous oxide,Isoflurane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.636,W/cm2,0.636,Xenon lamp,Xenon,570,3,20,Aspirin,Thrombolytics,20,mg/kg,0.5,After stroke,24,TTC (ex vivo),23.6,8.09,15.6,7.01,NA,NA,Direct rLV % whole brain,SD,23.6,15.6,8.09,8.09,7.01,Other,8,2.38,5.42,2.29,SD,24,No,No
Kawano_2000,"Kawano, K. I.",2000,"ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery",c,Rabbit,Japanese White,Male,None,NA,NR,NR,NR,2000,2500,3000,1,10,5,11,5,2,Nitrous oxide,Isoflurane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.636,W/cm2,0.636,Xenon lamp,Xenon,570,3,20,Ozagrel Sodium,Thrombolytics,49,mg/kg,0.5,After stroke,24,TTC (ex vivo),23.6,8.09,17.85,7.41,NA,NA,Direct rLV % whole brain,SD,23.6,17.85,8.09,8.09,7.41,Other,8,2.38,5.67,2.9,SD,24,No,No
Keiner_2008,"Keiner, S.",2008,Rehabilitative therapies differentially alter proliferation and survival of glial cell populations in the perilesional zone of cortical infarcts,a,Rat,Wistar,Male,None,NA,NR,12,NR,250,275,300,1,6,2,7,2,3,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,10,mg/ml,NA,15,W/cm2,15,Cold light,NR,NR,3,20,Enriched cage environment,Other,10,Days,24,After stroke,240,Other histology (ex vivo),15.28,2.41,18.32,3.13,NA,NA,mm3,SD,0.775240994,0.929477423,2.41,0.122272958,3.13,None,NA,NA,NA,NA,NA,NA,Yes,No
Keiner_2008,"Keiner, S.",2008,Rehabilitative therapies differentially alter proliferation and survival of glial cell populations in the perilesional zone of cortical infarcts,b,Rat,Wistar,Male,None,NA,NR,12,NR,250,275,300,1,6,2,10,2,3,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,10,mg/ml,NA,15,W/cm2,15,Cold light,NR,NR,3,20,Task-specific training (TST),Other,10,Days,24,After stroke,240,Other histology (ex vivo),15.28,2.41,18.44,2.72,NA,NA,mm3,SD,0.775240994,0.935565703,2.41,0.122272958,2.72,None,NA,NA,NA,NA,NA,NA,Yes,No
Keiner_2009,"Keiner, S.",2009,Immunocytochemical detection of newly generated neurons in the perilesional area of cortical infarcts after intraventricular application of brain-derived neurotrophic factor,a,Rat,Wistar,Male,None,NA,12,13,14,250,275,300,1,14,1,14,1,14,Nitrous oxide,Isoflurane,Other,Sensorimotor cortex,10,mg/ml,NA,15,W/cm2,15,Cold light,NR,NR,4,20,BDNF (Brain-derived neurotrophic factor),Anti-apoptosis/regeneration,1,ug/mL,NR,After stroke,42,Other histology (ex vivo),6.39,1.28,8.2,2.8,NA,NA,mm3,SD,0.324200913,0.416032471,1.28,0.064941654,2.8,None,NA,NA,NA,NA,NA,NA,Yes,No
Kelly_2001,"Kelly, K. M.",2001,Photothrombotic brain infarction results in seizure activity in aging Fischer 344 and Sprague Dawley rats,a,Rat,Fischer 344,Male,Aged,NA,8,68,128,NR,NR,NR,9,5,0,NA,NA,NA,Equithesin,NA,"Scalp retracted, skull intact",Fronto-parietal cerebral cortex,80,mg/kg,80,100,W,NA,Halogen lamp,Halogen,800,6,10,None,NA,NA,NA,NA,NA,720,Other histology (ex vivo),4.25,0.25,NA,NA,NA,NA,mm3,SEM,0.215626585,NA,0.559016994,0.0283621,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kelly_2001,"Kelly, K. M.",2001,Photothrombotic brain infarction results in seizure activity in aging Fischer 344 and Sprague Dawley rats,b,Rat,Fischer 344,Male,Aged,NA,12,58,104,NR,NR,NR,9,3,0,NA,NA,NA,Equithesin,NA,"Scalp retracted, skull intact",Fronto-parietal cerebral cortex,80,mg/kg,80,100,W,NA,Halogen lamp,Halogen,800,3,10,None,NA,NA,NA,NA,NA,720,Other histology (ex vivo),0.69,0.09,NA,NA,NA,NA,mm3,SEM,0.03500761,NA,0.155884573,0.007908908,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kharlamov_1997,"Kharlamov, A.",1997,Cycloheximide reduces the size of lesion caused in rats by a photothrombotic model of brain injury,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,260,280,300,1,10,1,10,1,10,NR,NA,NR,NR,80,mg/kg,80,NR,NA,NA,NR,NR,NR,NR,NR,Cycloheximide,Anti-apoptosis/regeneration,2.5,mg/kg,-1,Before stroke,24,Other histology (ex vivo),12.86,0.9,7.93,2.01,NA,NA,mm3,SEM,0.65246068,0.402333841,2.846049894,0.14439624,6.356178097,None,NA,NA,NA,NA,NA,NA,No,No
Kharlamov_2000,"Kharlamov, A.",2000,Age-dependent increase in infarct volume following photochemically induced cerebral infarction: putative role of astroglia,a,Rat,Fischer 344,NR,None,NA,NR,17,NR,NR,NR,NR,3,NR,0,NR,NA,NA,Equithesin,NA,"Scalp retracted, skull intact",Parietal sensorimotor neocortex,80,mg/kg,80,NR,NA,NA,Cold light,NR,NR,NR,10,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),27.47,NR,NA,NA,NA,NA,mm3,NR,1.393708777,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kharlamov_2000,"Kharlamov, A.",2000,Age-dependent increase in infarct volume following photochemically induced cerebral infarction: putative role of astroglia,b,Rat,Fischer 344,NR,Aged,NA,NR,89,NR,NR,NR,NR,3,NR,0,NR,NA,NA,Equithesin,NA,"Scalp retracted, skull intact",Parietal sensorimotor neocortex,80,mg/kg,80,NR,NA,NA,Cold light,NR,NR,NR,10,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),45.6,NR,NA,NA,NA,NA,mm3,NR,2.313546423,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kharlamov_2000,"Kharlamov, A.",2000,Age-dependent increase in infarct volume following photochemically induced cerebral infarction: putative role of astroglia,c,Rat,Fischer 344,NR,Aged,NA,NR,117,NR,NR,NR,NR,3,NR,0,NR,NA,NA,Equithesin,NA,"Scalp retracted, skull intact",Parietal sensorimotor neocortex,80,mg/kg,80,NR,NA,NA,Cold light,NR,NR,NR,10,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),46.51,NR,NA,NA,NA,NA,mm3,NR,2.35971588,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kharlamov_1994,"Kharlamov, A.",1994,"LIGA20, a lyso derivative of ganglioside GM1, given orally after cortical thrombosis reduces infarct size and associated cognition deficit",a,Rat,NR,NR,None,NA,NR,NR,NR,NR,NR,NR,2,10,3,10,1.5,6.666666667,NR,NA,"Scalp retracted, skull intact",Parietal sensorimotor neocortex,NR,NR,NA,NR,NA,NA,NR,NR,NR,3,10,LIGA20,Excitotoxicity,294,umol/kg,1,After stroke,168,Other histology (ex vivo),27,2.5,17,3.7,NA,NA,mm3,SE,1.369863014,0.862506342,7.90569415,0.401100667,11.70042734,None,NA,NA,NA,NA,NA,NA,No,Yes
Kharlamov_1994,"Kharlamov, A.",1994,"LIGA20, a lyso derivative of ganglioside GM1, given orally after cortical thrombosis reduces infarct size and associated cognition deficit",b,Rat,NR,NR,None,NA,NR,NR,NR,NR,NR,NR,2,10,3,10,1.5,6.666666667,NR,NA,"Scalp retracted, skull intact",Parietal sensorimotor neocortex,NR,NR,NA,NR,NA,NA,NR,NR,NR,3,10,MK-801 (dizocilpine maleate),Excitotoxicity,8.3,umol/kg,-1,Before stroke,168,Other histology (ex vivo),25,3.3,20,5.8,NA,NA,mm3,SE,1.268391679,1.014713343,10.43551628,0.529452881,18.34121043,None,NA,NA,NA,NA,NA,NA,No,No
Kim_2015,"Kim, D.",2015,Longitudinal changes in resting-state brain activity in a capsular infarct model,a,Rat,Sprague-Dawley,NR,None,NA,NR,9,NR,NR,NR,NR,2,7,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Posterior Limb of the Internal Capsule,20,mg/kg,20,4,mW,NA,Green laser,Diode-pumped solid state laser,NR,0.0625,1.5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),0.8,0.5,NA,NA,NA,NA,mm3,SD,0.040588534,NA,0.5,0.025367834,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kim_2000,"Kim, G. W.",2000,Involvement of oxidative stress and caspase-3 in cortical infarction after photothrombotic ischemia in mice,a,Mouse,CD-1,Male,None,NA,NR,12,NR,35,37.5,40,2,15,2,15,1,15,Chloral hydrate,Xylazine,"Scalp retracted, skull intact",NR,30,mg/kg,30,0.33,mW/cm2,0.00033,Halogen lamp,Halogen,560,1.4,5,U-74389G (Methylated Tirilazad),Anti-oxidants,10,mg/kg,-0.5,Before stroke,72,Other histology (ex vivo),18,4.3,9.9,3.2,NA,NA,mm3,SD,3.536971174,1.945334146,4.3,0.844943114,3.2,None,NA,NA,NA,NA,NA,NA,Yes,No
Kim_2014,"Kim, H. S",2014,"A rat model of photothrombotic capsular infarct with a marked motor deficit: a behavioral, histologic, and microPET study",a,Rat,Sprague-Dawley,Male,None,NA,8,8.5,9,NR,NR,NR,2,7,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Posterior Limb of the Internal Capsule,20,mg/kg,20,2.5,mW,NA,Fibre-optic,NR,532,0.0625,1.5,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),0.6,0.2,NA,NA,NA,NA,mm3,SEM,0.0304414,NA,0.529150262,0.026846792,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kim_2013,"Kim, J. H.",2013,Electroacupuncture preconditioning reduces cerebral ischemic injury via BDNF and SDF-1alpha in mice,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,12,1,12,1,12,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,0.1,mL,44.44444444,NR,NA,NA,LCD,NR,NR,4,15,Electroacupuncture,Other,2,Hz,-72,Before stroke,24,TTC (ex vivo),NR,NR,NR,NR,-43.5,NA,NR,SEM,NA,NA,NA,NA,NA,0-4 limb scale,0.33,0.14,0,0,SEM,24,No,No
Kim_2016,"Kim, J. Y.",2016,Day/night difference in extradural cortical stimulation for motor relearning in a subacute stroke rat model,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,275,300,1,7,2,10,2,3.5,Ketamine,Xylazine,Other,Primary forelimb somatosensory cortex (S1FL),20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,5,20,ECS: extradural cortical stimulation,Other,50,Hz,96,After stroke,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Garcia Score,NR,NR,NR,NR,NR,NR,No,Yes
Kim_2018,"Kim, M. J.",2018,Pretreatment with Shuanghe-Tang Extract Attenuates Postischemic Brain Injury and Edema in a Mouse Model of Stroke: An Analysis of Medicinal Herbs Listed in Dongui Bogam,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,NR,NR,NR,1,9,2,4,2,4.5,Nitrous oxide,Isoflurane,Skull breached,Sensorimotor cortex,10,mg/ml,NA,NR,NA,NA,LED,LED,NR,NR,15,Shuanghe-tang,Other,500,mg/kg,-96,Before stroke,24,TTC (ex vivo),52.13,4.68,24.37,0.38,NA,NA,mm3,SEM,10.24346152,4.788665972,14.04,2.758837515,0.76,0-4 limb scale,2.5,0.17,1.74,0.26,SEM,24,No,Yes
Kim_2018,"Kim, M. J.",2018,Pretreatment with Shuanghe-Tang Extract Attenuates Postischemic Brain Injury and Edema in a Mouse Model of Stroke: An Analysis of Medicinal Herbs Listed in Dongui Bogam,b,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,NR,NR,NR,1,9,2,4,2,4.5,Nitrous oxide,Isoflurane,Skull breached,Sensorimotor cortex,10,mg/ml,NA,NR,NA,NA,LED,LED,NR,NR,15,Zengsunsiwu-tang,Other,500,mg/kg,-96,Before stroke,24,TTC (ex vivo),52.13,4.68,36.19,4.31,NA,NA,mm3,SEM,10.24346152,7.111277043,14.04,2.758837515,8.62,0-4 limb scale,2.5,0.17,2,0,SEM,24,No,Yes
Kimura_2005,"Kimura, R.",2005,Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction,a,Rat,Wistar,Male,None,NA,NR,NR,NR,230,265,300,1,15,1,10,1,15,Nitrous oxide,Halothane,Skull thinned,Cerebral cortex,NR,NR,NA,NR,NR,NA,NR,NR,NR,NR,NR,VEGF antagonist (Vascular endothelial growth factor antagonist),Blood flow,2,mg/kg,0,During stroke,24,MRI (in vivo),3.96,1.13,0.58,0.28,NA,NA,mm3,SEM,0.200913242,0.029426687,4.376471181,0.222043185,0.885437745,None,NA,NA,NA,NA,NA,NA,No,No
Kitayama_2001,"Kitayama, J.",2001,Inhibition of Na+/H+ exchanger reduces infarct volume of focal cerebral ischemia in rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,22,28.5,35,330,384,438,1,10,1,10,1,10,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,NR,4,FR183998,Excitotoxicity,1,mg/kg,0,During stroke,72,TTC (ex vivo),115,12,82,8,NA,NA,mm3,SEM,5.834601725,4.160324708,37.94733192,1.925283203,25.29822128,None,NA,NA,NA,NA,NA,NA,No,No
Kleinschnitz_2003,"Kleinschnitz, C.",2003,In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging,a,Rat,Wistar,Male,None,NA,NR,NR,NR,220,235,250,1,58,0,NA,NA,NA,Enflurane,NA,"Scalp retracted, skull intact",NR,10,g/L,17.0212766,NR,NA,NA,Cold light,NR,NR,NR,20,None,NA,NA,NA,NA,NA,24,MRI (in vivo),15.08,0.93,NA,NA,NA,NA,mm3,NR,0.765093861,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kleinschnitz_2008,"Kleinschnitz, C.",2008,Blocking of platelets or intrinsic coagulation pathway-driven thrombosis does not prevent cerebral infarctions induced by photothrombosis,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,20,5,18,5,4,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",NR,10,g/L,88.88888889,NR,NA,NA,Cold light,NR,NR,NR,20,Anti-GPIbalpha antibodies,Thrombolytics,100,ug,-24,Before stroke,24,MRI (in vivo),12.2,3.8,10.8,3.2,NA,NA,Indirect rLV % hemisphere,SD,6.1,5.4,3.8,1.9,3.2,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Kleinschnitz_2008,"Kleinschnitz, C.",2008,Blocking of platelets or intrinsic coagulation pathway-driven thrombosis does not prevent cerebral infarctions induced by photothrombosis,b,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,20,5,9,5,4,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",NR,10,g/L,88.88888889,NR,NA,NA,Cold light,NR,NR,NR,20,JON/A-F(ab)2,Thrombolytics,100,ug,-24,Before stroke,24,MRI (in vivo),12.2,3.8,9.2,2.8,NA,NA,Indirect rLV % hemisphere,SD,6.1,4.6,3.8,1.9,2.8,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Kleinschnitz_2008,"Kleinschnitz, C.",2008,Blocking of platelets or intrinsic coagulation pathway-driven thrombosis does not prevent cerebral infarctions induced by photothrombosis,c,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,20,5,7,5,4,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",NR,10,g/L,88.88888889,NR,NA,NA,Cold light,NR,NR,NR,20,Low-molecular-weight heparin (LMWH),Thrombolytics,NR,NA,-24,Before stroke,24,MRI (in vivo),12.2,3.8,13.8,2.9,NA,NA,Indirect rLV % hemisphere,SD,6.1,6.9,3.8,1.9,2.9,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Kleinschnitz_2005,"Kleinschnitz, C.",2005,In vivo detection of developing vessel occlusion in photothrombotic ischemic brain lesions in the rat by iron particle enhanced MRI,a,Rat,Wistar,Male,None,NA,NR,NR,NR,200,210,220,1,6,0,NA,NA,NA,Enflurane,NA,"Scalp retracted, skull intact",NR,10,g/L,19.04761905,NR,NA,NA,Cold light,NR,NR,NR,20,None,NA,NA,NA,NA,NA,24,MRI (in vivo),8.79,2.39,NA,NA,NA,NA,Indirect rLV % hemisphere,SD,4.395,NA,2.39,1.195,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kluska_2005,"Kluska, M. M.",2005,"Neurogenesis in the adult dentate gyrus after cortical infarcts: effects of infarct location, N-methyl-D-aspartate receptor blockade and anti-inflammatory treatment",a,Rat,Wistar,Male,None,NA,12,13,14,280,295,310,1,7,2,5,2,3.5,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",Somatosensory cortex,1.3,mg/100mg,NA,NR,NA,NA,Cold light,NR,NR,NR,20,MK-801 (dizocilpine maleate),Excitotoxicity,2,mg/kg,-0.5,Before stroke,672,Other histology (ex vivo),1.9,0.4,2.4,0.5,NA,NA,mm (diameter),SD,NA,NA,0.4,NA,0.5,None,NA,NA,NA,NA,NA,NA,Yes,No
Kluska_2005,"Kluska, M. M.",2005,"Neurogenesis in the adult dentate gyrus after cortical infarcts: effects of infarct location, N-methyl-D-aspartate receptor blockade and anti-inflammatory treatment",b,Rat,Wistar,Male,None,NA,12,13,14,280,295,310,1,7,2,6,2,3.5,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",Somatosensory cortex,1.3,mg/100mg,NA,NR,NA,NA,Cold light,NR,NR,NR,20,Indomethacin,Anti-inflammation,2.5,mg/kg,-24,Before stroke,672,Other histology (ex vivo),1.9,0.4,2.5,0.2,NA,NA,mm (diameter),SD,NA,NA,0.4,NA,0.2,None,NA,NA,NA,NA,NA,NA,Yes,No
Knieling_2009,"Knieling, M.",2009,Enriched environment promotes efficiency of compensatory movements after cerebral ischemia in rats,a,Rat,Wistar,Male,None,NA,NR,NR,NR,280,290,300,2,8,0,NA,NA,NA,Enflurane,NA,"Scalp retracted, skull intact",Forelimb motor cortex,0.4,mL,NA,NR,NA,NA,Cold light,NR,NR,2.4,20,None,NA,NA,NA,NA,NA,672,Other histology (ex vivo),7.6,1.2,NA,NA,NA,NA,mm3,SEM,0.385591071,NA,3.39411255,0.172202565,NA,Other,22.5,NR,NA,NA,SEM,72,Yes,No
Knieling_2009,"Knieling, M.",2009,Enriched environment promotes efficiency of compensatory movements after cerebral ischemia in rats,b,Rat,Wistar,Male,None,NA,NR,NR,NR,280,290,300,2,8,0,NA,NA,NA,Enflurane,NA,"Scalp retracted, skull intact",Forelimb and hindlimb motor cortex,0.4,mL,NA,NR,NA,NA,Cold light,NR,NR,6,20,None,NA,NA,NA,NA,NA,672,Other histology (ex vivo),27.6,2.5,NA,NA,NA,NA,mm3,SEM,1.400304414,NA,7.071067812,0.358755343,NA,Other,16,3.7,NA,NA,SEM,72,Yes,No
Knieling_2009,"Knieling, M.",2009,Enriched environment promotes efficiency of compensatory movements after cerebral ischemia in rats,c,Rat,Wistar,Male,None,NA,NR,NR,NR,280,290,300,1,10,1,14,1,10,Enflurane,NA,"Scalp retracted, skull intact",Forelimb and hindlimb motor cortex,0.4,mL,NA,NR,NA,NA,Cold light,NR,NR,7,20,Enriched cage environment,Other,NA,NA,2,After stroke,672,Other histology (ex vivo),22.7,1.6,24.3,1.1,NA,NA,mm3,SEM,1.151699645,1.232876712,5.059644256,0.256704427,4.115823125,Other,22.6,NR,24.1,NR,SEM,672,Yes,No
Koroleva_1998,"Koroleva, V. I.",1998,The effect of MK-801 and of brain-derived polypeptides on the development of ischemic lesion induced by photothrombotic occlusion of the distal middle cerebral artery in rats,a,Rat,Long Evans,Male,None,NA,NR,13,NR,NR,NR,NR,1,18,2,11,2,9,Sodium Pentobarbital,NA,Skull breached,Distal middle cerebral artery (dMCA),12.5,mg/kg,12.5,10,mW/mm2,1,Halogen lamp,Halogen,545,1,10,Cerebrolysin,Anti-apoptosis/regeneration,2.5,ml/kg,1,After stroke,384,Other histology (ex vivo),13.77,1.23,10.96,1.06,NA,NA,mm3,SEM,0.698630137,0.556062912,5.218448045,0.264761443,3.515622278,None,NA,NA,NA,NA,NA,NA,No,No
Koroleva_1998,"Koroleva, V. I.",1998,The effect of MK-801 and of brain-derived polypeptides on the development of ischemic lesion induced by photothrombotic occlusion of the distal middle cerebral artery in rats,b,Rat,Long Evans,Male,None,NA,NR,13,NR,NR,NR,NR,1,18,2,11,2,9,Sodium Pentobarbital,NA,Skull breached,Distal middle cerebral artery (dMCA),12.5,mg/kg,12.5,10,mW/mm2,1,Halogen lamp,Halogen,545,1,10,MK-801 (dizocilpine maleate),Excitotoxicity,0.5,mg/kg,1,After stroke,384,Other histology (ex vivo),13.77,1.23,21.14,2.46,NA,NA,mm3,SEM,0.698630137,1.072552004,5.218448045,0.264761443,8.158896984,None,NA,NA,NA,NA,NA,NA,No,No
Krysl_2012,"Krysl, D.",2012,Perifocal and remote blood-brain barrier disruption in cortical photothrombotic ischemic lesion and its modulation by the choice of anesthesia,a,Rat,Wistar,Male,None,NA,NR,9,NR,200,210,220,2,8,0,NA,NA,NA,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,20,mg/kg,20,50,mW/mm2,5,Diode laser,Diode laser,532,1,18,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),9.36,10.64,NA,NA,NA,NA,mm3,SEM,0.474885845,NA,30.09446461,1.52686274,NA,None,NA,NA,NA,NA,NA,NA,No,No
Krysl_2012,"Krysl, D.",2012,Perifocal and remote blood-brain barrier disruption in cortical photothrombotic ischemic lesion and its modulation by the choice of anesthesia,b,Rat,Wistar,Male,None,NA,NR,9,NR,200,210,220,2,8,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,20,mg/kg,20,50,mW/mm2,5,Diode laser,Diode laser,532,1,18,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),8.31,2.14,NA,NA,NA,NA,mm3,SEM,0.421613394,NA,6.052834047,0.307094574,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kuroiwa_2016,"Kuroiwa, T.",2016,Analysis of Small Ischemic Lesions in the Examinees of a Brain Dock and Neurological Examination of Animals Subjected to Cortical or Basal Ganglia Photothrombotic Infarction,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,NR,NR,NR,3,NR,0,NA,NA,NA,Nitrous oxide,Isoflurane,NR,Parietal cortex,20,mg/kg,20,NR,NA,NA,NR,NR,NR,0.75,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),7.04,1.18,NA,NA,NA,NA,mm3,SD,0.357179097,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kuroiwa_2016,"Kuroiwa, T.",2016,Analysis of Small Ischemic Lesions in the Examinees of a Brain Dock and Neurological Examination of Animals Subjected to Cortical or Basal Ganglia Photothrombotic Infarction,b,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,NR,NR,NR,3,NR,0,NA,NA,NA,Nitrous oxide,Isoflurane,NR,Parietal cortex,20,mg/kg,20,NR,NA,NA,NR,NR,NR,0.5,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),4.2,1.24,NA,NA,NA,NA,mm3,SD,0.213089802,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kuroiwa_2016,"Kuroiwa, T.",2016,Analysis of Small Ischemic Lesions in the Examinees of a Brain Dock and Neurological Examination of Animals Subjected to Cortical or Basal Ganglia Photothrombotic Infarction,c,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,NR,NR,NR,3,NR,0,NA,NA,NA,Nitrous oxide,Isoflurane,NR,Parietal cortex,20,mg/kg,20,NR,NA,NA,NR,NR,NR,0.5,5,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),1.2,0.25,NA,NA,NA,NA,mm3,SD,0.060882801,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Kuroiwa_2009,"Kuroiwa, T.",2009,Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,270,295,320,6,5,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull breached,Caudoputamen,20,mg/ml,20,1700,lux,0.000248897,Halogen lamp,Halogen,535,0.5,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),4.16,0.56,NA,NA,NA,NA,mm3,SEM,0.211060375,NA,1.252198067,0.063531104,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kuroiwa_2009,"Kuroiwa, T.",2009,Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen,b,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,270,295,320,6,2,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull breached,Caudoputamen,20,mg/ml,20,2500,lux,0.000366025,Halogen lamp,Halogen,535,0.75,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),7.06,0.53,NA,NA,NA,NA,mm3,SEM,0.35819381,NA,0.749533188,0.038028066,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kuroiwa_2009,"Kuroiwa, T.",2009,Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen,c,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,270,295,320,6,2,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull breached,Caudoputamen,20,mg/ml,20,1700,lux,0.000248897,Halogen lamp,Halogen,535,0.5,5,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),1.25,0.1,NA,NA,NA,NA,mm3,SEM,0.063419584,NA,0.141421356,0.007175107,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Kuroiwa_2009,"Kuroiwa, T.",2009,Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen,d,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,270,295,320,1,6,2,6,2,3,Nitrous oxide,Isoflurane,Skull breached,Caudoputamen,20,mg/ml,20,1700,lux,0.000248897,Halogen lamp,Halogen,535,0.5,10,Aspirin,Thrombolytics,30,mg/kg,-2,Before stroke,24,Other histology (ex vivo),5.03,0.83,3.45,0.67,NA,NA,mm3,SEM,0.255200406,0.175038052,2.033076487,0.103149492,1.641158128,None,NA,NA,NA,NA,NA,NA,No,No
Kuroiwa_2009,"Kuroiwa, T.",2009,Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen,e,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,270,295,320,1,6,2,6,2,3,Nitrous oxide,Isoflurane,Skull breached,Caudoputamen,20,mg/ml,20,1700,lux,0.000248897,Halogen lamp,Halogen,535,0.5,10,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,10,mg/kg,0.5,After stroke,24,Other histology (ex vivo),5.03,0.83,1.95,0.74,NA,NA,mm3,SEM,0.255200406,0.098934551,2.033076487,0.103149492,1.81262241,None,NA,NA,NA,NA,NA,NA,No,No
Kurtys_2019,"Kurtys, E.",2019,Therapeutic effects of dietary intervention on neuroinflammation and brain metabolism in a rat model of photothrombotic stroke,a,Rat,Sprague-Dawley,Male,None,NA,NR,10,NR,299,302,305,2,5,4,5,2,2.5,Ketamine,Medetomidine,"Scalp retracted, skull intact",Somatosensory cortex,20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,20,Diet change,Other,NA,NA,1,After stroke,504,Other histology (ex vivo),5.78,1.82,3.8,0.59,NA,NA,mm2,SEM,NA,NA,4.069643719,NA,1.319280107,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Ladwig_2018,"Ladwig, A.",2018,Osteopontin Attenuates Secondary Neurodegeneration in the Thalamus after Experimental Stroke,a,Rat,Wistar,Male,None,NA,NR,NR,NR,200,250,300,1,7,1,8,1,7,Ketamine,Medetomidine,"Scalp retracted, skull intact",NR,1,ug/g,1,150,W,NA,Cold light,NR,NR,1.5,20,Osteopontin (OPN),Anti-inflammation,500,ug,0,During stroke,192,Other histology (ex vivo),40.23,13.91,22.26,5.326,NA,NA,mm3,SEM,2.04109589,1.129375951,36.80240074,1.867194355,15.06420287,None,NA,NA,NA,NA,NA,NA,No,No
Ladwig_2017,"Ladwig, A.",2017,Osteopontin Augments M2 Microglia Response and Separates M1- and M2-Polarized Microglial Activation in Permanent Focal Cerebral Ischemia,a,Rat,Fischer 344,Male,None,NA,NR,NR,NR,200,250,300,1,7,1,8,1,7,Ketamine,Medetomidine,"Scalp retracted, skull intact",NR,1,ug/g,1,150,W,NA,Cold light,NR,NR,1.5,20,Osteopontin (OPN),Anti-inflammation,500,ug,24,After stroke,192,Other histology (ex vivo),1949728,1179348,1331522,332880,NA,NA,um2,SD,NA,NA,1179348,NA,332880,None,NA,NA,NA,NA,NA,NA,No,No
Lai_2015,"Lai, S.",2015,Quantitative kinematic characterization of reaching impairments in mice after a stroke,a,Mouse,C57BL/6,Male,None,NA,8,9,10,22,24.5,27,1,7,0,NA,NA,NA,NR,NA,"Scalp retracted, skull intact",Cerebral cortex,10,mg/ml,81.63265306,NR,NA,NA,Cold light,NR,NR,NR,15,None,NA,NA,NA,NA,NA,720,Other histology (ex vivo),1.22,0.57,NA,NA,NA,NA,mm3,SEM,0.239728046,NA,1.508078247,0.29633496,NA,None,NA,NA,NA,NA,NA,NA,No,No
Lanens_1993,"Lanens, D.",1993,Complementary use of T2- and postcontrast T1-weighted NMR images for the sequential monitoring of focal ischemic lesions in the rat brain,a,Rat,Wistar,Female,None,NA,NR,NR,NR,250,275,300,1,12,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",Cerebral cortex,10,mg/kg,10,150,W,NA,Halogen lamp,Halogen,NR,2.5,30,None,NA,NA,NA,NA,NA,24,MRI (in vivo),16.9,1.9,NA,NA,NA,NA,mm2,SEM,NA,NA,6.581793069,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Lapash Daniels_2009,"Lapash Daniels, C. M.",2009,Axon sprouting in adult mouse spinal cord after motor cortex stroke,a,Mouse,C57BL/6,Male,None,NA,NR,14,NR,NR,NR,NR,1,3,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Motor cortex,20,mg/ml,NA,50,mW,NA,Halogen lamp,Halogen,562,1.5,15,None,NA,NA,NA,NA,NA,672,Other histology (ex vivo),1.2,0.2,NA,NA,NA,NA,mm (diameter),SEM,NA,NA,0.346410162,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Lee_2016,"Lee, H. I.",2016,Pre-conditioning with transcranial low-level light therapy reduces neuroinflammation and protects blood-brain barrier after focal cerebral ischemia in mice,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,10,1,10,1,10,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Sensorimotor cortex,10,mg/ml,44.44444444,NR,NA,NA,LED,LED,NR,4,15,LLLT (Low-level light therapy),Anti-inflammation,1.7,mW/cm2,-48,Before stroke,24,TTC (ex vivo),77.2,4,50.8,3.4,NA,NA,mm3,SEM,15.16967637,9.982118646,12.64911064,2.485529984,10.75174404,0-4 limb scale,0.45,0.17,0,0,SEM,24,No,No
Lee_2007,"Lee, J. K.",2007,Photochemically induced cerebral ischemia in a mouse model,a,Mouse,C57BL/6,Male,None,NA,8,9,10,20,22.5,25,1,15,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,10,mg/ml,44.44444444,NR,NA,NA,LCD,NR,NR,4.5,15,None,NA,NA,NA,NA,NA,672,Other histology (ex vivo),11.97,0.99,NA,NA,NA,NA,Indirect rLV % cortex,SEM,NA,NA,3.834253513,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Lee_2011,"Lee, M. C.",2011,Stem cell dynamics in an experimental model of stroke,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,180,255,330,1,NR,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",Frontal cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,6,2,None,NA,NA,NA,NA,NA,24,MRI (in vivo),56.89,NR,NA,NA,NA,NA,NR,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Lee_2014,"Lee, S. V.",2014,Hexane extracts of Polygonum multiflorum improve tissue and functional outcome following focal cerebral ischemia in mice,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,5,3,5,3,1.666666667,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,LCD,NR,NR,4,15,Polygonum multiflorum hexane extract (HEPM),Blood flow,100,mg/kg,-0.5,Before stroke,24,TTC (ex vivo),60.58,4.79,20.56,3.19,NA,NA,mm3,SEM,11.90387298,4.040007074,10.71076561,2.10464829,7.133056848,0-4 limb scale,1.5,0.19,0.4,0.31,SEM,24,No,Yes
Lee_2014,"Lee, S. V.",2014,Hexane extracts of Polygonum multiflorum improve tissue and functional outcome following focal cerebral ischemia in mice,b,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,5,3,5,3,1.666666667,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,LCD,NR,NR,4,15,Polygonum multiflorum ethyl acetate extract (EAEPM),Blood flow,100,mg/kg,-0.5,Before stroke,24,TTC (ex vivo),60.58,4.79,34.74,5.02,NA,NA,mm3,SEM,11.90387298,6.826354365,10.71076561,2.10464829,11.22506125,0-4 limb scale,1.5,0.19,1.33,0.33,SEM,24,No,No
Lee_2014,"Lee, S. V.",2014,Hexane extracts of Polygonum multiflorum improve tissue and functional outcome following focal cerebral ischemia in mice,c,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,5,3,5,3,1.666666667,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,LCD,NR,NR,4,15,Polygonum multiflorum methanol extract (MEPM),Blood flow,100,mg/kg,-0.5,Before stroke,24,TTC (ex vivo),60.58,4.79,29.04,9.57,NA,NA,mm3,SEM,11.90387298,5.706313494,10.71076561,2.10464829,21.39917054,0-4 limb scale,1.5,0.19,2,0.34,SEM,24,No,No
Leistra_1993,"Leistra, H. P.",1993,Effect of the histamine antagonist cimetidine on infarct size in the rat,a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,297.5,355,1,6,2,6,2,3,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,560,NR,4,Cimetidine,Blood flow,5,mg/kg,-0.25,Before stroke,120,Other histology (ex vivo),56,6,50,8,NA,NA,mm3,SEM,2.841197362,2.536783359,14.69693846,0.745658978,19.59591794,None,NA,NA,NA,NA,NA,NA,No,Yes
Lembach_2018,"Lembach, A.",2018,Sex-Dependent Effects of Bmal1-Deficiency on Mouse Cerebral Cortex Infarction in Response to Photothrombotic Stroke,a,Mouse,Bmal1+/+,Male,None,NA,8,10,12,NR,NR,NR,8,4.5,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,43,mg/kg,43,2500,lux,0.000366025,LCD,NR,NR,1.5,15,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),0.14,NR,NA,NA,NA,NA,mm3,NR,0.027509776,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Lembach_2018,"Lembach, A.",2018,Sex-Dependent Effects of Bmal1-Deficiency on Mouse Cerebral Cortex Infarction in Response to Photothrombotic Stroke,b,Mouse,Bmal1+/+,Female,None,NA,8,10,12,NR,NR,NR,8,4.5,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,43,mg/kg,43,2500,lux,0.000366025,LCD,NR,NR,1.5,15,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),0.25,NR,NA,NA,NA,NA,mm3,NR,0.0491246,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Lembach_2018,"Lembach, A.",2018,Sex-Dependent Effects of Bmal1-Deficiency on Mouse Cerebral Cortex Infarction in Response to Photothrombotic Stroke,c,Mouse,Bmal1-/-,Male,None,NA,8,10,12,NR,NR,NR,8,4.5,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,43,mg/kg,43,2500,lux,0.000366025,LCD,NR,NR,1.5,15,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),0.03,NR,NA,NA,NA,NA,mm3,NR,0.005894952,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Lembach_2018,"Lembach, A.",2018,Sex-Dependent Effects of Bmal1-Deficiency on Mouse Cerebral Cortex Infarction in Response to Photothrombotic Stroke,d,Mouse,Bmal1-/-,Female,None,NA,8,10,12,NR,NR,NR,8,4.5,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,43,mg/kg,43,2500,lux,0.000366025,LCD,NR,NR,1.5,15,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),0.23,NR,NA,NA,NA,NA,mm3,NR,0.045194632,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Lemmens_2013,"Lemmens, R.",2013,Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke,a,Mouse,C57BL/6,Male,None,NA,13,15,17,NR,NR,NR,2,6,2,6,1,6,Isoflurane,NA,"Scalp retracted, skull intact",NR,3,mg/ml,NA,NR,NA,NA,NR,NR,565,2.4,5,Y-27632,Multiple mechanisms,30,mg/kg,72,After stroke,864,Other histology (ex vivo),29.2,2,30.3,2.2,NA,NA,Indirect rLV % cortex,SEM,NA,NA,4.898979486,NA,5.388877434,None,NA,NA,NA,NA,NA,NA,No,No
Lemmens_2013,"Lemmens, R.",2013,Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke,b,Mouse,C57BL/6,Male,None,NA,13,15,17,NR,NR,NR,2,4,2,5,1,4,Isoflurane,NA,"Scalp retracted, skull intact",NR,3,mg/ml,NA,NR,NA,NA,NR,NR,565,2.4,5,Fasudil,Blood flow,60,mg/kg,72,After stroke,1032,Other histology (ex vivo),22.2,0.7,25.9,4,NA,NA,Indirect rLV % cortex,SEM,NA,NA,1.4,NA,8.94427191,None,NA,NA,NA,NA,NA,NA,No,No
Levi_2012,"Levi, H.",2012,Stimulation of the sphenopalatine ganglion induces reperfusion and blood-brain barrier protection in the photothrombotic stroke model,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,300,350,400,1,9,2,8,2,4.5,Ketamine,Xylazine,Skull breached,NR,7.5,mg/ml,9.975,NR,NA,NA,Halogen lamp,Halogen,561,NR,15,ES (electrical stimulation),Other,2,mA,0.25,After stroke,504,Other histology (ex vivo),37.1,6,17.9,5.1,NA,NA,Indirect rLV % cortex,SEM,NA,NA,18,NA,14.42497834,None,NA,NA,NA,NA,NA,NA,No,Yes
Li_2017,"Li, H.",2017,"Low-intensity (400 mW/cm(2), 500 kHz) pulsed transcranial ultrasound preconditioning may mitigate focal cerebral ischemia in rats",a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,300,320,340,1,8,1,12,1,8,Isoflurane,NA,Skull thinned,Primary hindlimb somatosensory cortex,80,mg/kg,80,NR,NA,NA,NR,NR,532,1.5,10,pTUS (pulsed transcranial ultrasound stimulation),Multiple mechanisms,100,Hz,-1,Before stroke,48,TTC (ex vivo),3.215,0.401,1.77,0.169,NA,NA,Indirect rLV % hemisphere,SD,1.6075,0.885,0.401,0.2005,0.169,None,NA,NA,NA,NA,NA,NA,No,No
Li_2015_a,"Li, H.",2015,Disruption of IP(3)R2-mediated Ca(2)(+) signaling pathway in astrocytes ameliorates neuronal death and brain damage while reducing behavioral deficits after focal ischemic stroke,a,Mouse,Wild type (WT),Mixed,None,NA,8,9,10,NR,NR,NR,2,11,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",Somatosensory cortex,30,mg/kg,30,13,mW,NA,Metal-halide lamp,Metal-halide,560,1.5,2,None,NA,NA,NA,NA,NA,4,Other histology (ex vivo),2.65,0.06,NA,NA,NA,NA,Indirect rLV % hemisphere,SEM,1.325,NA,0.198997487,0.099498744,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Li_2015_a,"Li, H.",2015,Disruption of IP(3)R2-mediated Ca(2)(+) signaling pathway in astrocytes ameliorates neuronal death and brain damage while reducing behavioral deficits after focal ischemic stroke,b,Mouse,IP3R2 knockout,Mixed,None,NA,8,9,10,NR,NR,NR,2,11,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",Somatosensory cortex,30,mg/kg,30,13,mW,NA,Metal-halide lamp,Metal-halide,560,1.5,2,None,NA,NA,NA,NA,NA,4,Other histology (ex vivo),1.84,0.12,NA,NA,NA,NA,Indirect rLV % hemisphere,SEM,0.92,NA,0.397994975,0.198997487,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Li_2013_a,"Li, H.",2013,Inhibition of the group I mGluRs reduces acute brain damage and improves long-term histological outcomes after photothrombosis-induced ischaemia,a,Mouse,C57BL/6,Male,None,NA,8,9,10,NR,NR,NR,1,21,5,4,5,4.2,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,30,mg/kg,30,NR,NA,NA,Metal-halide lamp,Metal-halide,560,1.5,2,MPEP (pyridine),Excitotoxicity,1,mg/kg,3,After stroke,24,Other histology (ex vivo),17.23,0.71,14.14,0.96,NA,NA,mm3,SEM,3.385667407,2.778487355,3.253628743,0.639332838,1.92,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Li_2013_a,"Li, H.",2013,Inhibition of the group I mGluRs reduces acute brain damage and improves long-term histological outcomes after photothrombosis-induced ischaemia,b,Mouse,C57BL/6,Male,None,NA,8,9,10,NR,NR,NR,1,21,5,7,5,4.2,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,30,mg/kg,30,NR,NA,NA,Metal-halide lamp,Metal-halide,560,1.5,2,LY367385,Excitotoxicity,1,mg/kg,3,After stroke,24,Other histology (ex vivo),17.23,0.71,13.72,0.32,NA,NA,mm3,SEM,3.385667407,2.695958028,3.253628743,0.639332838,0.84664042,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Li_2013_a,"Li, H.",2013,Inhibition of the group I mGluRs reduces acute brain damage and improves long-term histological outcomes after photothrombosis-induced ischaemia,c,Mouse,C57BL/6,Male,None,NA,8,9,10,NR,NR,NR,1,21,5,7,5,4.2,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,30,mg/kg,30,NR,NA,NA,Metal-halide lamp,Metal-halide,560,1.5,2,Calpeptin,Excitotoxicity,0.6,mg/kg,3,After stroke,24,Other histology (ex vivo),17.23,0.71,10.71,0.67,NA,NA,mm3,SEM,3.385667407,2.104497848,3.253628743,0.639332838,1.772653378,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Li_2014,"Li, H.",2014,"Histological, cellular and behavioral assessments of stroke outcomes after photothrombosis-induced ischemia in adult mice",a,Mouse,C57BL/6,Male,None,NA,NR,9,NR,NR,NR,NR,9,5,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",Somatosensory cortex,30,mg/kg,30,NR,NA,NA,Metal-halide lamp,Metal-halide,560,1.5,2,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),17.16,0.63,NA,NA,NA,NA,mm3,SEM,3.371912519,NA,1.408722826,0.276811779,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Li_2010,"Li, J.",2010,Human mesenchymal stem cell transplantation protects against cerebral ischemic injury and upregulates interleukin-10 expression in Macacafascicularis,a,Primate,"Cynomolgus monkey (Macaca fascicularis, crab-eating macaque)",Male,None,NA,209,261,313,3800,3900,4000,1,2,2,3,2,1,Ketamine,NA,Skull breached,Cerebral cortex,35,mg/kg,35,NR,NA,NA,LCD,NR,NR,NR,10,hBMSC (human bone marrow mesenchymal stem cell),Multiple mechanisms,10000000,Cells,NR,NR,336,Other histology (ex vivo),2368,163,1156,270,NA,NA,mm2,SD,NA,NA,163,NA,270,Kito 100 point score,NR,NR,NR,NR,NR,NR,No,Yes
Li_2018,"Li, M.",2018,Platelet bio-nanobubbles as microvascular recanalization nanoformulation for acute ischemic stroke lesion theranostics,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,19,20.5,22,1,5,2,5,2,2.5,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Cerebral cortex,10,uL/g,NA,NR,NA,NA,Cold light,NR,NR,4,15,PMV (platelet membrane vesicles),Thrombolytics,200,uL,NR,NR,24,TTC (ex vivo),16.24,1.47,12.74,3.23,NA,NA,Indirect rLV % hemisphere,SD,8.12,6.37,1.47,0.735,3.23,None,NA,NA,NA,NA,NA,NA,Yes,No
Li_2018,"Li, M.",2018,Platelet bio-nanobubbles as microvascular recanalization nanoformulation for acute ischemic stroke lesion theranostics,b,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,19,20.5,22,1,5,2,5,2,2.5,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Cerebral cortex,10,uL/g,NA,NR,NA,NA,Cold light,NR,NR,4,15,PNB (platelet membrane-derived nanobubbles),Thrombolytics,200,uL,NR,NR,24,TTC (ex vivo),16.24,1.47,8.71,1.12,NA,NA,Indirect rLV % hemisphere,SD,8.12,4.355,1.47,0.735,1.12,None,NA,NA,NA,NA,NA,NA,Yes,No
Li_2015_b,"Li, P. C.",2015,Cystamine improves functional recovery via axon remodeling and neuroprotection after stroke in mice,a,Mouse,C57BL/6,Male,None,NA,8,9,10,20,22.75,25.5,1,8,2,8,2,4,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",NR,100,mg/kg,100,NR,NA,NA,LCD,NR,NR,4,15,Cystamine,Anti-apoptosis/regeneration,100,mg/kg,24,After stroke,168,MRI (in vivo),16.21,2.11,15.06,0.95,NA,NA,Indirect rLV % hemisphere,SEM,8.105,7.53,5.967981233,2.983990617,2.687005769,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Li_2013_b,"Li, S.",2013,Hypoxic preconditioning stimulates angiogenesis in ischemic penumbra after acute cerebral infarction,a,Mouse,BALB/c,Mixed,None,NA,6,7,8,18,20,22,1,6,1,6,1,6,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,100,mg/kg,100,150,W,NA,Metal-halide lamp,Metal-halide,530,3,10,Hypoxic preconditioning,Blood flow,30,Minutes,-0.5,Before stroke,72,Other histology (ex vivo),287.7,12.6,185.7,11.7,NA,NA,mm3,SD,56.53258926,36.48975261,12.6,2.475879822,11.7,Garcia Score,9.5,1.29,11.75,0.96,SD,72,No,No
Liao_2014,"Liao, L. D.",2014,Improving neurovascular outcomes with bilateral forepaw stimulation in a rat photothrombotic ischemic stroke model,a,Rat,Wistar,Male,None,NA,NR,NR,NR,200,225,250,1,6,4,6,4,1.5,Sodium Pentobarbital,NA,Skull breached,Distal middle cerebral artery (dMCA),10,mg/ml,20,0.5,mW,NA,Continuous wave (CW) laser light,NR,532,NR,20,Peripheral sensory electrical stimulation (PSS),Other,2,mA,0,During stroke,48,TTC (ex vivo),21.28,1.81,3.28,1.66,NA,NA,Indirect rLV % hemisphere,SD,10.64,1.64,1.81,0.905,1.66,None,NA,NA,NA,NA,NA,NA,No,Yes
Liao_2015,"Liao, L. D.",2015,Rescue of cortical neurovascular functions during the hyperacute phase of ischemia by peripheral sensory stimulation,a,Rat,Wistar,Male,None,NA,NR,NR,NR,250,275,300,1,6,3,8,3,2,Sodium Pentobarbital,NA,Skull breached,Distal middle cerebral artery (dMCA),10,mg/ml,20,10,mW,NA,Continuous wave (CW) laser light,NR,532,NR,15,Peripheral sensory electrical stimulation (PSS),Other,2,mA,0,During stroke,48,TTC (ex vivo),13.7,1.7,4.6,2.1,NA,NA,Indirect rLV % hemisphere,SD,6.85,2.3,1.7,0.85,2.1,None,NA,NA,NA,NA,NA,NA,No,Yes
Lie_2017,"Lie, M. E.",2017,GAT3 selective substrate l-isoserine upregulates GAT3 expression and increases functional recovery after a focal ischemic stroke in mice,a,Mouse,C57BL/6,Male,None,NA,9,13,17,25,27,29,1,8,2,8,2,4,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,g/L,74.07407407,NR,NA,NA,LCD,NR,NR,2,15,L-isoserine,Excitotoxicity,38,uM,120,After stroke,1008,Other histology (ex vivo),NR,NR,NR,NR,NA,NA,mm3,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Lie_2018,"Lie, M. E.",2018,Inhibition of GABA transporters fails to afford significant protection following focal cerebral ischemia,a,Mouse,C57BL/6,Male,None,NA,9,13,17,24,27,30,2,10,4,6,2,5,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,g/L,74.07407407,NR,NA,NA,LCD,NR,NR,2,15,Tiagabine,Excitotoxicity,1,mg/kg,1,After stroke,168,Other histology (ex vivo),2.18,1.02,1.87,0.86,NA,NA,mm3,SD,0.428366509,0.367452005,1.02,0.200428367,0.86,None,NA,NA,NA,NA,NA,NA,No,Yes
Lie_2018,"Lie, M. E.",2018,Inhibition of GABA transporters fails to afford significant protection following focal cerebral ischemia,b,Mouse,C57BL/6,Male,None,NA,9,13,17,24,27,30,1,8,2,7,2,4,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,g/L,74.07407407,NR,NA,NA,LCD,NR,NR,2,15,(S)-SNAP-5114,Excitotoxicity,5,mg/kg,1,After stroke,168,Other histology (ex vivo),2.41,0.7,2.21,0.43,NA,NA,mm3,SD,0.47356114,0.434261461,0.7,0.137548879,0.43,None,NA,NA,NA,NA,NA,NA,No,Yes
Lie_2018,"Lie, M. E.",2018,Inhibition of GABA transporters fails to afford significant protection following focal cerebral ischemia,c,Mouse,C57BL/6,Male,None,NA,9,13,17,24,27,30,2,10,4,8,2,5,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,g/L,74.07407407,NR,NA,NA,LCD,NR,NR,2,15,EF-1502,Excitotoxicity,1,mg/kg,1,After stroke,168,Other histology (ex vivo),2.18,1.02,1.96,0.8,NA,NA,mm3,SD,0.428366509,0.385136861,1.02,0.200428367,0.8,None,NA,NA,NA,NA,NA,NA,No,Yes
Liebigt_2012,"Liebigt, S.",2012,Effects of rehabilitative training and anti-inflammatory treatment on functional recovery and cellular reorganization following stroke,a,Rat,Wistar,Male,None,NA,NR,13,NR,250,275,300,2,9,4,10,2,4.5,Nitrous oxide,Isoflurane,NR,Sensorimotor cortex,10,mg/ml,NA,NR,NA,NA,Cold light,NR,NR,3,20,Minocycline,Anti-inflammation,10,mg/kg,-12,Before stroke,1008,Other histology (ex vivo),15.75,6.85,10.59,3.48,NA,NA,mm3,SD,0.799086758,0.537290715,6.85,0.34753932,3.48,None,NA,NA,NA,NA,NA,NA,Yes,No
Liebigt_2012,"Liebigt, S.",2012,Effects of rehabilitative training and anti-inflammatory treatment on functional recovery and cellular reorganization following stroke,b,Rat,Wistar,Male,None,NA,NR,13,NR,250,275,300,2,9,4,6,2,4.5,Nitrous oxide,Isoflurane,NR,Sensorimotor cortex,10,mg/ml,NA,NR,NA,NA,Cold light,NR,NR,3,20,Indomethacin,Anti-inflammation,2.5,mg/kg,-12,Before stroke,1008,Other histology (ex vivo),15.75,6.85,7.27,1.84,NA,NA,mm3,SD,0.799086758,0.3688483,6.85,0.34753932,1.84,None,NA,NA,NA,NA,NA,NA,Yes,No
Liguz-Lecznar_2014,"Liguz-Lecznar, M.",2014,Functional assessment of sensory functions after photothrombotic stroke in the barrel field of mice,a,Mouse,C57BL/6,NR,None,NA,8,9,10,NR,NR,NR,1,7.5,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Barrel field,10,mg/ml,NA,2750,K,NA,LCD,NR,560,1.5,20,None,NA,NA,NA,NA,NA,432,Other histology (ex vivo),2.33,0.9,NA,NA,NA,NA,mm (diameter),SEM,NA,NA,2.464751509,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Liguz-Lecznar_2015,"Liguz-Lecznar, M.",2015,Inhibition of Tnf-alpha R1 signaling can rescue functional cortical plasticity impaired in early post-stroke period,a,Mouse,C57BL/6,Female,Aged,NA,NR,52,NR,NR,NR,NR,1,5,1,5,1,5,Isoflurane,NA,"Scalp retracted, skull intact",Barrel field,10,mg/ml,NA,2750,K,NA,LCD,NR,560,1.5,20,sTNF-alphaR1,Anti-inflammation,7,ug,NR,NR,168,Other histology (ex vivo),2.02,0.9,2.1,0.82,NA,NA,mm3,SD,0.396926765,0.412646637,0.9,0.176848559,0.82,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Lin_2018,"Lin, Y. H.",2018,Dissociation of nNOS from PSD-95 promotes functional recovery after cerebral ischaemia in mice through reducing excessive tonic GABA release from reactive astrocytes,a,Mouse,C57BL/6,Male,None,NA,6,6.5,7,NR,NR,NR,1,6,1,6,1,6,Isoflurane,NA,Other,NR,100,mg/kg,100,12000,lux,0.00175692,Cold light,NR,NR,2,15,ZL006,Blood flow,1.5,mg/kg/day,96,After stroke,264,NR,0.87,0.07,0.87,0.06,NA,NA,mm3,SEM,0.170953607,0.170953607,0.171464282,0.033692457,0.146969385,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Lindau_2014,"Lindau, N. T.",2014,Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-Nogo-A therapy,a,Rat,Long Evans,Female,None,NA,13,21.5,30,230,315,400,1,28,1,26,1,28,Isoflurane,Fentanyl/fluanisone,"Scalp retracted, skull intact",Cerebral cortex,13,mg/kg,13,150,W,NA,LCD,NR,NR,10,10,Anti-Nogo-A,Anti-apoptosis/regeneration,5,uL/h,0,After stroke,2016,Other histology (ex vivo),22.03,2.17,20.54,1.5,NA,NA,mm3,SEM,1.117706748,1.042110604,11.48256069,0.582575377,7.64852927,None,NA,NA,NA,NA,NA,NA,No,No
Lippoldt_1993,"Lippoldt, A.",1993,Photochemically induced focal cerebral ischemia in rat: time dependent and global increase in expression of basic fibroblast growth factor mRNA,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,NR,230,NR,1,NR,0,NA,NA,NA,Halothane,NA,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,80,mg/kg,80,150,W,NA,Halogen lamp,Halogen,NR,6,5,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),15.7,1.1,NA,NA,NA,NA,mm3,SEM,0.796549975,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Lipsanen_2013,"Lipsanen, A.",2013,Non-selective calcium channel blocker bepridil decreases secondary pathology in mice after photothrombotic cortical lesion,a,Mouse,C57BL/6xDBA,Male,Amyloid plaques,Genetic,17,19.5,22,25.9,36.3,46.7,2,15,2,15,1,15,Ketamine,Xylazine,"Scalp retracted, skull intact",Sensorimotor cortex,50,mg/kg,50,NR,NA,NA,Cold light,NR,NR,1,10,Bepridil,Blood flow,50,mg/kg,48,After stroke,720,Other histology (ex vivo),1.21,0.08,1.52,0.14,NA,NA,mm3,SEM,0.237763062,0.298677566,0.309838668,0.060882802,0.542217668,None,NA,NA,NA,NA,NA,NA,No,No
Lipsanen_2013,"Lipsanen, A.",2013,Non-selective calcium channel blocker bepridil decreases secondary pathology in mice after photothrombotic cortical lesion,b,Mouse,hAPPsl,Male,Amyloid plaques,Genetic,17,19.5,22,25.9,36.3,46.7,2,14,2,13,1,14,Ketamine,Xylazine,"Scalp retracted, skull intact",Sensorimotor cortex,50,mg/kg,50,NR,NA,NA,Cold light,NR,NR,1,10,Bepridil,Blood flow,50,mg/kg,48,After stroke,720,Other histology (ex vivo),1.18,0.09,1.03,0.12,NA,NA,mm3,SEM,0.23186811,0.20239335,0.336749165,0.066170672,0.432666153,None,NA,NA,NA,NA,NA,NA,No,No
Liu_2017_a,"Liu, N. W.",2017,Evolutional Characterization of Photochemically Induced Stroke in Rats: a Multimodality Imaging and Molecular Biological Study,a,Rat,Sprague-Dawley,Male,None,NA,NR,7,NR,NR,NR,NR,8,NR,0,NA,NA,NA,Dexmedetomidine,Zoletil,Skull breached,Somatosensory cortex,10,mg/ml,20,NR,NA,NA,NR,NR,532,1,20,None,NA,NA,NA,NA,NA,24,MRI (in vivo),11.4,NR,NA,NA,NA,NA,mm3,SD,0.578386606,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Liu_2017_b,"Liu, Q. S.",2017,Ellagic acid protects against neuron damage in ischemic stroke through regulating the ratio of Bcl-2/Bax expression,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,265,280,1,7,2,7,2,3.5,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,30,mg/kg,30,12000,lux,0.00175692,Cold light,NR,NR,6,20,EA (ellagic acid),Anti-oxidants,30,mg/kg,-24,Before stroke,48,TTC (ex vivo),0.7,0.06,0.48,0.07,NA,NA,Indirect rLV % hemisphere,SE,0.35,0.24,0.158745079,0.079372539,0.185202592,None,NA,NA,NA,NA,NA,NA,No,Yes
Liu_2017_c,"Liu, Q. S.",2017,Ellagic acid improves endogenous neural stem cells proliferation and neurorestoration through Wnt/beta-catenin signaling in vivo and in vitro,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,265,280,1,5,3,5,3,1.666666667,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,30,mg/kg,30,12000,lux,0.00175692,Cold light,NR,NR,6,20,EA (ellagic acid),Anti-oxidants,10,mg/kg,NR,After stroke,168,TTC (ex vivo),0.97,0.09,0.32,0.02,NA,NA,Indirect rLV % hemisphere,SD,0.485,0.16,0.09,0.045,0.02,None,NA,NA,NA,NA,NA,NA,No,Yes
Liu_2017_d,"Liu, Y. H.",2017,Integrated treatment modality of cathodal-transcranial direct current stimulation with peripheral sensory stimulation affords neuroprotection in a rat stroke model,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,275,300,1,16,2,21,2,8,Sodium Pentobarbital,NA,Skull breached,Primary forelimb somatosensory cortex (S1FL),10,mg/ml,20,5,mW,NA,Continuous wave (CW) laser light,NR,532,3,15,ES (electrical stimulation),Other,400,uA,NR,NR,48,TTC (ex vivo),11.47,2.08,9.59,1.77,NA,NA,Indirect rLV % hemisphere,SD,5.735,4.795,2.08,1.04,1.77,None,NA,NA,NA,NA,NA,NA,No,Yes
Liu_2015,"Liu, Y. H.",2015,Assessment of neurovascular dynamics during transient ischemic attack by the novel integration of micro-electrocorticography electrode array with functional photoacoustic microscopy,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,275,300,1,5,0,NA,NA,NA,Sodium Pentobarbital,NA,Skull breached,Primary forelimb somatosensory cortex (S1FL),10,mg/ml,20,5,mW,NA,Continuous wave (CW) laser light,NR,532,NR,NR,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),14.1,2.4,NA,NA,NA,NA,Indirect rLV % hemisphere,SD,7.05,NA,2.4,1.2,NA,None,NA,NA,NA,NA,NA,NA,No,No
Liu_2014_a,"Liu, Y.",2014,Linolenic acid provides multi-cellular protective effects after photothrombotic cerebral ischemia in rats,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,220,245,270,1,5,1,5,1,5,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",NR,7.5,mg/ml,0.9975,15,W,NA,LCD,NR,550,NR,20,Alpha-linolenic acid,Multiple mechanisms,100,uL,-0.5,Before stroke,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,mNSS,3.61,0.88,2.39,0.54,SD,168,Yes,No
Liu_2014_b,"Liu, Z.",2014,Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke,a,Mouse,C57Bl/6129Sv-129Ola,Male,None,NA,10,11,12,22,24.5,27,1,10,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,10,mg/ml,40.81632653,NR,NA,NA,LED,LED,NR,NR,10,None,NA,NA,NA,NA,NA,672,Other histology (ex vivo),9.89,1.11,NA,NA,NA,NA,Indirect rLV % hemisphere,SD,4.945,NA,1.11,0.555,NA,None,NA,NA,NA,NA,NA,NA,No,No
Liu_2014_b,"Liu, Z.",2014,Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke,b,Mouse,GFAP-/-Vim-/-,Male,None,NA,10,11,12,22,24.5,27,1,10,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,10,mg/ml,40.81632653,NR,NA,NA,LED,LED,NR,NR,10,None,NA,NA,NA,NA,NA,672,Other histology (ex vivo),10.55,1.29,NA,NA,NA,NA,Indirect rLV % hemisphere,SD,5.275,NA,1.29,0.645,NA,None,NA,NA,NA,NA,NA,NA,No,No
Llovera_2017,"Llovera, G.",2017,The choroid plexus is a key cerebral invasion route for T cells after stroke,a,Mouse,C57BL/6,Male,None,NA,8,10,12,NR,NR,NR,1,7,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull breached,Cerebral cortex,10,uL/g,NA,NR,NA,NA,NR,NR,561,1.5,15,None,NA,NA,NA,NA,NA,120,Other histology (ex vivo),4.62,2.56,NA,NA,NA,NA,mm3,SD,0.907822601,NA,2.56,0.5030359,NA,None,NA,NA,NA,NA,NA,NA,No,No
Lloyd-Burton_2013,"Lloyd-Burton, S. M.",2013,SPARC regulates microgliosis and functional recovery following cortical ischemia,a,Mouse,SPARC-/-,Mixed,None,NA,NR,NR,NR,NR,NR,NR,1,NR,0,NA,NA,NA,Isoflurane,NA,Skull thinned,NR,100,mg/kg,100,17,mW,NA,Green laser,Diode-pumped solid state laser,532,NR,20,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),0.51,0.16,NA,NA,NA,NA,mm3,SEM,0.100214183,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Lloyd-Burton_2013,"Lloyd-Burton, S. M.",2013,SPARC regulates microgliosis and functional recovery following cortical ischemia,b,Mouse,B6129SF2/J,Mixed,None,NA,NR,NR,NR,NR,NR,NR,1,NR,0,NA,NA,NA,Isoflurane,NA,Skull thinned,NR,100,mg/kg,100,17,mW,NA,Green laser,Diode-pumped solid state laser,532,NR,20,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),0.37,0.08,NA,NA,NA,NA,mm3,SEM,0.072704407,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Lopez-Valdes_2014,"Lopez-Valdes, H. E.",2014,Memantine enhances recovery from stroke,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,28,30,32,1,4,1,4,1,4,NR,NA,"Scalp retracted, skull intact",NR,10,mg/ml,66.66666667,NR,NA,NA,NR,NR,NR,2,5,Memantine,Excitotoxicity,30,mg/kg,2,After stroke,168,Other histology (ex vivo),1.13,0.11,1.21,0.11,NA,NA,mm3,SEM,0.22204319,0.237763062,0.22,0.043229648,0.22,None,NA,NA,NA,NA,NA,NA,No,No
Lorrio_2013,"Lorrio, S.",2013,Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia,a,Mouse,Swiss,Male,None,NA,12,13,14,35,37.5,40,1,10,4,9,4,2.5,Isoflurane,NA,"Scalp retracted, skull intact",NR,1,mg,26.66666667,NR,NA,NA,LCD,NR,NR,1.9,30,Melatonin,Anti-oxidants,15,mg/kg,-0.5,Before stroke,72,TTC (ex vivo),8.6,1.8,4.92,1.31,NA,NA,Indirect rLV % cortex,SEM,NA,NA,5.692099788,NA,3.93,None,NA,NA,NA,NA,NA,NA,No,No
Lorrio_2013,"Lorrio, S.",2013,Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia,b,Mouse,Swiss,Male,None,NA,12,13,14,35,37.5,40,1,10,4,8,4,2.5,Isoflurane,NA,"Scalp retracted, skull intact",NR,1,mg,26.66666667,NR,NA,NA,LCD,NR,NR,1.9,30,ITH33/IQM9.21,Multiple mechanisms,5,mg/kg,-0.5,Before stroke,72,TTC (ex vivo),8.6,1.8,3.76,0.99,NA,NA,Indirect rLV % cortex,SEM,NA,NA,5.692099788,NA,2.800142853,None,NA,NA,NA,NA,NA,NA,No,Yes
Lorrio_2013,"Lorrio, S.",2013,Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia,c,Mouse,Swiss,Male,None,NA,12,13,14,35,37.5,40,1,12,1,8,1,12,Isoflurane,NA,"Scalp retracted, skull intact",NR,1,mg,26.66666667,NR,NA,NA,LCD,NR,NR,1.9,30,ITH33/IQM9.21,Multiple mechanisms,5,mg/kg,1,After stroke,72,TTC (ex vivo),6.18,2.19,3.12,1.78,NA,NA,Indirect rLV % cortex,SEM,NA,NA,7.586382537,NA,5.034600282,None,NA,NA,NA,NA,NA,NA,No,No
Losem-Heinrichs_2005,"Losem-Heinrichs, E.",2005,"1alpha,25-dihydroxy-vitamin D3 in combination with 17beta-estradiol lowers the cortical expression of heat shock protein-27 following experimentally induced focal cortical ischemia in rats",a,Rat,Wistar,Male,None,NA,NR,NR,NR,250,275,300,1,6,0,NA,NA,NA,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,1.3,mg/100g,13,150,W,NA,Cold light,NR,NR,1.5,20,None,NA,NA,NA,NA,NA,48,Other histology (ex vivo),61.16,3.9,NA,NA,NA,NA,mm3,SD,3.102993404,NA,3.9,0.197869102,NA,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Lu_2014,"Lu, H.",2014,Induction and imaging of photothrombotic stroke in conscious and freely moving rats,a,Rat,Sprague-Dawley,Male,None,NA,NR,12,NR,300,320,340,1,12,0,NA,NA,NA,None,NA,Cranial window (awake induction),Distal middle cerebral artery (dMCA),80,mg/kg,80,5,mW/mm2,0.5,Fibre-optic,NR,532,0.75,15,None,NA,NA,NA,NA,NA,24,MRI (in vivo),77.38,11.09,NA,NA,NA,NA,mm3,SD,3.925925926,NA,11.09,0.562658549,NA,NSS,6,1,NA,NA,SD,24,No,No
Lu_2017,"Lu, H.",2017,Hemodynamic effects of intraoperative anesthetics administration in photothrombotic stroke model: a study using laser speckle imaging,a,Rat,Sprague-Dawley,Male,None,NA,NR,12,NR,300,320,340,2,11,0,NA,NA,NA,None,NA,Cranial window (awake induction),Distal middle cerebral artery (dMCA),80,mg/kg,80,5,mW/mm2,0.5,Fibre-optic,NR,532,0.75,15,None,NA,NA,NA,NA,NA,24,MRI (in vivo),47,15,NA,NA,NA,NA,mm3,SEM,2.384576357,NA,49.74937186,2.524067573,NA,NSS,5.9,1,NA,NA,SEM,24,Yes,No
Lu_2017,"Lu, H.",2017,Hemodynamic effects of intraoperative anesthetics administration in photothrombotic stroke model: a study using laser speckle imaging,b,Rat,Sprague-Dawley,Male,None,NA,NR,12,NR,300,320,340,2,11,0,NA,NA,NA,Isoflurane,NA,Cranial window (asleep induction),Distal middle cerebral artery (dMCA),80,mg/kg,80,5,mW/mm2,0.5,Fibre-optic,NR,532,0.75,15,None,NA,NA,NA,NA,NA,24,MRI (in vivo),32,12,NA,NA,NA,NA,mm3,SEM,1.62354135,NA,39.79949748,2.019254058,NA,NSS,4.6,1,NA,NA,SEM,24,Yes,No
Lv_2018,"Lv, Z. M.",2018,Expression of DCX and Transcription Factor Profiling in Photothrombosis-Induced Focal Ischemia in Mice,a,Mouse,C57BL/6,Male,None,NA,8,9,10,18,21,24,5,5,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Striatum,100,mg/kg,100,NR,NA,NA,LCD,NR,NR,NR,11,None,NA,NA,NA,NA,NA,48,Other histology (ex vivo),2.15,0.22,NA,NA,NA,NA,mm2,SD,NA,NA,0.22,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Ma_2015,"Ma, J.",2015,Neural stem cell transplantation promotes behavioral recovery in a photothrombosis stroke model,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,6,1,6,1,6,Ketamine,Xylazine,Skull thinned,Sensorimotor cortex,24,mg/kg,24,NR,NA,NA,Green laser,Diode-pumped solid state laser,NR,NR,3,NSC (neural stem cell) transplantation,Anti-apoptosis/regeneration,1050,Cells/uL,48,After stroke,168,Other histology (ex vivo),28.01,2.62,23.31,2.22,NA,NA,mm3,SEM,5.503920143,4.58037767,6.417663126,1.261060527,5.437867229,None,NA,NA,NA,NA,NA,NA,No,No
Madinier_2009,"Madinier, A.",2009,Microglial involvement in neuroplastic changes following focal brain ischemia in rats,a,Rat,Wistar,Male,None,NA,NR,NR,NR,290,300,310,5,6,5,6,1,6,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,90,mW,NA,Diode-pumped solid state laser,Diode-pumped solid state laser,532,1,5,3-aminobenzamide (3-AB),Anti-inflammation,90,mg/kg,0,During stroke,4,Other histology (ex vivo),10.85,1.09,7.94,0.93,NA,NA,mm3,SEM,0.550481989,0.402841197,2.66994382,0.135461381,2.278025461,None,NA,NA,NA,NA,NA,NA,Yes,No
Madinier_2014_a,"Madinier, A.",2014,Enriched housing enhances recovery of limb placement ability and reduces aggrecan-containing perineuronal nets in the rat somatosensory cortex after experimental stroke,a,Rat,Sprague-Dawley,Male,None,NA,NR,8,NR,NR,NR,NR,1,7,1,7,1,7,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mg/ml,NA,NR,NA,NA,LCD,NR,NR,8,15,Enriched cage environment,Other,NA,NA,48,After stroke,1512,Other histology (ex vivo),53,5,52,7,NA,NA,mm3,SEM,2.68899036,2.638254693,13.22875656,0.67116979,18.52025918,Clark 28 point scale,NR,NR,NR,NR,NR,NA,Yes,No
Madinier_2014_b,"Madinier, A.",2014,Impact of estrogen receptor beta activation on functional recovery after experimental stroke,a,Rat,Sprague-Dawley,Male,None,NA,NR,8,NR,NR,NR,NR,1,8,3,8,3,2.666666667,Isoflurane,NA,"Scalp retracted, skull intact",NR,15,mg/ml,NA,NR,NA,NA,LCD,NR,NR,8,20,4-(1-phenyl-cyclohexyl)-phenol (AC-131),Multiple mechanisms,10,mg/kg,48,After stroke,408,Other histology (ex vivo),47,7,49,4,NA,NA,mm3,SEM,2.384576357,2.486047692,19.79898987,1.004514961,11.3137085,None,NA,NA,NA,NA,NA,NA,No,Yes
Maeda_2002,"Maeda, M.",2002,A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window,a,Rat,Sprague-Dawley,Male,None,NA,8,9,10,NR,NR,NR,1,7,3,11,3,2.333333333,Halothane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,540,3,10,FK506 (Tacrolimus),Other,1,mg/kg,0,During stroke,24,TTC (ex vivo),225.46,42.12,202.84,51.65,NA,NA,mm3,SD,11.43886352,10.29122273,42.12,2.136986301,51.65,None,NA,NA,NA,NA,NA,NA,No,Yes
Maeda_2002,"Maeda, M.",2002,A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window,b,Rat,Sprague-Dawley,Male,None,NA,8,9,10,NR,NR,NR,1,7,3,5,3,2.333333333,Halothane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,540,3,10,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,3.2,mg/kg,0,During stroke,24,TTC (ex vivo),16.97,3.13,8.64,3.42,NA,NA,Direct rLV % whole brain,SD,16.97,8.64,3.13,3.13,3.42,None,NA,NA,NA,NA,NA,NA,No,Yes
Maeda_2009,"Maeda, M.",2009,Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,17,18,19,NR,NR,NR,1,14.5,3,14.5,3,4.833333333,Halothane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,540,3,10,FK506 (Tacrolimus),Other,1,mg/kg,3,After stroke,24,TTC (ex vivo),15.47,1.29,14.57,1.31,NA,NA,Direct rLV % whole brain,SEM,15.47,14.57,4.912173653,4.912173653,4.988331384,None,NA,NA,NA,NA,NA,NA,No,Yes
Maeda_2009,"Maeda, M.",2009,Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model,b,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,17,18,19,NR,NR,NR,1,14.5,3,14.5,3,4.833333333,Halothane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,540,3,10,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,10,mg/kg,3,After stroke,24,TTC (ex vivo),15.47,1.29,18.36,0.81,NA,NA,Direct rLV % whole brain,SEM,15.47,18.36,4.912173653,4.912173653,3.084388108,None,NA,NA,NA,NA,NA,NA,No,Yes
Maeda_2005,"Maeda, M.",2005,Characterization of a novel thrombotic middle cerebral artery occlusion model in monkeys that exhibits progressive hypoperfusion and robust cortical infarction,a,Primate,"Cynomolgus monkey (Macaca fascicularis, crab-eating macaque)",Male,None,NA,156,208.5,261,3700,5100,6500,1,5,0,NA,NA,NA,Ketamine,Isoflurane,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,4000000,lux,0.58564,Xenon lamp,Xenon,540,NR,20,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),5137,850,NA,NA,NA,NA,mm3,SEM,NA,NA,1900.657781,NA,NA,Kito 100 point score,50,3,NA,NA,SEM,24,No,No
Marumo_2010,"Marumo, T.",2010,"The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice",a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,20,23,26,1,9,1,9,1,9,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,6,mW,NA,Krypton laser,Krypton laser,568,NR,8,TS-011 (N-(3-chloro-4-morpholin-4-yl) phenyl-N?-hydroxyimido formamide),Blood flow,0.3,mg/kg,NR,NR,72,TTC (ex vivo),23.74,3.52,14.54,2.37,NA,NA,mm3,SEM,4.664871981,2.857086715,10.56,2.075023089,7.11,None,NA,NA,NA,NA,NA,NA,No,No
Masoero_2000,"Masoero, E.",2000,Effect of acute alcohol on ischemia-induced glutamate release and brain damage,a,Rat,Wistar,Male,None,NA,NR,NR,NR,200,225,250,1,5,2,6,2,2.5,Equitensine,NA,NR,NR,1.7,mg/100g,17,150,W,NA,Halogen lamp,Halogen,NR,NR,30,Alcohol,Harm induction,1.5,g/kg,-1,Before stroke,24,Other histology (ex vivo),0.044,0.007,0.038,0.009,NA,NA,cm2,SEM,NA,NA,0.015652476,NA,0.022045408,None,NA,NA,NA,NA,NA,NA,No,Yes
Masuko_2018,"Masuko, T.",2018,"N(1)-Nonyl-1,4-diaminobutane ameliorates brain infarction size in photochemically induced thrombosis model mice",a,Mouse,ddY,Male,None,NA,NR,NR,NR,30,32.5,35,1,10.5,3,10.5,3,3.5,Isoflurane,NA,NR,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,"C6-4 (N1-Hexyl-1,4-butanediamine)",Anti-oxidants,2,mg/kg,0.5,After stroke,24,TTC (ex vivo),71.76,3.09,66.95,7.21,NA,NA,mm3,NR,14.10072508,13.15556778,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Masuko_2018,"Masuko, T.",2018,"N(1)-Nonyl-1,4-diaminobutane ameliorates brain infarction size in photochemically induced thrombosis model mice",b,Mouse,ddY,Male,None,NA,NR,NR,NR,30,32.5,35,1,10.5,3,10.5,3,3.5,Isoflurane,NA,NR,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,"C9-4 (N1-Nonyl-1,4-butanediamine)",Anti-oxidants,10,mg/kg,0.5,After stroke,24,TTC (ex vivo),69.71,3.74,41.25,2.8,NA,NA,mm3,NR,13.69790336,8.10555894,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Masuko_2018,"Masuko, T.",2018,"N(1)-Nonyl-1,4-diaminobutane ameliorates brain infarction size in photochemically induced thrombosis model mice",c,Mouse,ddY,Male,None,NA,NR,NR,NR,30,32.5,35,1,10.5,3,10.5,3,3.5,Isoflurane,NA,NR,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,"C13-4 (N1-Tridecyl-1,4-butanediamine)",Anti-oxidants,2,mg/kg,0.5,After stroke,24,TTC (ex vivo),71.76,3.09,38.45,3.78,NA,NA,mm3,NR,14.10072508,7.555363424,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Masuko_2018,"Masuko, T.",2018,"N(1)-Nonyl-1,4-diaminobutane ameliorates brain infarction size in photochemically induced thrombosis model mice",d,Mouse,ddY,Male,None,NA,NR,NR,NR,30,32.5,35,1,10.5,5,10.5,5,2.1,Isoflurane,NA,NR,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,MDL72527,Anti-oxidants,100,mg/kg,0.5,After stroke,24,TTC (ex vivo),69.8,3.57,43.27,1.73,NA,NA,mm3,NR,13.71558822,8.502485705,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Masuko_2018,"Masuko, T.",2018,"N(1)-Nonyl-1,4-diaminobutane ameliorates brain infarction size in photochemically induced thrombosis model mice",e,Mouse,ddY,Male,None,NA,NR,NR,NR,30,32.5,35,1,10.5,5,10.5,5,2.1,Isoflurane,NA,NR,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,N-benzylhydroxylamine,Anti-oxidants,100,mg/kg,0.5,After stroke,24,TTC (ex vivo),69.8,3.57,43.78,2.65,NA,NA,mm3,NR,13.71558822,8.602699888,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Masuko_2018,"Masuko, T.",2018,"N(1)-Nonyl-1,4-diaminobutane ameliorates brain infarction size in photochemically induced thrombosis model mice",f,Mouse,ddY,Male,None,NA,NR,NR,NR,30,32.5,35,1,10.5,5,10.5,5,2.1,Isoflurane,NA,NR,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,Edaravone (MCI-186),Anti-oxidants,10,mg/kg,0.5,After stroke,24,TTC (ex vivo),69.8,3.57,35.41,7.14,NA,NA,mm3,NR,13.71558822,6.958008292,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Matsuno_1993,"Matsuno, H.",1993,A simple and reproducible cerebral thrombosis model in rats induced by a photochemical reaction and the effect of a plasminogen-plasminogen activator chimera in this model,a,Rat,Wistar,Male,None,NA,NR,NR,NR,260,270,280,1,13,1,9,1,13,Sodium Pentobarbital,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,8,SUN9216,Thrombolytics,1,mg/kg,0.5,After stroke,24,TTC (ex vivo),19.1,0.76,14.9,1.27,NA,NA,Direct rLV % hemisphere,SEM,9.55,7.45,2.740218969,1.370109485,3.81,None,NA,NA,NA,NA,NA,NA,Yes,No
Maxwell_2005,"Maxwell, K. A.",2005,Induction of reproducible focal ischemic lesions in neonatal mice by photothrombosis,a,Mouse,CD-1,Mixed,None,NA,NR,1,NR,NR,NR,NR,3,4,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Medial frontal cortex,50,mg/kg,50,20,mW,NA,Diode laser,Diode laser,532,2.4,0.75,None,NA,NA,NA,NA,NA,48,Other histology (ex vivo),2.99,0.94,NA,NA,NA,NA,mm3,SEM,0.587530212,NA,1.88,0.369416989,NA,None,NA,NA,NA,NA,NA,NA,No,No
Maxwell_2005,"Maxwell, K. A.",2005,Induction of reproducible focal ischemic lesions in neonatal mice by photothrombosis,b,Mouse,CD-1,Mixed,None,NA,NR,1,NR,NR,NR,NR,3,4,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Medial frontal cortex,50,mg/kg,50,20,mW,NA,Diode laser,Diode laser,532,2.4,1,None,NA,NA,NA,NA,NA,48,Other histology (ex vivo),6.17,1.32,NA,NA,NA,NA,mm3,SEM,1.212395119,NA,2.64,0.518755772,NA,None,NA,NA,NA,NA,NA,NA,No,No
Maxwell_2005,"Maxwell, K. A.",2005,Induction of reproducible focal ischemic lesions in neonatal mice by photothrombosis,c,Mouse,CD-1,Mixed,None,NA,NR,1,NR,NR,NR,NR,3,4,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Medial frontal cortex,50,mg/kg,50,20,mW,NA,Diode laser,Diode laser,532,2.4,1.3,None,NA,NA,NA,NA,NA,48,Other histology (ex vivo),10.93,2.11,NA,NA,NA,NA,mm3,SEM,2.147727496,NA,4.22,0.829223242,NA,None,NA,NA,NA,NA,NA,NA,No,No
Metz_2005,"Metz, G. A.",2005,Motor improvements after focal cortical ischemia in adult rats are mediated by compensatory mechanisms,a,Rat,Wistar,Female,None,NA,NR,17,NR,200,230,260,1,21,0,NA,NA,NA,Enflurane,NA,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,4,mg,17.39130435,NR,NA,NA,Cold light,NR,NR,2.4,20,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),2.76,0.85,NA,NA,NA,NA,mm3,SE,0.140030441,NA,3.895189341,0.19762503,NA,None,NA,NA,NA,NA,NA,NA,No,No
Mikulski_2001,"Mikulski, A.",2001,The effects of oral and intravenous direct thrombin inhibitors on the size of photochemically induced cortical infarction in rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,NR,NR,NR,250,310,370,1,12,2,12,2,6,Isoflurane,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,100000,lux,0.014641,Halogen lamp,Halogen,570,5.2,10,Melagatran/Ximelagatran,Thrombolytics,13,mg/kg,-0.5,Before stroke,20,Other histology (ex vivo),2.38,2.17,1.12,1.01,NA,NA,mm3,SD,0.120750888,0.056823947,2.17,0.110096398,1.01,None,NA,NA,NA,NA,NA,NA,No,No
Mikulski_2001,"Mikulski, A.",2001,The effects of oral and intravenous direct thrombin inhibitors on the size of photochemically induced cortical infarction in rats,b,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,NR,NR,NR,250,310,370,1,12,2,12,2,6,Isoflurane,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,100000,lux,0.014641,Halogen lamp,Halogen,570,5.2,10,Inogatran,Thrombolytics,44,mg/kg,-0.5,Before stroke,20,Other histology (ex vivo),2.38,2.17,1.93,1.08,NA,NA,mm3,SD,0.120750888,0.097919838,2.17,0.110096398,1.08,None,NA,NA,NA,NA,NA,NA,No,Yes
Millerot_2005,"Millerot, E.",2005,Serum ferritin in stroke: a marker of increased body iron stores or stroke severity?,a,Rat,Wistar,Male,None,NA,NR,NR,NR,NR,NR,NR,2,6,2,6,1,6,Chloral hydrate,NA,NR,Cerebral cortex,20,mg/kg,20,30,mW,NA,Diode-pumped solid state laser,Diode-pumped solid state laser,532,NR,NR,Iron dextran,Harm induction,25,mg/kg,-0.25,Before stroke,NR,Other histology (ex vivo),22.1,8.6,23.9,7.6,NA,NA,mm3,SD,1.121258245,1.212582445,8.6,0.436326738,7.6,Other,NR,NR,NR,NR,NR,24,No,No
Millerot_2005,"Millerot, E.",2005,Serum ferritin in stroke: a marker of increased body iron stores or stroke severity?,b,Rat,Wistar,Male,None,NA,NR,NR,NR,NR,NR,NR,2,4,2,7,1,4,Chloral hydrate,NA,NR,Cerebral cortex,20,mg/kg,20,30,mW,NA,Diode-pumped solid state laser,Diode-pumped solid state laser,532,NR,NR,Ferric Chloride (FeCl3),Harm induction,560,ug/kg,-0.25,Before stroke,NR,Other histology (ex vivo),32.6,7.7,32.4,6.5,NA,NA,mm3,SD,1.65398275,1.643835616,7.7,0.390664637,6.5,Other,NR,NR,NR,NR,NR,24,No,No
Millerot-Serrurot_2007,"Millerot-Serrurot, E.",2007,"Effect of early decrease in the lesion size on late brain tissue loss, synaptophysin expression and functionality after a focal brain lesion in rats",a,Rat,Wistar,Male,None,NA,NR,NR,NR,250,300,350,2,5,2,5,1,5,Chloral hydrate,NA,"Scalp retracted, skull intact",Cerebral cortex,20,mg/kg,20,90,mW,NA,Diode-pumped solid state laser,Diode-pumped solid state laser,532,1,5,"2,2'-Dipyridyl (2,2'-Bipyridine)",Anti-oxidants,20,mg/kg,-0.25,Before stroke,24,Other histology (ex vivo),79.68,2.08,38.56,4.16,NA,NA,mm3,SEM,4.04261796,1.956367326,4.651021393,0.235972673,9.302042786,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Miyazaki_2011,"Miyazaki, T.",2011,Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion,a,Mouse,CD-1,Male,None,NA,NR,NR,NR,25,30,35,1,6,2,6,2,3,Isoflurane,NA,Skull breached,Distal middle cerebral artery (dMCA),40,mg/kg,40,15,mW,NA,Diode laser,Diode laser,561,NR,10,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,10,mg/kg,0.5,After stroke,24,TTC (ex vivo),6.97,1.22,17.28,2.48,NA,NA,mm3,SEM,1.369593838,3.395492327,2.988377486,0.58721139,6.074734562,None,NA,NA,NA,NA,NA,NA,No,No
Miyazaki_2011,"Miyazaki, T.",2011,Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion,b,Mouse,CD-1,Male,None,NA,NR,NR,NR,25,30,35,1,6,2,6,2,3,Isoflurane,NA,Skull breached,Distal middle cerebral artery (dMCA),40,mg/kg,40,15,mW,NA,Diode laser,Diode laser,561,NR,10,SMTP-7,Anti-inflammation,10,mg/kg,0.5,After stroke,24,TTC (ex vivo),6.97,1.22,5.6,1.3,NA,NA,mm3,SEM,1.369593838,1.100391032,2.988377486,0.58721139,3.184336666,None,NA,NA,NA,NA,NA,NA,No,No
Mizuno_1998,"Mizuno, A.",1998,"Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusion",a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,255,270,1,7,1,7,1,7,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,10,Edaravone (MCI-186),Anti-oxidants,3,mg/kg,0.3,After stroke,24,TTC (ex vivo),23.67,1.47,17.92,1.46,NA,NA,Direct rLV % whole brain,SE,23.67,17.92,3.889254427,3.889254427,3.862796914,None,NA,NA,NA,NA,NA,NA,No,No
Mizutani_2016,"Mizutani, K.",2016,Effects of exercise and bryostatin-1 on serotonin dynamics after cerebral infarction,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,380,407.5,435,1,3,3,3,3,1,Isoflurane,NA,"Scalp retracted, skull intact",Forelimb and hindlimb motor cortex,30,mg/kg,30,NR,NA,NA,NR,NR,540,3,20,Bryostatin-1,Excitotoxicity,10,ug/m2 of body surface area,120,After stroke,192,Other histology (ex vivo),5.5,1.1,5.5,0.9,NA,NA,% (not specified percentage of),SD,NA,NA,1.1,NA,0.9,None,NA,NA,NA,NA,NA,NA,No,Yes
Mizutani_2016,"Mizutani, K.",2016,Effects of exercise and bryostatin-1 on serotonin dynamics after cerebral infarction,b,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,380,407.5,435,1,3,3,3,3,1,Isoflurane,NA,"Scalp retracted, skull intact",Forelimb and hindlimb motor cortex,30,mg/kg,30,NR,NA,NA,NR,NR,540,3,20,Exercise cage environment,Other,8,Days,NR,After stroke,192,Other histology (ex vivo),5.5,1.1,5.7,0.7,NA,NA,% (not specified percentage of),SD,NA,NA,1.1,NA,0.7,None,NA,NA,NA,NA,NA,NA,No,Yes
Moller_2015,"Moller, K.",2015,Arterial Hypertension Aggravates Innate Immune Responses after Experimental Stroke,a,Rat,Wistar-Kyoto,NR,None,NA,12,13,14,NR,NR,NR,2,18,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Frontal cortex,0.3,mL,NA,NR,NA,NA,Cold light,NR,NR,4.5,20,None,NA,NA,NA,NA,NA,24,MRI (in vivo),5.9,3.7,NA,NA,NA,NA,Direct rLV % hemisphere,SD,2.95,NA,3.7,1.85,NA,mNSS,NR,NR,NA,NA,NR,24,Yes,No
Moller_2015,"Moller, K.",2015,Arterial Hypertension Aggravates Innate Immune Responses after Experimental Stroke,b,Rat,Spontaneously Hypertensive Rat (SHR),NR,Hypertension,Genetic,12,13,14,NR,NR,NR,2,22,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Frontal cortex,0.3,mL,NA,NR,NA,NA,Cold light,NR,NR,4.5,20,None,NA,NA,NA,NA,NA,24,MRI (in vivo),6.8,5.4,NA,NA,NA,NA,Direct rLV % hemisphere,SD,3.4,NA,5.4,2.7,NA,mNSS,NR,NR,NA,NA,NR,24,Yes,No
Moon_2016,"Moon, J. H.",2016,Neuroprotective effects of systemic cerebral endothelial cell transplantation in a rat model of cerebral ischemia,a,Rat,Sprague-Dawley,Male,None,NA,NR,8,NR,250,275,300,1,5,1,5,1,5,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,50,mg/kg,50,NR,NA,NA,LCD,NR,NR,4.5,10,hCMEC/D3 (human cerebral microendothelial cells),Anti-apoptosis/regeneration,1000000,Cells,NR,NR,168,TTC (ex vivo),10.01,0.66,6.81,1.08,NA,NA,Indirect rLV % whole brain,SD,10.01,6.81,0.66,0.66,1.08,None,NA,NA,NA,NA,NA,NA,Yes,No
Moon_2009_a,"Moon, S. K.",2009,Both compensation and recovery of skilled reaching following small photothrombotic stroke to motor cortex in the rat,a,Rat,Long Evans,Female,None,NA,13,13.5,14,NR,NR,NR,1,8,0,NA,NA,NA,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Motor cortex,10,mg/kg,10,78000,lux,0.01141998,Fibre-optic,NR,NR,5,20,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),2.84,0.58,NA,NA,NA,NA,mm3,SEM,0.144089295,NA,1.640487732,0.08323124,NA,None,NA,NA,NA,NA,NA,NA,No,No
Moon_2009_b,"Moon, S. K.",2009,Effect of prolonged cortical stimulation differs with size of infarct after sensorimotor cortical lesions in rats,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,275,300,2,10,0,NA,NA,NA,Ketamine,Xylazine,Other,Forelimb motor cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,6,18,None,NA,NA,NA,NA,NA,336,Other histology (ex vivo),10.63,7.22,NA,NA,NA,NA,mm3,SD,0.539320142,NA,7.22,0.366311517,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Moon_2009_b,"Moon, S. K.",2009,Effect of prolonged cortical stimulation differs with size of infarct after sensorimotor cortical lesions in rats,b,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,275,300,2,13,0,NA,NA,NA,Ketamine,Xylazine,Other,Forelimb motor cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,4,18,None,NA,NA,NA,NA,NA,336,Other histology (ex vivo),24,6.94,NA,NA,NA,NA,mm3,SD,1.217656012,NA,6.94,0.35210553,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Moriguchi_2004_a,"Moriguchi, A.",2004,"Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban",a,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,342.2,484.2,626.2,1,12.5,6,12.5,6,2.083333333,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,10,FK419,Thrombolytics,0.2,mg/kg/h,0.083,During stroke,24,TTC (ex vivo),12.14,0.92,6.5,0.66,NA,NA,% (not specified percentage of),SEM,NA,NA,3.252691193,NA,2.333452378,Bederson Scale,4.12,0.47,2.82,0.38,SEM,24,No,Yes
Moriguchi_2004_a,"Moriguchi, A.",2004,"Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban",b,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,342.2,484.2,626.2,1,12.5,6,12.5,6,2.083333333,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,10,Ozagrel Sodium,Thrombolytics,100,mg/kg/h,0.083,During stroke,24,TTC (ex vivo),12.14,0.92,9.09,0.99,NA,NA,% (not specified percentage of),SEM,NA,NA,3.252691193,NA,3.500178567,Bederson Scale,NR,NR,NR,NR,NR,24,No,Yes
Moriguchi_2004_a,"Moriguchi, A.",2004,"Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban",c,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,342.2,484.2,626.2,1,12.5,6,12.5,6,2.083333333,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,10,Argatroban,Thrombolytics,60,mg/kg/h,0.083,During stroke,24,TTC (ex vivo),12.14,0.92,15.42,1.56,NA,NA,% (not specified percentage of),SEM,NA,NA,3.252691193,NA,5.515432893,Bederson Scale,NR,NR,NR,NR,NR,24,No,No
Moriguchi_2004_b,"Moriguchi, A.",2004,Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig,a,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,308.2,446.35,584.5,1,11,3,11,3,3.666666667,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,15,FK419,Thrombolytics,0.2,mg/kg/h,0,During stroke,24,TTC (ex vivo),20.46,1.37,9.72,1.11,NA,NA,Direct rLV % whole brain,SEM,20.46,9.72,4.543775963,4.543775963,3.681453517,Bederson Scale,5.6,0.37,3,0.56,SEM,24,No,Yes
Moriguchi_2004_b,"Moriguchi, A.",2004,Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig,b,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,308.2,446.35,584.5,1,11,3,11,3,3.666666667,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,15,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,5.76,mg/kg/h,0,During stroke,24,TTC (ex vivo),16.59,0.78,9.12,1.34,NA,NA,Direct rLV % whole brain,SEM,16.59,9.12,2.586967336,2.586967336,4.444277219,Bederson Scale,6,0.37,3.5,0.5,SEM,24,No,Yes
Moriguchi_2004_b,"Moriguchi, A.",2004,Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig,c,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,308.2,446.35,584.5,1,11,4,11,4,2.75,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,15,Aspirin,Thrombolytics,3.2,mg/kg/h,0,During stroke,24,TTC (ex vivo),17.4,1.96,15.54,1.29,NA,NA,Direct rLV % whole brain,SEM,17.4,15.54,6.500584589,6.500584589,4.27844598,Bederson Scale,6.58,0.36,7.08,0.19,SEM,24,No,No
Moriguchi_2004_b,"Moriguchi, A.",2004,Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig,d,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,308.2,446.35,584.5,1,11,4,11,4,2.75,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,15,Ozagrel Sodium,Thrombolytics,100,mg/kg/h,0,During stroke,24,TTC (ex vivo),17.4,1.96,16.78,1.29,NA,NA,Direct rLV % whole brain,SEM,17.4,16.78,6.500584589,6.500584589,4.27844598,Bederson Scale,6.58,0.36,6.17,0.32,SEM,24,No,No
Moriguchi_2004_b,"Moriguchi, A.",2004,Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig,e,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,308.2,446.35,584.5,1,11,4,11,4,2.75,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,15,Argatroban,Thrombolytics,6,U/kg/h,0,During stroke,24,TTC (ex vivo),17.4,1.96,21.92,1.48,NA,NA,Direct rLV % whole brain,SEM,17.4,21.92,6.500584589,6.500584589,4.90860469,Bederson Scale,6.58,0.36,6.92,0.26,SEM,24,No,No
Moriguchi_2004_b,"Moriguchi, A.",2004,Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig,f,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,308.2,446.35,584.5,1,11,4,11,4,2.75,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,15,Heparin,Thrombolytics,60,U/kg/h,0,During stroke,24,TTC (ex vivo),17.4,1.96,15.02,1.24,NA,NA,Direct rLV % whole brain,SEM,17.4,15.02,6.500584589,6.500584589,4.11261474,Bederson Scale,6.58,0.36,6.18,0.35,SEM,24,No,No
Moriguchi_2005,"Moriguchi, A.",2005,"FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban",a,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,362.6,464.1,565.6,1,10,3,10,3,3.333333333,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,15,FK419,Thrombolytics,0.16,mg/kg/h,0,During stroke,24,TTC (ex vivo),15.92,6.99,7.31,3.79,NA,NA,Direct rLV % whole brain,SD,15.92,7.31,6.99,6.99,3.79,Bederson Scale,6.63,0.76,3.61,1.7,SD,24,No,Yes
Moriguchi_2005,"Moriguchi, A.",2005,"FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban",b,Guinea Pig,Hartley,Male,None,NA,NR,NR,NR,362.6,464.1,565.6,1,10,3,10,3,3.333333333,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,15,Tirofiban,Thrombolytics,1,mg/kg/h,0,During stroke,24,TTC (ex vivo),17.56,7.58,14.55,4.81,NA,NA,Direct rLV % whole brain,SD,17.56,14.55,7.58,7.58,4.81,Bederson Scale,6.84,0.55,6.22,1.48,SD,24,No,Yes
Muller_2008,"Muller, H. D.",2008,Brain-derived neurotrophic factor but not forced arm use improves long-term outcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain,a,Rat,Wistar,Male,None,NA,NR,NR,NR,280,300,320,1,5,3,5,3,1.666666667,Ketamine,Xylazine,"Scalp retracted, skull intact",Frontal cortex,10,mg/ml,3,150,W,NA,Other,Other,NR,1.5,20,BDNF (Brain-derived neurotrophic factor),Anti-apoptosis/regeneration,20,ug,1,After stroke,504,Other histology (ex vivo),11.3,4.4,14.7,3.4,NA,NA,mm3,SEM,0.573313039,0.745814307,9.838699101,0.499172963,7.602631123,NSS,2.76,0.26,1.39,0.42,SEM,1008,Yes,Yes
Muller_2008,"Muller, H. D.",2008,Brain-derived neurotrophic factor but not forced arm use improves long-term outcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain,b,Rat,Wistar,Male,None,NA,NR,NR,NR,280,300,320,1,5,3,5,3,1.666666667,Ketamine,Xylazine,"Scalp retracted, skull intact",Frontal cortex,10,mg/ml,3,150,W,NA,Other,Other,NR,1.5,20,FAU (Forced arm use),Other,NA,NA,1,After stroke,504,Other histology (ex vivo),11.3,4.4,12.9,2.7,NA,NA,mm3,SEM,0.573313039,0.654490107,9.838699101,0.499172963,6.037383539,NSS,2.76,0.26,4.57,0,SEM,1008,Yes,Yes
Murakami_2013,"Murakami, K.",2013,"Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats",a,Rat,Sprague-Dawley,Male,None,NA,NR,7,NR,NR,NR,NR,1,16,2,8,2,8,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,10,mg/kg,1,After stroke,24,TTC (ex vivo),286.5,10.6,NR,NR,-28.64,9.64,mm3,SEM,14.53576865,NA,42.4,2.151192288,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Murakami_2013,"Murakami, K.",2013,"Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats",b,Rat,Sprague-Dawley,Male,None,NA,NR,7,NR,NR,NR,NR,1,8,2,8,2,4,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,TAK-937,Harm induction,30,ug/kg/h,1,After stroke,24,TTC (ex vivo),329.4,12.5,NR,NR,-39.75,3.62,mm3,SEM,16.71232877,NA,35.35533906,1.793776715,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Nagai_2010_a,"Nagai, N.",2010,Initial brain lesion size affects the extent of subsequent pathophysiological responses,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,22,26,30,3,5,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Parietal cortex,20,mg/kg,20,0.00047,W/cm2,0.00047,Fibre-optic,NR,540,1,10,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),7.4,0.85,NA,NA,NA,NA,Indirect rLV % whole brain,SD,7.4,NA,0.85,0.85,NA,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Nagai_2010_a,"Nagai, N.",2010,Initial brain lesion size affects the extent of subsequent pathophysiological responses,b,Mouse,BALB/c,Male,None,NA,NR,NR,NR,22,26,30,3,5,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Parietal cortex,20,mg/kg,20,0.00047,W/cm2,0.00047,Fibre-optic,NR,540,1,10,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),7.44,0.5,NA,NA,NA,NA,Indirect rLV % whole brain,SD,7.44,NA,0.5,0.5,NA,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Nagai_2010_a,"Nagai, N.",2010,Initial brain lesion size affects the extent of subsequent pathophysiological responses,c,Mouse,129/Sv,Male,None,NA,NR,NR,NR,22,26,30,3,5,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Parietal cortex,20,mg/kg,20,0.00047,W/cm2,0.00047,Fibre-optic,NR,540,1,10,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),7.33,0.52,NA,NA,NA,NA,Indirect rLV % whole brain,SD,7.33,NA,0.52,0.52,NA,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Nagai_2010_b,"Nagai, N.",2010,Systemic transplantation of embryonic stem cells accelerates brain lesion decrease and angiogenesis,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,22,26,30,1,5.5,1,5.5,1,5.5,Isoflurane,NA,"Scalp retracted, skull intact",Parietal cortex,20,mg/kg,20,0.00047,W/cm2,0.00047,Fibre-optic,NR,540,1,10,Endothelial stem cell transplantation,Anti-apoptosis/regeneration,100000,Cells,24,After stroke,192,Other histology (ex vivo),2.76,0.35,1.9,0.25,NA,NA,Indirect rLV % whole brain,SEM,2.76,1.9,0.820822758,0.820822758,0.58630197,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Nagai_2007,"Nagai, N.",2007,Plasminogen activator inhibitor-1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice,a,Mouse,C57BL/6,Male,None,NA,NR,20,NR,31,37,43,1,10,1,9,1,10,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,540,1,10,High fat diet,Other,15,Weeks,NA,Before stroke,24,TTC (ex vivo),24,0.9,32,2.1,NA,NA,mm3,SEM,4.715961565,6.287948753,2.846049894,0.559244246,6.3,None,NA,NA,NA,NA,NA,NA,No,No
Nagai_2007,"Nagai, N.",2007,Plasminogen activator inhibitor-1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice,b,Mouse,PAI-1-/-,Male,None,NA,NR,20,NR,30,35,40,1,11,1,9,1,11,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,540,1,10,High fat diet,Other,15,Weeks,NA,Before stroke,24,TTC (ex vivo),27,2.8,31,1.8,NA,NA,mm3,SEM,5.305456761,6.091450355,9.286549413,1.824792088,5.4,None,NA,NA,NA,NA,NA,NA,No,No
Nagai_2007,"Nagai, N.",2007,Plasminogen activator inhibitor-1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice,c,Mouse,Lep/ob (obese),Male,Obesity,Genetic,NR,20,NR,NR,53,NR,1,9,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,NR,NA,NA,Xenon lamp,Xenon,540,1,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),30,2.9,NA,NA,NA,NA,mm3,SEM,5.894951956,NA,8.7,1.709536067,NA,None,NA,NA,NA,NA,NA,NA,No,No
Nagai_2002,"Nagai, N.",2002,Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice,a,Mouse,Wild type (WT),NR,None,NA,NR,NR,NR,20,22.5,25,6,10,0,NA,NA,NA,Halothane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,0.38,W/cm2,0.38,Green laser,Diode-pumped solid state laser,540,1.5,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),0.83,1.5,NA,NA,NA,NA,mm3,SD,0.163093671,NA,1.5,0.294747598,NA,None,NA,NA,NA,NA,NA,NA,No,No
Nagai_2002,"Nagai, N.",2002,Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice,b,Mouse,tPA-/-,NR,None,NA,NR,NR,NR,20,22.5,25,6,10,0,NA,NA,NA,Halothane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,0.38,W/cm2,0.38,Green laser,Diode-pumped solid state laser,540,1.5,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),4.6,4.2,NA,NA,NA,NA,mm3,SD,0.903892633,NA,4.2,0.825293274,NA,None,NA,NA,NA,NA,NA,NA,No,No
Nagai_2002,"Nagai, N.",2002,Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice,c,Mouse,Wild type (WT),NR,None,NA,NR,NR,NR,20,22.5,25,6,10,0,NA,NA,NA,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,1,W/cm2,1,Green laser,Diode-pumped solid state laser,540,1.5,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),4,2,NA,NA,NA,NA,mm3,SD,0.785993594,NA,2,0.392996797,NA,None,NA,NA,NA,NA,NA,NA,No,No
Nagai_2002,"Nagai, N.",2002,Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice,d,Mouse,tPA-/-,NR,None,NA,NR,NR,NR,20,22.5,25,6,10,0,NA,NA,NA,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,1,W/cm2,1,Green laser,Diode-pumped solid state laser,540,1.5,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),5.8,3.1,NA,NA,NA,NA,mm3,SD,1.139690712,NA,3.1,0.609145035,NA,None,NA,NA,NA,NA,NA,NA,No,No
Nagai_2002,"Nagai, N.",2002,Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice,e,Mouse,Wild type (WT),NR,None,NA,NR,NR,NR,20,22.5,25,6,10,0,NA,NA,NA,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,1.4,W/cm2,1.4,Green laser,Diode-pumped solid state laser,540,1.5,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),14,6.4,NA,NA,NA,NA,mm3,SD,2.75097758,NA,6.4,1.257589751,NA,None,NA,NA,NA,NA,NA,NA,No,No
Nagai_2002,"Nagai, N.",2002,Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice,f,Mouse,tPA-/-,NR,None,NA,NR,NR,NR,20,22.5,25,6,10,0,NA,NA,NA,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,1.4,W/cm2,1.4,Green laser,Diode-pumped solid state laser,540,1.5,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),8.2,2.5,NA,NA,NA,NA,mm3,SD,1.611286868,NA,2.5,0.491245996,NA,None,NA,NA,NA,NA,NA,NA,No,No
Nagy_2009,"Nagy, D.",2009,Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex,a,Rat,Wistar,Male,None,NA,NR,NR,NR,200,225,250,1,12,1,8,1,12,Urethane,NA,"Scalp retracted, skull intact",Somatosensory cortex,3,mg/100g,30,NR,NA,NA,Cold light,NR,NR,NR,20,Oxaloacetic acid,Excitotoxicity,1.2,mg/100g,0,During stroke,4,Other histology (ex vivo),53.1,3.08,39.14,7.86,NA,NA,mm3,SEM,2.694063927,1.985794013,10.66943297,0.5413208,22.2314372,None,NA,NA,NA,NA,NA,NA,No,No
Nahirney_2016,"Nahirney, P. C.",2016,Ultrastructural analysis of blood-brain barrier breakdown in the peri-infarct zone in young adult and aged mice,a,Mouse,C57BL/6,Male,None,NA,13,15,17,NR,NR,NR,2,4,0,NA,NA,NA,Isoflurane,NA,Skull thinned,Forelimb sensorimotor cortex,110,mg/kg,110,17,mW,NA,Green laser,Diode-pumped solid state laser,532,NR,15,None,NA,NA,NA,NA,NA,3,Other histology (ex vivo),3.67,1.21,NA,NA,NA,NA,mm2,SEM,NA,NA,2.42,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Nahirney_2016,"Nahirney, P. C.",2016,Ultrastructural analysis of blood-brain barrier breakdown in the peri-infarct zone in young adult and aged mice,b,Mouse,C57BL/6,Male,Aged,NA,NR,78,NR,NR,NR,NR,2,4,0,NA,NA,NA,Isoflurane,NA,Skull thinned,Forelimb sensorimotor cortex,110,mg/kg,110,17,mW,NA,Green laser,Diode-pumped solid state laser,532,NR,15,None,NA,NA,NA,NA,NA,3,Other histology (ex vivo),3.77,0.83,NA,NA,NA,NA,mm2,SEM,NA,NA,1.66,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Nakagawa_2005,"Nakagawa, I.",2005,MitoKATP-channel opener protects against neuronal death in rat venous ischemia,a,Rat,Wistar,Male,None,NA,NR,NR,NR,305,351,400,1,17,3,12,3,5.666666667,Chloral hydrate,NA,Skull breached,Fronto-parietal cerebral cortex,50,mg/kg,50,7000,lux,0.00102487,Mercury lamp,Mercury,540,0.1,25,Diazoxide,Blood flow,2,mmol/L,-0.25,Before stroke,168,Other histology (ex vivo),6.2,0.7,3.7,0.4,NA,NA,mm3,SEM,0.314561136,0.187721969,2.886173938,0.14643196,1.385640646,None,NA,NA,NA,NA,NA,NA,No,Yes
Nakagawa_2005,"Nakagawa, I.",2005,MitoKATP-channel opener protects against neuronal death in rat venous ischemia,b,Rat,Wistar,Male,None,NA,NR,NR,NR,305,351,400,1,17,3,7,3,5.666666667,Chloral hydrate,NA,Skull breached,Fronto-parietal cerebral cortex,50,mg/kg,50,7000,lux,0.00102487,Mercury lamp,Mercury,540,0.1,25,5-HD (5-hydroxydecanoate),Other,100,mmol/L,-0.25,Before stroke,168,Other histology (ex vivo),6.2,0.7,8.8,1,NA,NA,mm3,SEM,0.314561136,0.446473871,2.886173938,0.14643196,2.645751311,None,NA,NA,NA,NA,NA,NA,No,Yes
Nakamura_2016,"Nakamura, M.",2016,Toxic acrolein production due to Ca(2+) influx by the NMDA receptor during stroke,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,1,6,3,6,3,2,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,"TB34 (N1,N4,N8-tri-benzyl-spermidine)",Excitotoxicity,50,mg/kg,0,During stroke,24,TTC (ex vivo),35.39,1.31,22.14,1.94,NA,NA,mm3,SE,6.954078324,4.350474544,3.208831563,0.630530263,4.752010101,None,NA,NA,NA,NA,NA,NA,No,Yes
Nakase_1997_a,"Nakase, H.",1997,Microcirculation after cerebral venous occlusions as assessed by laser Doppler scanning,a,Rat,Wistar,Male,None,NA,NR,NR,NR,260,300,340,1,7,0,NA,NA,NA,Ether,Chloral hydrate,Skull breached,Fronto-parietal cerebral cortex,50,mg/kg,50,NR,NA,NA,NR,NR,NR,0.1,20,None,NA,NA,NA,NA,NA,48,Other histology (ex vivo),9.8,4.5,NA,NA,NA,NA,Direct rLV % hemisphere,SD,4.9,NA,4.5,2.25,NA,None,NA,NA,NA,NA,NA,NA,No,No
Nakase_1997_b,"Nakase, H.",1997,An experimental model of intraoperative venous injury in the rat,a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,315,390,2,9,0,NA,NA,NA,Chloral hydrate,NA,Skull breached,NR,50,mg/kg,50,NR,NA,NA,NR,NR,NR,0.1,10,None,NA,NA,NA,NA,NA,48,Other histology (ex vivo),2.9,1.3,NA,NA,NA,NA,Direct rLV % hemisphere,NR,1.45,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Nakayama_1988,"Nakayama, H.",1988,Photothrombotic occlusion of rat middle cerebral artery: histopathological and hemodynamic sequelae of acute recanalization,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,280,305,330,1,7,2,6,2,3.5,Nitrous oxide,Halothane,Skull breached,Middle cerebral artery (MCA),30,mg/ml,20.1,10,W/cm2,10,Helium-Neon laser,Helium-Neon laser,543.5,0.2,20,Nimodipine,Blood flow,150,uL,1,After stroke,168,Other histology (ex vivo),32.6,10.1,3.2,1.9,NA,NA,mm3,SE,1.65398275,0.162354135,26.72208824,1.355762975,4.654030511,None,NA,NA,NA,NA,NA,NA,No,Yes
Neumann-Haefelin_1998,"Neumann-Haefelin, T.",1998,Immunohistochemical evidence for dysregulation of the GABAergic system ipsilateral to photochemically induced cortical infarcts in rats,a,Rat,Wistar,Male,None,NA,13,19.5,26,280,315,350,1,7,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Somatosensory cortex,1.3,mg/100g,13,15,W/cm2,15,Cold light,NR,NR,2,20,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),2.4,0.45,NA,NA,NA,NA,mm (diameter),SD,NA,NA,0.45,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Ning_2019,"Ning, J.",2019,TOM7 silencing exacerbates focal cerebral ischemia injury in rat by targeting PINK1/Beclin1-mediated autophagy,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,275,300,2,6,2,6,1,6,Chloral hydrate,NA,Skull thinned,NR,10,mg/ml,20,90,mW,NA,NR,NR,532,NR,20,TOM7 siRNA,Anti-apoptosis/regeneration,NR,NA,-48,Before stroke,NR,TTC (ex vivo),17.17,3.47,24.1,1.84,NA,NA,Indirect rLV % hemisphere,SEM,8.585,12.05,8.499729407,4.249864704,4.507061127,Longa score,1.32,0.52,3.16,0.76,SEM,NR,Yes,Yes
Niv_2012,"Niv, F.",2012,Aberrant neurogenesis after stroke: a retroviral cell labeling study,a,Rat,Wistar,Male,None,NA,NR,NR,NR,250,260,270,1,6,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,1.3,mg/100mg,NA,NR,NA,NA,Cold light,NR,NR,2.4,20,None,NA,NA,NA,NA,NA,1008,Other histology (ex vivo),4.85,0.59,NA,NA,NA,NA,mm3,SEM,0.246067986,NA,1.445198948,0.073323133,NA,None,NA,NA,NA,NA,NA,NA,No,No
Ogawa_2009,"Ogawa, T.",2009,"Effects of prasugrel, a novel P2Y(12) inhibitor, in rat models of cerebral and peripheral artery occlusive diseases",a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,200,276,352,1,10,3,10,3,3.333333333,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,150000,lux,0.0219615,Xenon lamp,Xenon,540,3,8,Prasugrel,Thrombolytics,10,mg/kg,-4,Before stroke,24,TTC (ex vivo),13.9,1.5,8.4,0.6,NA,NA,Indirect rLV % hemisphere,SEM,6.95,4.2,4.74341649,2.371708245,1.897366596,None,NA,NA,NA,NA,NA,NA,No,Yes
Ogawa_2009,"Ogawa, T.",2009,"Effects of prasugrel, a novel P2Y(12) inhibitor, in rat models of cerebral and peripheral artery occlusive diseases",b,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,200,276,352,1,10,3,10,3,3.333333333,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,150000,lux,0.0219615,Xenon lamp,Xenon,540,3,8,Clopidogrel,Thrombolytics,30,mg/kg,-4,Before stroke,24,TTC (ex vivo),13.9,1.5,12.64,1.63,NA,NA,Indirect rLV % hemisphere,SEM,6.95,6.32,4.74341649,2.371708245,5.154512586,None,NA,NA,NA,NA,NA,NA,No,No
Ohmori_2018,"Ohmori, C.",2018,Increase in blood-brain barrier permeability does not directly induce neuronal death but may accelerate ischemic neuronal damage,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,22,24,26,2,5,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,0.00047,W/cm2,0.00047,Green laser,Diode-pumped solid state laser,540,1,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),9.15,0.92,NA,NA,NA,NA,mm2,SD,NA,NA,0.92,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Okabe_2018,"Okabe, N.",2018,Constraint-induced movement therapy improves efficacy of task-specific training after severe cortical stroke depending on the ipsilesional corticospinal projections,a,Rat,Fischer 344,Male,None,NA,NR,9,NR,160,170,180,1,9,4,8,4,2.25,Ketamine,Xylazine,Skull thinned,Caudal and rostral forelimb areas,15,mg/kg,15,NR,NA,NA,NR,NR,NR,NR,10,CIMT (Constraint-induced movement therapy),Other,3,Weeks,96,After stroke,672,Other histology (ex vivo),23.04,1.2,22.37,5.15,NA,NA,mm3,SEM,1.168949772,1.134956875,3.6,0.182648402,14.56639969,None,NA,NA,NA,NA,NA,NA,No,Yes
Okabe_2016,"Okabe, N.",2016,Neural network remodeling underlying motor map reorganization induced by rehabilitative training after ischemic stroke,a,Rat,Fischer 344,Male,None,NA,NR,9,NR,160,170,180,1,10,1,11,1,10,Ketamine,Xylazine,Skull thinned,Caudal forelimb area,15,mg/kg,15,NR,NA,NA,Green laser,Diode-pumped solid state laser,532,4,15,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),17.2,1.4,NA,NA,NA,NA,mm3,SEM,0.872653475,NA,4.427188724,0.224616374,NA,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Ong_2017,"Ong, L. K.",2017,Chronic stress exposure following photothrombotic stroke is associated with increased levels of Amyloid beta accumulation and altered oligomerisation at sites of thalamic secondary neurodegeneration in mice,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,NR,NR,NR,1,8,1,8,1,8,NR,NA,"Scalp retracted, skull intact",NR,10,mg/ml,NA,NR,NA,NA,Cold light,NR,NR,4.5,15,Stress (restraint),Other,5,Days,72,After stroke,1008,Other histology (ex vivo),4.78,1.27,10.5,1.69,NA,NA,Indirect rLV % hemisphere,SEM,2.39,5.25,3.592102448,1.796051224,4.780041841,None,NA,NA,NA,NA,NA,NA,No,No
Ostrovskaya_1999,"Ostrovskaya, R. U.",1999,"Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model",a,Rat,Wistar,Male,None,NA,NR,NR,NR,180,200,220,1,7,1,7,1,7,Chloral hydrate,NA,"Scalp retracted, skull intact",Frontal cortex,40,mg/kg,40,250,W,NA,Halogen lamp,Halogen,NR,3,NR,GVS-111,Nootropics/cognition,0.5,mg/kg/day,1,After stroke,216,Other histology (ex vivo),6.2,1.14,3.03,0.5,NA,NA,mm3,SEM,0.314561136,0.153729072,3.016156495,0.153026712,1.322875656,None,NA,NA,NA,NA,NA,NA,No,No
Otsuka_2000_a,"Otsuka, H.",2000,Effect of age on cerebral venous circulation disturbances in the rat,a,Rat,Wistar,Male,None,NA,10,12,14,260,300,340,2,6,0,NA,NA,NA,Chloral hydrate,NA,Skull thinned,NR,50,mg/kg,50,7000,lux,0.00102487,Fibre-optic,NR,540,0.1,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),3.02,1.27,NA,NA,NA,NA,Direct rLV % hemisphere,SD,1.51,NA,1.27,0.635,NA,None,NA,NA,NA,NA,NA,NA,No,No
Otsuka_2000_a,"Otsuka, H.",2000,Effect of age on cerebral venous circulation disturbances in the rat,b,Rat,Wistar,Male,Aged,NA,80,90,100,520,610,700,2,7,0,NA,NA,NA,Chloral hydrate,NA,Skull thinned,Cerebral cortex,25,mg/kg,25,7000,lux,0.00102487,Fibre-optic,NR,540,0.1,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),10.06,5.25,NA,NA,NA,NA,Direct rLV % hemisphere,SD,5.03,NA,5.25,2.625,NA,None,NA,NA,NA,NA,NA,NA,No,No
Otsuka_2000_b,"Otsuka, H.",2000,"Effects of cortical spreading depression on cortical blood flow, impedance, DC potential, and infarct size in a rat venous infarct model",a,Rat,Wistar,Male,None,NA,NR,NR,NR,255,302,350,1,10,2,11,2,5,Chloral hydrate,Ether,Skull breached,Cerebral cortex,50,mg/kg,50,7000,lux,0.00102487,Mercury lamp,Mercury,540,0.1,10,KCL (Potassium chloride),Harm induction,2,uL,0,During stroke,120,Other histology (ex vivo),3.6,2.2,10.5,4.9,NA,NA,mm3,SD,0.182648402,0.532724505,2.2,0.111618468,4.9,None,NA,NA,NA,NA,NA,NA,No,Yes
Pan_2017,"Pan, H. C.",2017,Neurovascular function recovery after focal ischemic stroke by enhancing cerebral collateral circulation via peripheral stimulation-mediated interarterial anastomosis,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,300,325,350,1,15,2,15,2,7.5,Sodium Pentobarbital,NA,Skull breached,Primary forelimb somatosensory cortex (S1FL),30,mg/kg,30,67.5,mW/cm2,0.0675,Green laser,Diode-pumped solid state laser,532,0.4,15,Peripheral sensory electrical stimulation (PSS),Other,5,Hz,0,During stroke,24,TTC (ex vivo),17.05,2.7,7.35,0.23,NA,NA,mm3,SEM,0.865043125,0.372907154,10.45705503,0.530545664,0.89078617,None,NA,NA,NA,NA,NA,NA,No,Yes
Parada_2014,"Parada, E.",2014,Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression,a,Mouse,C57BL/6,NR,None,NA,NR,NR,NR,NR,NR,NR,1,8,2,8,2,4,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,1,mg,NA,NR,NA,NA,LCD,NR,NR,2,20,Melatonin,Anti-oxidants,15,mg/kg,NR,NR,24,TTC (ex vivo),15.6,0.9,8.5,0.7,NA,NA,Direct rLV % cortex,SEM,NA,NA,2.545584412,NA,1.979898987,None,NA,NA,NA,NA,NA,NA,No,Yes
Parada_2013,"Parada, E.",2013,The microglial alpha7-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2,a,Mouse,C57BL/6,NR,None,NA,6,9,12,NR,NR,NR,1,8,3,8,3,2.666666667,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,1,mg,NA,NR,NA,NA,LCD,NR,NR,2,20,PNU282987,Anti-inflammation,10,mg/kg,1,After stroke,24,TTC (ex vivo),15.7,0.9,9.4,0.4,NA,NA,Direct rLV % cortex,SEM,NA,NA,2.545584412,NA,1.13137085,None,NA,NA,NA,NA,NA,NA,No,Yes
Parada_2013,"Parada, E.",2013,The microglial alpha7-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2,b,Mouse,C57BL/6,NR,None,NA,6,9,12,NR,NR,NR,1,8,3,8,3,2.666666667,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,1,mg,NA,NR,NA,NA,LCD,NR,NR,2,20,ZnDPBG,Other,10,mg/kg,0.25,After stroke,24,TTC (ex vivo),15.7,0.9,16.96,1.19,NA,NA,Direct rLV % cortex,SEM,NA,NA,2.545584412,NA,3.365828278,None,NA,NA,NA,NA,NA,NA,No,Yes
Park_2011_a,"Park, C. H.",2011,Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,21,23,25,3,4,3,4,1,4,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,10,mg/ml,43.47826087,NR,NA,NA,LCD,NR,NR,4,15,Doxycycline,Anti-inflammation,20,mg/kg,-0.5,Before stroke,24,TTC (ex vivo),65.32,5.09,44.61,5.08,NA,NA,mm3,SEM,12.83527539,8.765793559,10.18,2.000353697,10.16,None,NA,NA,NA,NA,NA,NA,No,No
Park_2011_a,"Park, C. H.",2011,Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice,b,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,21,23,25,3,4,3,4,1,4,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,10,mg/ml,43.47826087,NR,NA,NA,LCD,NR,NR,4,15,Minocycline,Anti-inflammation,45,mg/kg,2,After stroke,24,TTC (ex vivo),65.03,2.45,39.74,1.74,NA,NA,mm3,SEM,12.77829086,7.808846358,4.9,0.962842153,3.48,None,NA,NA,NA,NA,NA,NA,No,No
Park_2011_b,"Park, S. H.",2011,Protective effect of hexane extracts of Uncaria sinensis against photothrombotic ischemic injury in mice,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,5,5,5,5,1,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,LCD,NR,NR,4,15,HEUS (Hexane extracts of Uncaria sinensis),Blood flow,100,mg/kg,-0.5,Before stroke,24,TTC (ex vivo),56.6,1.7,8.9,4.2,NA,NA,mm3,SEM,11.12180936,1.748835747,3.801315562,0.74695242,9.391485505,0-4 limb scale,1.4,0.28,0.61,0.26,SEM,24,No,Yes
Park_2011_b,"Park, S. H.",2011,Protective effect of hexane extracts of Uncaria sinensis against photothrombotic ischemic injury in mice,b,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,5,5,5,5,1,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,LCD,NR,NR,4,15,MEUS (Methanol extracts of Uncaria sinensis),Blood flow,100,mg/kg,-0.5,Before stroke,24,TTC (ex vivo),56.6,1.7,31.83,4.07,NA,NA,mm3,SEM,11.12180936,6.254544025,3.801315562,0.74695242,9.100796668,0-4 limb scale,NR,NR,NR,NR,SEM,24,No,No
Park_2011_b,"Park, S. H.",2011,Protective effect of hexane extracts of Uncaria sinensis against photothrombotic ischemic injury in mice,c,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,5,5,5,5,1,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,LCD,NR,NR,4,15,EAEUS (Ethyl acetate extracts of Uncaria sinensis),Blood flow,100,mg/kg,-0.5,Before stroke,24,TTC (ex vivo),56.6,1.7,37.8,11.35,NA,NA,mm3,SEM,11.12180936,7.427639465,3.801315562,0.74695242,25.37937154,0-4 limb scale,NR,NR,NR,NR,SEM,24,No,No
Parker_2017,"Parker, K.",2017,PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia,a,Mouse,C57BL/6,Male,None,NA,9,11,13,25,26,27,2,5,6,5,3,1.666666667,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,g/L,76.92307692,NR,NA,NA,LCD,NR,NR,2,17,PEG-IGF-I,Anti-apoptosis/regeneration,1,mg/kg,3,After stroke,336,Other histology (ex vivo),1.45,0.09,0.56,0.04,NA,NA,mm3,SEM,0.284922678,0.110039103,0.201246118,0.03954454,0.089442719,None,NA,NA,NA,NA,NA,NA,No,Yes
Parker_2017,"Parker, K.",2017,PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia,b,Mouse,C57BL/6,Male,Aged,NA,96,100,104,30,32,34,1,5,3,5,3,1.666666667,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,g/L,62.5,NR,NA,NA,LCD,NR,NR,2,17,PEG-IGF-I,Anti-apoptosis/regeneration,1,mg/kg,3,After stroke,336,Other histology (ex vivo),1.26,0.11,0.91,0.06,NA,NA,mm3,SEM,0.247587982,0.178813543,0.245967478,0.048332215,0.134164079,None,NA,NA,NA,NA,NA,NA,No,Yes
Petrovic-Djergovic_2012,"Petrovic-Djergovic, D.",2012,Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain,a,Mouse,C57BL/6,Male,None,NA,NR,10,NR,NR,NR,NR,1,6,1,6,1,6,Ketamine,Xylazine,Skull breached,Distal middle cerebral artery (dMCA),40,mg/kg,40,1.5,mW,NA,Green laser,Diode-pumped solid state laser,540,NR,25,5'-nucleotidase,Anti-inflammation,7.5,U,-0.5,Before stroke,48,MRI (in vivo),34.72,0.86,22.77,1.91,NA,NA,mm3,SEM,6.822424397,4.474268535,2.106561179,0.413935898,4.678525409,Five-point scale (Crowell et al. 1970),1.48,0.56,1,0,SEM,48,No,Yes
Petrovic-Djergovic_2012,"Petrovic-Djergovic, D.",2012,Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain,b,Mouse,CD73-/-,Male,None,NA,NR,10,NR,NR,NR,NR,1,6,1,6,1,6,Ketamine,Xylazine,Skull breached,Distal middle cerebral artery (dMCA),40,mg/kg,40,1.5,mW,NA,Green laser,Diode-pumped solid state laser,540,NR,25,5'-nucleotidase,Anti-inflammation,7.5,U,-0.5,Before stroke,48,MRI (in vivo),68.14,2.25,30.04,3.12,NA,NA,mm3,SEM,13.38940088,5.902811892,5.511351921,1.082971826,7.642407997,Five-point scale (Crowell et al. 1970),3.69,0.79,1.49,0.55,SEM,48,No,Yes
Pielecka-Fortuna_2015,"Pielecka-Fortuna, J.",2015,A Small Motor Cortex Lesion Abolished Ocular Dominance Plasticity in the Adult Mouse Primary Visual Cortex and Impaired Experience-Dependent Visual Improvements,a,Mouse,C57BL/6,NR,None,NA,NR,NR,NR,NR,NR,NR,1,NR,1,NR,1,NA,Isoflurane,NA,"Scalp retracted, skull intact",Motor cortex,10,mg/ml,NA,NR,NA,NA,Cold light,NR,NR,1,15,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),0.12,0.03,NA,NA,NA,NA,mm3,SEM,0.023579808,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Porritt_2012,"Porritt, M. J.",2012,Photothrombosis-induced infarction of the mouse cerebral cortex is not affected by the Nrf2-activator sulforaphane,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,NR,25,NR,2,10.5,4,10.5,2,5.25,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mg/ml,40,50,mW,NA,Cobolt,Cobolt,561,NR,10,Sulforaphane,Anti-inflammation,50,mg/kg,0.25,After stroke,24,Other histology (ex vivo),14.38,NR,17.9,NR,NA,NA,mm3,SD,2.825646971,3.517321334,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Prado_1996,"Prado, R.",1996,L-arginine does not improve cortical perfusion or histopathological outcome in spontaneously hypertensive rats subjected to distal middle cerebral artery photothrombotic occlusion,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,NR,NR,NR,270,307.5,345,1,7,1,7,1,7,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),15,mg/kg,15,20,mW,NA,Argon laser,Argon laser,562,NR,4,Arginine (L-Arg),Blood flow,300,mg/kg,-18,Before stroke,72,Other histology (ex vivo),37,9.7,49.1,17.2,NA,NA,mm3,SD,1.877219685,2.491121258,9.7,0.492135972,17.2,None,NA,NA,NA,NA,NA,NA,No,No
Qian_2016,"Qian, C.",2016,Precise Characterization of the Penumbra Revealed by MRI: A Modified Photothrombotic Stroke Model Study,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,22,23.5,25,1,6,0,NA,NA,NA,Sodium Pentobarbital,NA,Skull breached,Proximal middle cerebral artery (pMCA),25,mg/kg,25,35,mW,NA,Green laser,Diode-pumped solid state laser,532,0.1,2,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),0.35,0.1,NA,NA,NA,NA,Indirect rLV % hemisphere,SD,0.175,NA,0.1,0.05,NA,Other,2.29,0.76,NA,NA,SD,24,Yes,No
Qiu_2016,"Qiu, Z. D.",2016,A new method for evaluating regional cerebral blood flow changes: Laser speckle contrast imaging in a C57BL/6J mouse model of photothrombotic ischemia,a,Mouse,C57BL/6,Male,None,NA,8,9,10,18,21,24,4,10,0,NA,NA,NA,Chloral hydrate,NA,"Scalp retracted, skull intact",Somatosensory cortex,50,mg/kg,50,100,mV,NA,Diode laser,Diode laser,532,NR,1.5,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),5.8,0.7,NA,NA,NA,NA,mm3,NR,1.139690712,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Qu_2010,"Qu, W. S.",2010,Galectin-1 enhances astrocytic BDNF production and improves functional outcome in rats following ischemia,a,Rat,Wistar,Male,None,NA,NR,NR,NR,220,250,280,1,30,1,18,1,30,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,10,mg/kg,10,15,W,NA,LCD,NR,550,NR,20,Galectin-1,Anti-apoptosis/regeneration,1,ug/day,0,During stroke,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,mNSS,4.14,0.27,2.83,0.18,SE,360,Yes,No
Quattromani_2014,"Quattromani, M. J.",2014,Enriched housing down-regulates the Toll-like receptor 2 response in the mouse brain after experimental stroke,a,Mouse,TLR2+/?,Male,None,NA,9,13,17,20,25,30,1,6,1,8,1,6,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,10,mg/ml,100,NR,NA,NA,Cold light,NR,NR,2.5,20,Enriched cage environment,Other,12,Days,48,After stroke,336,Other histology (ex vivo),8.6,1.9,8,1.9,NR,NR,mm3,SEM,1.689886227,1.571987188,4.654030511,0.914509542,5.374011537,Paw placement score,0,0,0.56,0.07,SEM,336,No,No
Quattromani_2018_a,"Quattromani, M. J.",2018,Changes in resting-state functional connectivity after stroke in a mouse brain lacking extracellular matrix components,a,Mouse,129S1/SvImJ,Female,None,NA,10,27.5,45,20,22,24,1,9,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mg/ml,NA,2725,K,NA,LCD,NR,NR,4,20,None,NA,NA,NA,NA,NA,336,Other histology (ex vivo),10.7,1.69,NA,NA,NA,NA,mm3,SEM,2.102532864,NA,5.07,0.996246881,NA,Paw placement score,1,0.25,NA,NA,SEM,48,Yes,No
Quattromani_2018_a,"Quattromani, M. J.",2018,Changes in resting-state functional connectivity after stroke in a mouse brain lacking extracellular matrix components,b,Mouse,Q4 mouse,Female,None,NA,10,27.5,45,20,22,24,1,9,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mg/ml,NA,2725,K,NA,LCD,NR,NR,4,20,None,NA,NA,NA,NA,NA,336,Other histology (ex vivo),11.9,1.41,NA,NA,NA,NA,mm3,SEM,2.338330943,NA,4.23,0.831188226,NA,Paw placement score,0,0.75,NA,NA,SEM,48,Yes,No
Quattromani_2018_b,"Quattromani, M. J.",2018,Extracellular Matrix Modulation Is Driven by Experience-Dependent Plasticity During Stroke Recovery,a,Rat,Sprague-Dawley,Male,None,NA,8,9.5,11,NR,NR,NR,1,5,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,10,mg/ml,NA,NR,NA,NA,LCD,NR,NR,8,15,Enriched cage environment,Other,5,Days,48,After stroke,168,Other histology (ex vivo),33.64,4.28,34.28,6.38,NA,NA,mm3,SEM,1.706747844,1.739218671,9.570370944,0.485559155,NA,Paw placement score,0,0,1,0.5,SEM,48,No,No
Rahman_2018,"Rahman, M.",2018,Investigation of Mature BDNF and proBDNF Signaling in a Rat Photothrombotic Ischemic Model,a,Rat,Sprague-Dawley,NR,None,NA,8,10,12,250,300,350,2,4,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,150,W,NA,Cold light,NR,NR,NR,20,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),38.38,4.8,NA,NA,NA,NA,mm3,SEM,1.947234906,NA,9.6,0.487062405,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Reichenbach_2016,"Reichenbach, Z. W.",2016,"The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia",a,Mouse,C57BL/6,Male,None,NA,7,7.5,8,20,22.5,25,2,5,3,5,1.5,3.333333333,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,10,mg/ml,44.44444444,NR,NA,NA,NR,NR,NR,NR,20,SR141716A,Harm induction,5,mg/kg,-1,Before stroke,24,TTC (ex vivo),68.63,7.16,38.67,5.16,NA,NA,mm3,SEM,13.48568509,7.598593071,16.01024672,3.14598784,11.53811076,0-4 limb scale,2.1,0.58,0.5,0,SEM,24,No,Yes
Rogers_1997,"Rogers, D. C.",1997,Photothrombotic lesions of the rat cortex impair acquisition of the water maze,a,Rat,Lister Hooded Rat,Male,None,NA,NR,NR,NR,250,275,300,1,8,1,8,1,8,Halothane,NA,"Scalp retracted, skull intact",Motor cortex,20,mg/ml,20,300,W,NA,Xenon lamp,Xenon,NR,3,5,Flunarizine,Blood flow,2,mg/kg,-0.5,Before stroke,192,Other histology (ex vivo),5.5,1,5.2,0.6,NA,NA,mm3,SEM,0.279046169,0.263825469,2.828427125,0.143502137,1.697056275,None,NA,NA,NA,NA,NA,NA,No,Yes
Romanova_2015,"Romanova, G. A.",2015,Neuroprotective and antiamnesic effect of erythropoietin derivatives after experimental ischemic injury of cerebral cortex,a,Rat,Other,Male,None,NA,NR,NR,NR,200,210,220,1,8,3,8,3,2.666666667,Chloral hydrate,NA,NR,Frontal cortex,40,mg/kg,40,250,W,NA,Halogen lamp,Halogen,560,3,30,EPO (erythropoietin),Energy substrates,50,ug/kg,1,After stroke,192,Other histology (ex vivo),12.1,1.8,14.4,3.2,NA,NA,mm3,NR,0.613901573,0.730593607,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Romanova_2015,"Romanova, G. A.",2015,Neuroprotective and antiamnesic effect of erythropoietin derivatives after experimental ischemic injury of cerebral cortex,b,Rat,Other,Male,None,NA,NR,NR,NR,200,210,220,1,8,3,8,3,2.666666667,Chloral hydrate,NA,NR,Frontal cortex,40,mg/kg,40,250,W,NA,Halogen lamp,Halogen,560,3,30,EPO-TR,Energy substrates,50,ug/kg,1,After stroke,192,Other histology (ex vivo),12.1,1.8,8,2.1,NA,NA,mm3,NR,0.613901573,0.405885337,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Romanova_2015,"Romanova, G. A.",2015,Neuroprotective and antiamnesic effect of erythropoietin derivatives after experimental ischemic injury of cerebral cortex,c,Rat,Other,Male,None,NA,NR,NR,NR,200,210,220,1,8,3,7,3,2.666666667,Chloral hydrate,NA,NR,Frontal cortex,40,mg/kg,40,250,W,NA,Halogen lamp,Halogen,560,3,30,EPO-Fc,Energy substrates,50,ug/kg,1,After stroke,192,Other histology (ex vivo),12.1,1.8,11.8,1.5,NA,NA,mm3,NR,0.613901573,0.598680873,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Sadanaga-Akiyoshi_2003,"Sadanaga-Akiyoshi, F.",2003,Nicotinamide attenuates focal ischemic brain injury in rats: with special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumbra,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,22,26,30,315,370,425,1,9,2,8,2,4.5,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,NR,4,Nicotinamide,Anti-apoptosis/regeneration,125,mg/kg,-0.5,Before stroke,72,TTC (ex vivo),84.2,11.1,52,17.5,NA,NA,mm3,SD,4.271943176,2.638254693,11.1,0.563165906,17.5,None,NA,NA,NA,NA,NA,NA,No,Yes
Saiki_2013_a,"Saiki, R.",2013,Acrolein stimulates the synthesis of IL-6 and C-reactive protein (CRP) in thrombosis model mice and cultured cells,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,3,7,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),54.41,8.2,NA,NA,NA,NA,mm3,SE,10.69147786,NA,21.69516075,4.263064344,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Saiki_2009,"Saiki, R.",2009,Intense correlation between brain infarction and protein-conjugated acrolein,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,1,10,1,10,1,10,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,N-acetylcysteine,Anti-oxidants,250,mg/kg,0,During stroke,24,TTC (ex vivo),23.3,1.4,15.87,1.31,NA,NA,mm3,SE,4.578412686,3.118429585,4.427188724,0.869935494,4.142583735,None,NA,NA,NA,NA,NA,NA,No,No
Saiki_2011,"Saiki, R.",2011,Brain infarction correlates more closely with acrolein than with reactive oxygen species,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,1,5,8,5,8,0.625,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,Edaravone (MCI-186),Anti-oxidants,40,mg/kg,0,During stroke,24,TTC (ex vivo),29.17,0.89,20.26,1.78,NA,NA,mm3,SE,5.731858285,3.981057554,1.9901005,0.391051561,3.980201,None,NA,NA,NA,NA,NA,NA,No,Yes
Saiki_2011,"Saiki, R.",2011,Brain infarction correlates more closely with acrolein than with reactive oxygen species,b,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,1,5,8,5,8,0.625,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,N-benzylhydroxylamine,Anti-oxidants,200,mg/kg,0,During stroke,24,TTC (ex vivo),29.17,0.89,17.29,2.08,NA,NA,mm3,SE,5.731858285,3.397457311,1.9901005,0.391051561,4.651021393,None,NA,NA,NA,NA,NA,NA,No,Yes
Saiki_2011,"Saiki, R.",2011,Brain infarction correlates more closely with acrolein than with reactive oxygen species,c,Mouse,B6C3H,Male,None,NA,NR,8,NR,22,24,26,1,5,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),25.57,2.08,NA,NA,NA,NA,mm3,SE,5.024464051,NA,4.651021393,0.913918255,NA,None,NA,NA,NA,NA,NA,NA,No,No
Saiki_2011,"Saiki, R.",2011,Brain infarction correlates more closely with acrolein than with reactive oxygen species,d,Mouse,Spermine-less Gy,Male,None,NA,NR,8,NR,22,24,26,1,5,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),16.8,1.6,NA,NA,NA,NA,mm3,SE,3.301173095,NA,3.577708764,0.703014043,NA,None,NA,NA,NA,NA,NA,NA,No,No
Saiki_2011,"Saiki, R.",2011,Brain infarction correlates more closely with acrolein than with reactive oxygen species,e,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,1,5,2,5,2,2.5,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,MDL72527,Anti-oxidants,300,mg/kg,NR,NR,24,TTC (ex vivo),33.12,3.51,18.51,2.27,NA,NA,mm3,SE,6.50802696,3.637185357,7.848598601,1.542237056,5.075874309,None,NA,NA,NA,NA,NA,NA,No,Yes
Saiki_2011,"Saiki, R.",2011,Brain infarction correlates more closely with acrolein than with reactive oxygen species,f,Mouse,TG2-/-,Male,None,NA,NR,8,NR,22,24,26,1,5,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),18.34,2.88,NA,NA,NA,NA,mm3,SE,3.603780629,NA,6.439875775,1.265425277,NA,None,NA,NA,NA,NA,NA,NA,No,No
Saiki_2011,"Saiki, R.",2011,Brain infarction correlates more closely with acrolein than with reactive oxygen species,g,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,1,5,2,5,2,2.5,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,Cystamine,Anti-apoptosis/regeneration,200,mg/kg,NR,NR,24,TTC (ex vivo),28.53,3.79,18.25,2,NA,NA,mm3,SE,5.60609931,3.586095773,8.474697635,1.665264513,4.472135955,None,NA,NA,NA,NA,NA,NA,No,Yes
Saiki_2013_b,"Saiki, R.",2013,In vitro and in vivo evaluation of polymethylene tetraamine derivatives as NMDA receptor channel blockers,a,Mouse,NR,NR,None,NA,NR,NR,NR,NR,NR,NR,1,8,7,8,7,1.142857143,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,Methoctramine,Excitotoxicity,0.4,mg/kg,NR,NR,NR,NR,1,0.05,0.62,0.1,NA,NA,Relative size (control as baseline),SE,NA,NA,0.141421356,NA,0.282842712,None,NA,NA,NA,NA,NA,NA,No,Yes
Saiki_2013_b,"Saiki, R.",2013,In vitro and in vivo evaluation of polymethylene tetraamine derivatives as NMDA receptor channel blockers,b,Mouse,NR,NR,None,NA,NR,NR,NR,NR,NR,NR,1,8,7,8,7,1.142857143,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,Memantine,Excitotoxicity,10,mg/kg,NR,NR,NR,NR,1,0.05,0.61,0.08,NA,NA,Relative size (control as baseline),SE,NA,NA,0.141421356,NA,0.22627417,None,NA,NA,NA,NA,NA,NA,No,Yes
Salber_2006,"Salber, D.",2006,Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia,a,Rat,Other,Male,None,NA,8,10,12,150,280,410,1,3,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",Cerebral cortex,1.3,mg/100g,13,NR,NA,NA,LCD,NR,NR,NR,20,None,NA,NA,NA,NA,NA,24,NR,6.833,1.342,NA,NA,NA,NA,mm (diameter),SD,NA,NA,1.342468704,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Saleh_2004,"Saleh, A.",2004,Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging,a,Rat,Wistar,Male,None,NA,NR,NR,NR,280,300,320,1,4,1,4,1,4,Enflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,0.13,mg/kg,0.13,NR,NA,NA,NR,NR,NR,NR,20,USPIO (ultrasmall superparamagnetic iron oxide),Other,300,umol/kg,120,After stroke,144,MRI (in vivo),2.6,1,18.9,3.9,NA,NA,mm3,NR,0.131912735,0.95890411,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Sanikidze_2013,"Sanikidze, T. V.",2013,Neuroprotective treatment of cerebral infarction: an experimental study,a,Rat,Wistar,Male,None,NA,NR,NR,NR,220,235,250,1,5,1,5,1,5,NR,NA,"Scalp retracted, skull intact",Sensorimotor cortex,7.5,mg/ml,9.975,NR,NA,NA,Cold light,NR,NR,NR,45,Plaferon-LB,Anti-oxidants,0.1,mg/kg,-0.5,Before stroke,4,Other histology (ex vivo),21.9,3.3,3.3,0.8,NA,NA,mm3,SD,1.111111111,0.167427702,3.3,0.167427702,0.8,None,NA,NA,NA,NA,NA,NA,No,No
Saraiva_2018,"Saraiva, C.",2018,MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo,a,Mouse,C57BL/6,Male,None,NA,NR,9,NR,NR,NR,NR,2,11,3,12,1.5,7.333333333,Isoflurane,NA,"Scalp retracted, skull intact",Motor cortex,10,mg/ml,NA,3200,K,NA,LCD,NR,NR,2,20,MicroRNA-124 loaded nanoparticles,Anti-inflammation,4,nmol,NR,After stroke,336,Other histology (ex vivo),0.81,0.15,0.81,0.13,NA,NA,mm3,SEM,0.159163703,0.159163703,0.497493719,0.097756719,0.45033321,None,NA,NA,NA,NA,NA,NA,No,No
Saraiva_2018,"Saraiva, C.",2018,MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo,b,Mouse,C57BL/6,Male,None,NA,NR,9,NR,NR,NR,NR,2,11,3,12,1.5,7.333333333,Isoflurane,NA,"Scalp retracted, skull intact",Motor cortex,10,mg/ml,NA,3200,K,NA,LCD,NR,NR,2,20,MicroRNA-124 (scrambled) loaded nanoparticles,Anti-inflammation,4,nmol,NR,After stroke,336,Other histology (ex vivo),0.81,0.15,0.67,0.09,NA,NA,mm3,SEM,0.159163703,0.131653927,0.497493719,0.097756719,0.311769145,None,NA,NA,NA,NA,NA,NA,No,No
Sawada_2014,"Sawada, H.",2014,"SMTP-7, a novel small-molecule thrombolytic for ischemic stroke: a study in rodents and primates",a,Primate,"Cynomolgus monkey (Macaca fascicularis, crab-eating macaque)",Male,None,NA,104,130,156,NR,NR,NR,1,6,1,6,1,6,NR,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,1400000,lux,0.204974,NR,NR,540,NR,20,SMTP-7,Anti-inflammation,10,mg/kg,1,After stroke,24,TTC (ex vivo),2675,950,1449,570,NA,NA,mm3,SD,NA,NA,950,NA,570,Kito 100 point score,43.7,8.1,31.2,7.9,SD,24,No,No
Schabitz_2004,"Schabitz, W. R.",2004,Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia,a,Rat,Wistar,Male,None,NA,NR,NR,NR,280,300,320,1,6,2,6,2,3,Ketamine,NA,"Scalp retracted, skull intact",Parietal cortex,10,mg/ml,1.33,150,W,NA,NR,NR,NR,1.5,20,BDNF (Brain-derived neurotrophic factor),Anti-apoptosis/regeneration,20,ug,1,After stroke,168,Other histology (ex vivo),28.5,2.3,31.7,6.4,NA,NA,mm3,SEM,1.445966514,1.608320649,5.633826408,0.285835942,15.67673435,mNSS,4.32,0.28,2.53,0.16,SEM,840,Yes,No
Schabitz_2004,"Schabitz, W. R.",2004,Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia,b,Rat,Wistar,Male,None,NA,NR,NR,NR,280,300,320,1,6,2,6,2,3,Ketamine,NA,"Scalp retracted, skull intact",Parietal cortex,10,mg/ml,1.33,150,W,NA,NR,NR,NR,1.5,20,FAU (Forced arm use),Other,5,Days,1,After stroke,168,Other histology (ex vivo),28.5,2.3,37.1,3.6,NA,NA,mm3,SEM,1.445966514,1.882293252,5.633826408,0.285835942,8.818163074,mNSS,4.32,0.28,3.82,0.07,SEM,840,Yes,Yes
Schabitz_2007,"Schabitz, W. R.",2007,Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis,a,Rat,Wistar,Male,None,NA,NR,NR,NR,280,300,320,1,10,1,6,1,6,Ketamine,Xylazine,"Scalp retracted, skull intact",Parietal cortex,0.133,mL/kg,NA,150,W,NA,Cold light,NR,NR,NR,20,BDNF (Brain-derived neurotrophic factor),Anti-apoptosis/regeneration,20,ug,1,After stroke,888,Other histology (ex vivo),37.8,9.4,27.7,9.5,NA,NA,mm3,SEM,1.917808219,1.405377981,29.72541001,1.508138509,23.27015256,NSS,5.09,0.34,3.2,0.53,SEM,1008,Yes,No
Schmidt_2015,"Schmidt, A.",2015,Progressive cognitive deficits in a mouse model of recurrent photothrombotic stroke,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,NR,NR,NR,1,8,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,mg/ml,NA,NR,NA,NA,Cold light,NR,NR,4,20,None,NA,NA,NA,NA,NA,336,Other histology (ex vivo),6.86,0.77,NA,NA,NA,NA,mm3,SEM,1.347979014,NA,2.177888886,0.427951678,NA,None,NA,NA,NA,NA,NA,NA,No,No
Schmidt_2017,"Schmidt, A.",2017,Targeting Different Monocyte/Macrophage Subsets Has No Impact on Outcome in Experimental Stroke,a,Mouse,C57BL/6,Male,None,NA,NR,12,NR,NR,NR,NR,1,NR,2,NR,2,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,10,mg/ml,NA,NR,NA,NA,NR,NR,NR,8,15,MC-21-antibody,Anti-inflammation,20,ug,-1,Before stroke,336,Other histology (ex vivo),0.67,0.1,0.87,0.21,NA,NA,mm3,SEM,0.131653927,0.170953607,NA,NA,NA,Modified Menzies scale,NR,NR,NR,NR,SEM,NR,No,No
Schmidt_2017,"Schmidt, A.",2017,Targeting Different Monocyte/Macrophage Subsets Has No Impact on Outcome in Experimental Stroke,b,Mouse,C57BL/6,Male,None,NA,NR,12,NR,NR,NR,NR,1,NR,2,NR,2,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,10,mg/ml,NA,NR,NA,NA,NR,NR,NR,8,15,M2-macrophages (anti-inflammatory),Anti-inflammation,2000000,Cells,-1,Before stroke,336,Other histology (ex vivo),0.67,0.1,0.65,0.09,NA,NA,mm3,SEM,0.131653927,0.127723959,NA,NA,NA,Modified Menzies scale,NR,NR,NR,NR,SEM,NR,No,No
Schneider_2007,"Schneider, J. S.",2007,Postnatal lead poisoning impairs behavioral recovery following brain damage,a,Rat,Long Evans,Male,None,NA,NR,4,NR,NR,NR,NR,1,NR,1,NR,1,NA,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Hindlimb sensorimotor cortex,30,mg/kg,30,200,mW,NA,Argon laser,Argon laser,514,3,5,Lead poisoning,Harm induction,1500,ppm in diet,NA,Before stroke,192,Other histology (ex vivo),75.3,23.1,62.4,17.6,NA,NA,mm3,NR,3.820395738,3.165905632,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Schroeter_1997,"Schroeter, M.",1997,Phagocytic response in photochemically induced infarction of rat cerebral cortex. The role of resident microglia,a,Rat,Wistar,Male,None,NA,NR,NR,NR,NR,NR,NR,1,6,1,6,1,6,Enflurane,NA,"Scalp retracted, skull intact",NR,10,mg/ml,1.33,150,W,NA,Cold light,NR,NR,1.5,20,Cl2MDP (dichloromethylene diphosphonate),Other,NR,NA,-48,Before stroke,72,Other histology (ex vivo),18.3,6.6,14.3,6.3,NA,NA,mm3,SD,0.928462709,0.725520041,6.6,0.334855403,6.3,None,NA,NA,NA,NA,NA,NA,Yes,No
Schroeter_2002,"Schroeter, M.",2002,Non-invasive induction of focal cerebral ischemia in mice by photothrombosis of cortical microvessels: characterization of inflammatory responses,a,Mouse,C57BL/6,Female,None,NA,8,10,12,20,22.5,25,4,4,0,NA,NA,NA,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",Sensorimotor cortex,10,mg/ml,44.44444444,3000,K,NA,Cold light,NR,NR,1.5,15,None,NA,NA,NA,NA,NA,72,Other histology (ex vivo),4.39,0.87,NA,NA,NA,NA,mm3,SD,0.86262797,NA,0.87,0.170953607,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Schubring-Giese_2016,"Schubring-Giese, M.",2016,Protein Synthesis Inhibition in the Peri-Infarct Cortex Slows Motor Recovery in Rats,a,Rat,Long Evans,Male,None,NA,9,10.5,12,200,285,370,1,15,1,20,1,15,Ketamine,Xylazine,Skull breached,Forelimb motor cortex,13,ug/g,13,NR,NA,NA,Cold light,NR,NR,2,20,Anisomycin,Harm induction,100,ug/uL,48,After stroke,48,Other histology (ex vivo),10.1,1.2,11.8,1.5,NA,NA,mm3,SEM,0.512430238,0.598680873,4.647580015,0.235798073,6.708203932,None,NA,NA,NA,NA,NA,NA,No,No
Schubring-Giese_2007,"Schubring-Giese, M.",2007,Speed of motor re-learning after experimental stroke depends on prior skill,a,Rat,Long Evans,Male,None,NA,NR,12,NR,280,315,350,1,6,2,8,2,3,Ketamine,Xylazine,Skull breached,Forelimb motor cortex,13,ug/g,13,NR,NA,NA,Cold light,NR,NR,3,20,Task-specific training (TST),Other,8,Days,-192,Before stroke,432,Other histology (ex vivo),15.5,2.42,17.3,3.02,NA,NA,mm3,SEM,0.786402841,0.877727042,5.927765178,0.300749121,8.541849917,None,NA,NA,NA,NA,NA,NA,No,Yes
Seo_2015,"Seo, H. B.",2015,Partially purified components of Uncaria sinensis attenuate blood brain barrier disruption after ischemic brain injury in mice,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,20,22.5,25,1,5,2,5,2,2.5,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",Sensorimotor cortex,10,mg/ml,44.44444444,NR,NA,NA,LCD,NR,NR,4,15,HEUS (Hexane extracts of Uncaria sinensis),Blood flow,3,mg/kg,-0.5,Before stroke,24,TTC (ex vivo),53.4,4.1,38.6,3.8,NA,NA,mm3,SEM,10.49301448,7.584838184,9.167878708,1.801473484,8.497058314,0-4 limb scale,1.2,0.2,0,0,SEM,24,No,Yes
Seredenin_2008,"Seredenin, S. B.",2008,Neuroprotective effect of afobazole on rats with bilateral local photothrombosis of vessels in the prefrontal cortex,a,Rat,Other,Male,None,NA,NR,NR,NR,200,225,250,1,7,2,13,2,3.5,Chloral hydrate,NA,"Scalp retracted, skull intact",Frontal cortex,40,mg/kg,40,250,W,NA,Halogen lamp,Halogen,560,3,20,Fabomotizole (Afobazole),Anti-oxidants,5,mg/kg,1,After stroke,216,NR,5.9,0.5,2.6,0.3,NA,NA,mm3,NR,0.299340436,0.131912735,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Seredenin_2008,"Seredenin, S. B.",2008,Neuroprotective effect of afobazole on rats with bilateral local photothrombosis of vessels in the prefrontal cortex,b,Rat,Other,Male,None,NA,NR,NR,NR,200,225,250,1,7,2,7,2,3.5,Chloral hydrate,NA,"Scalp retracted, skull intact",Frontal cortex,40,mg/kg,40,250,W,NA,Halogen lamp,Halogen,560,3,20,Vinpocetine (Cavinton),Anti-oxidants,4,mg/kg,1,After stroke,216,NR,5.9,0.5,4.66,0.19,NA,NA,mm3,NR,0.299340436,0.236428209,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Seto_2014,"Seto, A.",2014,Induction of ischemic stroke in awake freely moving mice reveals that isoflurane anesthesia can mask the benefits of a neuroprotection therapy,a,Mouse,C57BL/6,Male,None,NA,9,13,17,NR,NR,NR,3,11,7,9,2.333333333,4.714285714,Isoflurane,NA,Skull thinned,Middle cerebral artery (MCA),110,mg/kg,110,25,mW,NA,Diode laser,Diode laser,532,1,60,DHbetaE,Anti-inflammation,3,mg/kg,1.5,After stroke,24,Other histology (ex vivo),13.4,1.02,11.9,1.41,NA,NA,mm3,SEM,2.63307854,2.338330943,3.382957286,0.664745689,4.23,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Seto_2014,"Seto, A.",2014,Induction of ischemic stroke in awake freely moving mice reveals that isoflurane anesthesia can mask the benefits of a neuroprotection therapy,b,Mouse,C57BL/6,Male,None,NA,9,13,17,NR,NR,NR,3,11,7,9,2.333333333,4.714285714,Isoflurane,NA,Skull thinned,Middle cerebral artery (MCA),110,mg/kg,110,25,mW,NA,Diode laser,Diode laser,532,1,60,Ro25-6981,Excitotoxicity,6,mg/kg,1.5,After stroke,24,Other histology (ex vivo),13.4,1.02,12.5,1.62,NA,NA,mm3,SEM,2.63307854,2.456229982,3.382957286,0.664745689,4.86,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Seto_2014,"Seto, A.",2014,Induction of ischemic stroke in awake freely moving mice reveals that isoflurane anesthesia can mask the benefits of a neuroprotection therapy,c,Mouse,C57BL/6,Male,None,NA,9,13,17,NR,NR,NR,3,10,7,9,2.333333333,4.285714286,Isoflurane,NA,Cranial window (awake induction),Middle cerebral artery (MCA),110,mg/kg,110,25,mW,NA,Diode laser,Diode laser,532,1,60,DHbetaE,Anti-inflammation,3,mg/kg,1.5,After stroke,24,Other histology (ex vivo),17.2,1.12,13.3,0.78,NA,NA,mm3,SEM,3.379772455,2.613428701,3.541750979,0.695948395,2.34,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Seto_2014,"Seto, A.",2014,Induction of ischemic stroke in awake freely moving mice reveals that isoflurane anesthesia can mask the benefits of a neuroprotection therapy,d,Mouse,C57BL/6,Male,None,NA,9,13,17,NR,NR,NR,3,10,7,10,2.333333333,4.285714286,Isoflurane,NA,Cranial window (awake induction),Middle cerebral artery (MCA),110,mg/kg,110,25,mW,NA,Diode laser,Diode laser,532,1,60,Ro25-6981,Excitotoxicity,6,mg/kg,1.5,After stroke,24,Other histology (ex vivo),17.2,1.12,15.9,1.06,NA,NA,mm3,SEM,3.379772455,3.124324537,3.541750979,0.695948395,3.35201432,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Shanina_2005,"Shanina, E. V.",2005,"Long-term effects of sequential cortical infarcts on scar size, brain volume and cognitive function",a,Rat,Wistar,Male,None,NA,NR,NR,NR,250,280,310,5,3,0,NA,NA,NA,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,1.3,mg/100g,13,15,W/cm2,15,Cold light,NR,NR,2.4,20,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),14.6,3.8,NA,NA,NA,NA,mm3,SD,0.740740741,NA,3.8,0.192795535,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Shimakura_2000,"Shimakura, A.",2000,Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion,a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,250,260,1,8,4,8,4,2,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,18,mW,NA,Xenon lamp,Xenon,540,3,10,ONO-5046,Anti-inflammation,30,mg/kg/h,0,During stroke,24,TTC (ex vivo),35.4,3.9,25.5,2.6,NA,NA,Indirect rLV % hemisphere,SE,17.7,12.75,11.03086579,5.515432893,7.353910524,Yamamoto 1988 score,3.5,0.76,2.5,0.53,SD,24,No,Yes
Shimakura_2000,"Shimakura, A.",2000,Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion,b,Rat,Wistar,Male,None,NA,NR,NR,NR,240,250,260,1,8,4,6,4,2,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,18,mW,NA,Xenon lamp,Xenon,540,3,10,Anti-PMN antibody,Anti-oxidants,1,mg,-3,Before stroke,24,TTC (ex vivo),35.4,3.9,17.8,2.1,NA,NA,Indirect rLV % hemisphere,SE,17.7,8.9,11.03086579,5.515432893,5.14392846,Yamamoto 1988 score,NR,NR,NR,NR,NR,NR,No,No
Shin_2009,"Shin, T. K.",2009,Fluoxetine and sertraline attenuate postischemic brain injury in mice,a,Mouse,ICR,Male,None,NA,NR,NR,NR,25,27.5,30,1,6,2,6,2,3,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,10,mg/ml,36.36363636,NR,NA,NA,LCD,NR,NR,4,10,Fluoxetine,Blood flow,10,mg/kg,1,After stroke,336,TTC (ex vivo),37.07,0.57,27.57,0.64,NA,NA,mm3,SEM,7.284195634,5.417460848,1.396209153,0.274352863,1.567673435,None,NA,NA,NA,NA,NA,NA,No,No
Shin_2009,"Shin, T. K.",2009,Fluoxetine and sertraline attenuate postischemic brain injury in mice,b,Mouse,ICR,Male,None,NA,NR,NR,NR,25,27.5,30,1,6,2,6,2,3,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,10,mg/ml,36.36363636,NR,NA,NA,LCD,NR,NR,4,10,Sertraline,Blood flow,20,mg/kg,1,After stroke,336,TTC (ex vivo),37.07,0.57,28.21,0.64,NA,NA,mm3,SEM,7.284195634,5.543219823,1.396209153,0.274352863,1.567673435,None,NA,NA,NA,NA,NA,NA,No,No
Shiromoto_2017,"Shiromoto, T.",2017,The Role of Endogenous Neurogenesis in Functional Recovery and Motor Map Reorganization Induced by Rehabilitative Therapy after Stroke in Rats,a,Rat,Fischer 344,Male,None,NA,7,7.5,8,160,170,180,1,7,1,6,1,7,Ketamine,Xylazine,Skull breached,Caudal forelimb area,60,mg/kg,60,NR,NA,NA,Green laser,Diode-pumped solid state laser,532,2,15,Cytarabine (Ara-C),Harm induction,1,uL/h,96,After stroke,672,Other histology (ex vivo),9.09,2.25,9.82,2.37,NA,NA,Direct rLV % hemisphere,SD,4.545,4.91,2.25,1.125,2.37,None,NA,NA,NA,NA,NA,NA,No,No
Sist_2014,"Sist, B.",2014,"Plasticity beyond peri-infarct cortex: spinal up regulation of structural plasticity, neurotrophins, and inflammatory cytokines during recovery from cortical stroke",a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,350,375,400,8,NR,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull thinned,Forelimb sensorimotor cortex,30,mg/kg,30,50,mW,NA,NR,NR,532,3,NR,None,NA,NA,NA,NA,NA,672,Other histology (ex vivo),2.8,0.3,NA,NA,NA,NA,mm3,SEM,0.142059868,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Sist_2014,"Sist, B.",2014,"Plasticity beyond peri-infarct cortex: spinal up regulation of structural plasticity, neurotrophins, and inflammatory cytokines during recovery from cortical stroke",b,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,350,375,400,8,NR,0,NA,NA,NA,Nitrous oxide,Isoflurane,Skull thinned,Forelimb sensorimotor cortex,30,mg/kg,30,50,mW,NA,NR,NR,532,6,NR,None,NA,NA,NA,NA,NA,672,Other histology (ex vivo),6.6,0.7,NA,NA,NA,NA,mm3,SEM,0.334855403,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Snape_1993,"Snape, M. F.",1993,The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat,a,Rat,Lister Hooded Rat,Male,None,NA,NR,NR,NR,300,350,400,2,7,3,7,1.5,4.666666667,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Parietal cortex,20,mg/kg,20,NR,NA,NA,Green laser,Diode-pumped solid state laser,NR,0.5,7,Chlormethiazole,Excitotoxicity,200,mg/kg,0.08,During stroke,24,TTC (ex vivo),9.18,1,6.57,0.59,NA,NA,mm2,SEM,NA,NA,2.645751311,NA,1.560993274,None,NA,NA,NA,NA,NA,NA,No,Yes
Snape_1993,"Snape, M. F.",1993,The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat,b,Rat,Lister Hooded Rat,Male,None,NA,NR,NR,NR,300,350,400,2,4,3,8,1.5,2.666666667,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Parietal cortex,20,mg/kg,20,NR,NA,NA,Green laser,Diode-pumped solid state laser,NR,0.5,7,Nimodipine,Blood flow,0.5,mg/kg,0.08,During stroke,24,TTC (ex vivo),5.74,NR,6.93,NR,NA,NA,mm2,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Song_2018,"Song, H.",2018,Transcortical photothrombotic pyramidotomy model with persistent motor deficits,a,Rat,Sprague-Dawley,Male,None,NA,NR,8,NR,280,290,300,1,8,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Medullary pyramid,20,mg/kg,20,4,mW,NA,NR,NR,532,NR,3,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),2.2,1.2,NA,NA,NA,NA,mm3,SEM,0.111618468,NA,3.39411255,0.172202565,NA,None,NA,NA,NA,NA,NA,NA,No,No
Song_2017,"Song, H.",2017,Capsular stroke modeling based on somatotopic mapping of motor fibers,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,300,350,400,2,10,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Posterior Limb of the Internal Capsule (forelimb area),20,mg/kg,20,3.7,mW,NA,Green laser,Diode-pumped solid state laser,532,NR,1.5,None,NA,NA,NA,NA,NA,336,Other histology (ex vivo),1.67,0.64,NA,NA,NA,NA,mm3,SD,0.084728564,NA,0.64,0.032470827,NA,None,NA,NA,NA,NA,NA,NA,No,No
Song_2017,"Song, H.",2017,Capsular stroke modeling based on somatotopic mapping of motor fibers,b,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,300,350,400,2,10,0,NA,NA,NA,Ketamine,Xylazine,Skull breached,Posterior Limb of the Internal Capsule (hindlimb area),20,mg/kg,20,3.7,mW,NA,Green laser,Diode-pumped solid state laser,532,NR,1.5,None,NA,NA,NA,NA,NA,336,Other histology (ex vivo),1.29,0.37,NA,NA,NA,NA,mm3,SD,0.065449011,NA,0.37,0.018772197,NA,None,NA,NA,NA,NA,NA,NA,No,No
Stieg_1999,"Stieg, P. E.",1999,Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat,a,Rat,Long Evans,NR,None,NA,1,1.2,1.4,20,23.5,27,1,12,1,12,1,12,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,40,mg/kg,40,300,W,NA,Xenon lamp,Xenon,560,2,3,Memantine,Excitotoxicity,20,mg/kg,-0.25,Before stroke,144,MRI (in vivo),NR,NR,NR,NR,36.3,11.9,NR,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Stokowska_2017,"Stokowska, A.",2017,Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia,a,Mouse,C57BL/6,Male,None,NA,30,34.5,39,35,40,45,3,10,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Somatosensory cortex,10,mg/ml,50,50,mW,NA,Cobolt,Cobolt,561,2,12,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),1.09,0.07,NA,NA,NA,NA,mm3,SEM,0.214183254,NA,0.221359436,0.043496775,NA,None,NA,NA,NA,NA,NA,NA,No,No
Stokowska_2017,"Stokowska, A.",2017,Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia,b,Mouse,C3aR-/-,Male,None,NA,30,34.5,39,35,40,45,3,14,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Somatosensory cortex,10,mg/ml,50,50,mW,NA,Cobolt,Cobolt,561,2,12,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),1.34,0.08,NA,NA,NA,NA,mm3,SEM,0.263307854,NA,0.299332591,0.058818375,NA,None,NA,NA,NA,NA,NA,NA,No,No
Stokowska_2017,"Stokowska, A.",2017,Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia,c,Mouse,GFAP-C3a,Male,None,NA,30,34.5,39,35,40,45,3,12,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Somatosensory cortex,10,mg/ml,50,50,mW,NA,Cobolt,Cobolt,561,2,12,None,NA,NA,NA,NA,NA,504,Other histology (ex vivo),2.14,0.24,NA,NA,NA,NA,mm3,SEM,0.420506573,NA,0.831384388,0.163365701,NA,None,NA,NA,NA,NA,NA,NA,No,No
Stokowska_2017,"Stokowska, A.",2017,Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia,d,Mouse,C57BL/6CNr,Male,None,NA,NR,22,NR,30,32.5,35,1,14,1,14,1,14,Isoflurane,NA,"Scalp retracted, skull intact",Motor cortex,10,mg/ml,61.53846154,50,mW,NA,Cobolt,Cobolt,561,2,15,C3a peptide,Anti-inflammation,1.13,ug/kg,168,After stroke,504,Other histology (ex vivo),0.89,0.06,0.98,0.12,NA,NA,mm3,SEM,0.174883575,0.192568431,0.224499443,0.044113781,0.448998886,None,NA,NA,NA,NA,NA,NA,No,No
Su_2011,"Su, E. J.",2011,The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model,a,Mouse,C57BL/6,Male,None,NA,NR,10,NR,NR,NR,NR,2,6,2,10,1,6,Chloral hydrate,NA,Skull breached,Middle cerebral artery (MCA),50,mg/kg,50,3.5,mW,NA,Green laser,Diode-pumped solid state laser,540,NR,NR,Solulin,Thrombolytics,1,mg/kg,0.5,After stroke,72,TTC (ex vivo),25.13,2.17,13.95,1.43,NA,NA,Direct rLV % hemisphere,SEM,12.565,6.975,5.315392742,2.657696371,4.522057054,None,NA,NA,NA,NA,NA,NA,No,Yes
Su_2011,"Su, E. J.",2011,The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model,b,Mouse,FV Leiden,Male,None,NA,NR,10,NR,NR,NR,NR,1,8,1,9,1,8,Chloral hydrate,NA,Skull breached,Middle cerebral artery (MCA),50,mg/kg,50,3.5,mW,NA,Green laser,Diode-pumped solid state laser,540,NR,NR,Solulin,Thrombolytics,1,mg/kg,1,After stroke,72,TTC (ex vivo),26.04,1.06,26.04,1.35,NA,NA,Direct rLV % hemisphere,SEM,13.02,13.02,2.998132752,1.499066376,4.05,None,NA,NA,NA,NA,NA,NA,No,No
Summers_2017,"Summers, P. M.",2017,Functional deficits induced by cortical microinfarcts,a,Mouse,C57BL/6,Male,None,NA,13,19.5,26,NR,NR,NR,1,3,0,NA,NA,NA,Isoflurane,NA,Skull breached,Sensorimotor cortex,0.025,mL,NA,1,mW,NA,Continuous wave (CW) laser light,NR,532,0.02,0.5,None,NA,NA,NA,NA,NA,72,MRI (in vivo),192,58,NA,NA,NA,NA,um (radius),SEM,NA,NA,100.4589468,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Suzuki_2004,"Suzuki, Y.",2004,Microplasmin reduces ischemic brain damage and improves neurological function in a rat stroke model monitored with MRI,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,220,285,350,1,8,2,8,2,4,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,Microplasmin,Thrombolytics,7.5,mg/kg,1.5,After stroke,24,TTC (ex vivo),250,69,150,30,NA,NA,mm3,SD,12.68391679,7.610350076,69,3.500761035,30,Bederson Scale,NR,NR,NR,NR,NR,24,No,Yes
Suzuki_2003,"Suzuki, Y.",2003,Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats,a,Rat,Sprague-Dawley,Male,None,NA,NR,8,NR,250,285,320,4,8,4,8,1,8,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,MK-801 (dizocilpine maleate),Excitotoxicity,0.1,mg/kg,0,During stroke,24,TTC (ex vivo),17.6,1.23,12.62,1.9,NA,NA,Indirect rLV % hemisphere,SE,8.8,6.31,3.478965363,1.739482682,5.374011537,None,NA,NA,NA,NA,NA,NA,No,No
Suzuki_2003,"Suzuki, Y.",2003,Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats,b,Rat,Sprague-Dawley,Male,None,NA,NR,8,NR,250,285,320,4,8,4,8,1,8,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,NBQX,Excitotoxicity,30,mg,0,During stroke,24,TTC (ex vivo),18.24,1.45,12.36,1.26,NA,NA,Indirect rLV % hemisphere,SE,9.12,6.18,4.101219331,2.050609665,3.563818177,None,NA,NA,NA,NA,NA,NA,No,No
Suzuki_2003,"Suzuki, Y.",2003,Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats,c,Rat,Sprague-Dawley,Male,Aged,NA,NR,104,NR,450,575,700,4,8,4,8,1,8,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,MK-801 (dizocilpine maleate),Excitotoxicity,0.1,mg/kg,0,During stroke,24,TTC (ex vivo),18.1,0.85,15.55,1.4,NA,NA,Indirect rLV % hemisphere,SE,9.05,7.775,2.404163056,1.202081528,3.959797975,None,NA,NA,NA,NA,NA,NA,No,No
Suzuki_2003,"Suzuki, Y.",2003,Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats,d,Rat,Sprague-Dawley,Male,Aged,NA,NR,104,NR,450,575,700,4,6,4,6,1,6,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,10,NBQX,Excitotoxicity,30,mg,0,During stroke,24,TTC (ex vivo),20.46,2.14,19.05,2.33,NA,NA,Indirect rLV % hemisphere,SE,10.23,9.525,5.24190805,2.620954025,5.707311101,None,NA,NA,NA,NA,NA,NA,No,No
Takamatsu_1998,"Takamatsu, H.",1998,Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,280,290,300,6,9,6,8,1,9,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,MK-801 (dizocilpine maleate),Excitotoxicity,0.1,mg/kg,0,During stroke,24,TTC (ex vivo),202.4,8.5,126.1,20.3,NA,NA,mm3,SEM,10.26889904,6.397767631,25.5,1.293759513,57.41707063,None,NA,NA,NA,NA,NA,NA,No,No
Takamatsu_1998,"Takamatsu, H.",1998,Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion,b,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,280,290,300,6,8,6,8,1,8,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,YM90K,Nootropics/cognition,30,mg/kg/h,0,During stroke,24,TTC (ex vivo),195.8,9.8,122.6,10.3,NA,NA,mm3,SEM,9.934043633,6.220192796,27.71858582,1.406320945,29.13279938,None,NA,NA,NA,NA,NA,NA,No,No
Takamatsu_1998,"Takamatsu, H.",1998,Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion,c,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,280,290,300,6,9,6,9,1,9,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,S-312-d,Blood flow,0.3,mg/kg,0,During stroke,24,TTC (ex vivo),228.9,9.7,164.7,13.3,NA,NA,mm3,SEM,11.61339422,8.356164384,29.1,1.476407915,39.9,None,NA,NA,NA,NA,NA,NA,No,No
Takamatsu_1998,"Takamatsu, H.",1998,Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion,d,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,280,290,300,6,8,6,8,1,8,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,Edaravone (MCI-186),Anti-oxidants,6,mg/kg/h,0,During stroke,24,TTC (ex vivo),206.2,14.4,158.8,27,NA,NA,mm3,SEM,10.46169457,8.056823947,40.7293506,2.066430776,76.36753237,None,NA,NA,NA,NA,NA,NA,No,No
Takamatsu_1998,"Takamatsu, H.",1998,Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion,e,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,280,290,300,6,8,6,8,1,8,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,EPC-K1,Anti-oxidants,10,mg/kg,3,After stroke,24,TTC (ex vivo),239.6,10.6,149.3,14.9,NA,NA,mm3,SEM,12.15626585,7.574835109,29.98132752,1.521122655,42.14356416,None,NA,NA,NA,NA,NA,NA,No,No
Takamatsu_1998,"Takamatsu, H.",1998,Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion,f,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,280,290,300,6,9,6,8,1,9,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,FK506 (Tacrolimus),Other,0.3,mg/kg,0,During stroke,24,TTC (ex vivo),225.1,6.5,156.6,19.2,NA,NA,mm3,SEM,11.42059868,7.945205479,19.5,0.98934551,54.3058008,None,NA,NA,NA,NA,NA,NA,No,No
Takamatsu_2000,"Takamatsu, H.",2000,Changes in local cerebral blood flow in photochemically induced thrombotic occlusion model in rats,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,280,290,300,4,7.5,0,NA,NA,NA,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),21.77,1.67,NA,NA,NA,NA,Indirect rLV % whole brain,SD,21.77,NA,1.67,1.67,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Takamatsu_2002,"Takamatsu, H.",2002,Time courses of progress to the chronic stage of middle cerebral artery occlusion models in rats,a,Rat,Sprague-Dawley,Male,None,NA,NR,9,NR,280,290,300,18,8,0,NA,NA,NA,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),17.45,3.47,NA,NA,NA,NA,Indirect rLV % whole brain,SD,17.45,NA,3.47,3.47,NA,Bederson Scale,9.87,1.53,NA,NA,SD,24,Yes,No
Takeshima_2011,"Takeshima, Y.",2011,Neuroprotection with intraventricular brain-derived neurotrophic factor in rat venous occlusion model,a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,260,280,2,8,2,6,1,8,Chloral hydrate,NA,Skull breached,NR,50,mg/kg,50,7000,lux,0.00102487,Fibre-optic,NR,540,NR,20,BDNF (Brain-derived neurotrophic factor),Anti-apoptosis/regeneration,2.1,ug/day,NR,During stroke,48,Other histology (ex vivo),3.66,1.51,1.49,1.44,NA,NA,Direct rLV % hemisphere,SD,1.83,0.745,1.51,0.755,1.44,None,NA,NA,NA,NA,NA,NA,Yes,No
Takizawa_2009,"Takizawa, S.",2009,A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,267,278,289,1,10,2,10,2,5,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,600000,lux,0.087846,Xenon lamp,Xenon,540,3,10,R-147176,Multiple mechanisms,10,mg/kg,-168,Before stroke,24,TTC (ex vivo),320.6,30.1,252.3,55,NA,NA,mm3,SD,16.2658549,12.80060883,30.1,1.527143582,55,Bederson Scale,2.7,0.5,2.4,0.5,SD,24,No,Yes
Tamao_1997,"Tamao, Y.",1997,"Effect of argatroban, a selective thrombin inhibitor, on animal models of cerebral thrombosis",a,Rat,NR,Male,None,NA,NR,NR,NR,NR,NR,NR,2,10,2,10,1,10,NR,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,Argatroban,Thrombolytics,40,mg/kg,0,During stroke,6,Other histology (ex vivo),13.66,1.9,6.79,0.4,NA,NA,Direct rLV % whole brain,SEM,13.66,6.79,6.008327554,6.008327554,1.264911064,None,NA,NA,NA,NA,NA,NA,Yes,No
Tamura_2011,"Tamura, K.",2011,"The effect of a gap-junction blocker, carbenoxolone, on ischemic brain injury and cortical spreading depression",a,Rat,Wistar,Male,None,NA,NR,NR,NR,356.27,360.8,365.33,1,6,2,6,2,3,Chloral hydrate,NA,Skull breached,NR,37.5,mg/kg,37.5,7000,lux,0.00102487,Mercury lamp,Mercury,540,0.1,25,CBX (Carbenoxolone),Nootropics/cognition,250,ug,0.5,After stroke,168,Other histology (ex vivo),1.46,0.23,3.04,0.4,NA,NA,mm3,SEM,0.074074074,0.154236428,0.563382641,0.028583594,0.979795897,None,NA,NA,NA,NA,NA,NA,No,Yes
Tanaka_2007_a,"Tanaka, Y.",2007,Serum S100B is a useful surrogate marker for long-term outcomes in photochemically-induced thrombotic stroke rat models,a,Rat,Wistar,Male,None,NA,NR,9,NR,NR,NR,NR,2,7,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,800000,lux,0.117128,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,168,TTC (ex vivo),150.8,7.1,NA,NA,NA,NA,mm3,SE,7.65093861,NA,18.78483431,0.953061101,NA,Other,14.43,0.69,NA,NA,SE,168,No,No
Tanaka_2007_a,"Tanaka, Y.",2007,Serum S100B is a useful surrogate marker for long-term outcomes in photochemically-induced thrombotic stroke rat models,b,Rat,Wistar,Male,None,NA,NR,9,NR,NR,NR,NR,2,8,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,800000,lux,0.117128,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,168,TTC (ex vivo),90,9.2,NA,NA,NA,NA,mm3,SE,4.566210046,NA,26.02152955,1.320219662,NA,Other,9.25,1.16,NA,NA,SE,168,No,No
Tanaka_2007_a,"Tanaka, Y.",2007,Serum S100B is a useful surrogate marker for long-term outcomes in photochemically-induced thrombotic stroke rat models,c,Rat,Wistar,Male,None,NA,NR,9,NR,NR,NR,NR,1,15,1,15,1,15,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,800000,lux,0.117128,Xenon lamp,Xenon,540,3,10,MK-801 (dizocilpine maleate),Excitotoxicity,3,mg/kg,0,During stroke,168,TTC (ex vivo),84.4,9.3,40.3,4.5,NA,NA,mm3,SE,4.282090309,2.044647387,36.01874512,1.827435064,17.42842506,Other,10.7,1,5,0.9,SE,168,No,No
Tanaka_2007_b,"Tanaka, Y.",2007,Quantitative assessments of cerebral vascular damage with a silicon rubber casting method in photochemically-induced thrombotic stroke rat models,a,Rat,Wistar,Male,None,NA,NR,9,NR,NR,NR,NR,2,6,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,800000,lux,0.117128,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),215.74,12.76,NA,NA,NA,NA,mm3,NR,10.94571284,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Tanaka_2007_b,"Tanaka, Y.",2007,Quantitative assessments of cerebral vascular damage with a silicon rubber casting method in photochemically-induced thrombotic stroke rat models,b,Rat,Wistar,Male,None,NA,NR,9,NR,NR,NR,NR,2,6,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,800000,lux,0.117128,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),128.78,19.85,NA,NA,NA,NA,mm3,NR,6.533739219,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Tanaka_2007_b,"Tanaka, Y.",2007,Quantitative assessments of cerebral vascular damage with a silicon rubber casting method in photochemically-induced thrombotic stroke rat models,c,Rat,Wistar,Male,None,NA,NR,9,NR,NR,NR,NR,1,7,1,8,1,7,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,800000,lux,0.117128,Xenon lamp,Xenon,540,3,10,MK-801 (dizocilpine maleate),Excitotoxicity,3,mg/kg,0,During stroke,24,Other histology (ex vivo),201.32,9.47,163.42,9.47,NA,NA,mm3,NR,10.21410452,8.29122273,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Tanaka_2008,"Tanaka, Y.",2008,Relationship between cerebrospinal and peripheral S100B levels after focal cerebral ischemia in rats,a,Rat,Wistar,Male,None,NA,NR,9,NR,NR,NR,NR,1,13,0,NA,NA,NA,Isoflurane,NA,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,800000,lux,0.117128,Xenon lamp,Xenon,540,3,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),91.45,5.76,NA,NA,NA,NA,mm3,SEM,4.639776763,NA,20.76797535,1.053677085,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Tang_2017,"Tang, Y.",2017,Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke,a,Mouse,HDAC2-/-,Male,None,NA,NR,NR,NR,NR,NR,NR,1,8,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,100,mg/kg,100,12000,lux,0.00175692,NR,NR,NR,2,15,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),1.21,0.12,NA,NA,NA,NA,mm3,SEM,0.237763062,NA,0.339411255,0.066693768,NA,mNSS,NR,NR,NA,NA,NR,NR,No,No
Tang_2017,"Tang, Y.",2017,Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke,b,Mouse,C57BL/6,Male,None,NA,6,6.5,7,NR,NR,NR,1,8,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,100,mg/kg,100,12000,lux,0.00175692,NR,NR,NR,2,15,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),1.25,0.05,NA,NA,NA,NA,mm3,SEM,0.245622998,NA,0.141421356,0.02778907,NA,mNSS,NR,NR,NA,NA,NR,NR,No,No
Tang_2017,"Tang, Y.",2017,Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke,c,Mouse,C57BL/6,Male,None,NA,6,6.5,7,NR,NR,NR,1,8,1,8,1,8,Isoflurane,NA,Other,NR,100,mg/kg,100,12000,lux,0.00175692,NR,NR,NR,2,15,"SAHA (Suberoylanilide hydroxamic acid, Vorinostat)",Anti-apoptosis/regeneration,NR,NA,96,After stroke,240,Other histology (ex vivo),0.83,0.08,0.81,0.12,NA,NA,mm3,SEM,0.163093671,0.159163703,0.22627417,0.044462512,0.339411255,mNSS,NR,NR,NR,NR,NR,NR,No,No
Taylor_2016,"Taylor, Z. J.",2016,Microvascular basis for growth of small infarcts following occlusion of single penetrating arterioles in mouse cortex,a,Mouse,C57BL/6,Male,None,NA,13,19.5,26,NR,NR,NR,1,10,0,NA,NA,NA,Isoflurane,NA,Skull breached,Sensorimotor cortex,0.25,mL,NA,1,mW,NA,Continuous wave (CW) laser light,NR,532,0.02,0.5,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),612,210,NA,NA,NA,NA,nL,SEM,0.12025702,NA,664.0783086,0.130490324,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Tennant_2013,"Tennant, K. A.",2013,Diabetes augments in vivo microvascular blood flow dynamics after stroke,a,Mouse,GFP-M,Male,None,NA,9,13,17,26,26.6,27.2,1,7,0,NA,NA,NA,Isoflurane,NA,Cranial window (asleep induction),Somatosensory cortex,100,mg/kg,100,25.8,mW,NA,LED,LED,532,1,20,None,NA,NA,NA,NA,NA,1008,Other histology (ex vivo),0.79,0.27,NA,NA,NA,NA,mm3,SEM,0.155233735,NA,0.714352854,0.140369192,NA,None,NA,NA,NA,NA,NA,NA,No,No
Tennant_2013,"Tennant, K. A.",2013,Diabetes augments in vivo microvascular blood flow dynamics after stroke,b,Mouse,GFP-M,Male,Hyperglycemia,Streptozotocin,9,13,17,24.6,25.1,25.6,1,11,1,5,1,11,Isoflurane,NA,Cranial window (asleep induction),Somatosensory cortex,100,mg/kg,100,25.8,mW,NA,LED,LED,532,1,20,Insulin,Energy substrates,NR,NR,NR,After stroke,1008,Other histology (ex vivo),1.26,0.79,1.25,0.74,NA,NA,mm3,SEM,0.247587982,0.245622998,2.620133584,0.514852053,1.654690303,None,NA,NA,NA,NA,NA,NA,No,No
Thura_2009,"Thura, M.",2009,GIF-0173 protects against cerebral infarction through DP1 receptor activation,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,260,280,300,1,12,3,12,3,4,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,10,GIF-0173,Excitotoxicity,0.1,mg/kg,0,During stroke,24,TTC (ex vivo),30.01,6.05,18.15,10.73,NA,NA,Indirect rLV % whole brain,SD,30.01,18.15,6.05,6.05,10.73,Other,9.333333333,2.2852182,4.166666667,1.462494065,SD,24,No,Yes
Tian_2016,"Tian, D. S.",2016,Deficiency in the voltage-gated proton channel Hv1 increases M2 polarization of microglia and attenuates brain damage from photothrombotic ischemic stroke,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,NR,NR,NR,2,4,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,1,mg,NA,NR,NA,NA,LCD,NR,NR,4,15,None,NA,NA,NA,NA,NA,24,MRI (in vivo),6.38,0.78,NA,NA,NA,NA,mm3,SEM,1.253659783,NA,1.56,0.306537502,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Tian_2016,"Tian, D. S.",2016,Deficiency in the voltage-gated proton channel Hv1 increases M2 polarization of microglia and attenuates brain damage from photothrombotic ischemic stroke,b,Mouse,Hv1-/-,Male,None,NA,NR,NR,NR,NR,NR,NR,2,4,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",NR,1,mg,NA,NR,NA,NA,LCD,NR,NR,4,15,None,NA,NA,NA,NA,NA,24,MRI (in vivo),3.3,0.91,NA,NA,NA,NA,mm3,SEM,0.648444715,NA,1.82,0.357627085,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Toda_2014,"Toda, T.",2014,"Down-regulation of KCC2 expression and phosphorylation in motoneurons, and increases the number of in primary afferent projections to motoneurons in mice with post-stroke spasticity",a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,25,27.5,30,1,6,0,NA,NA,NA,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Caudal and rostral forelimb areas,0.03,mg/g,30,194,lumens,NA,LED,LED,NR,NR,15,None,NA,NA,NA,NA,NA,168,Other histology (ex vivo),5.13,1.23,NA,NA,NA,NA,mm3,SEM,1.008036785,NA,3.012872384,0.592024598,NA,None,NA,NA,NA,NA,NA,NA,No,No
Tregub_2015,"Tregub, P.",2015,Combined exposure to hypercapnia and hypoxia provides its maximum neuroprotective effect during focal ischemic injury in the brain,a,Rat,Wistar,Male,None,NA,35,37,39,240,280,320,1,11,3,15,3,3.666666667,Ketamine,Xylazine,"Scalp retracted, skull intact",NR,40,mg/kg,40,15,mW,NA,Green laser,Diode-pumped solid state laser,532,2,10,Respiratory intervention,Other,NA,NA,-360,Before stroke,72,Other histology (ex vivo),NR,NR,NR,NR,NA,NA,mm3,NR,NA,NA,NA,NA,NA,NSS,NR,NR,NR,NR,NR,72,No,Yes
Trieu_1999,"Trieu, V. N.",1999,In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke,a,Mouse,BALB/c,Male,None,NA,NR,9,NR,NR,NR,NR,2,81,22,3,11,7.363636364,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,1.6,5,Genistein,Anti-oxidants,8,mg/kg,-24,Before stroke,24,Other histology (ex vivo),14.6,0.7,3.2,0.7,NA,NA,mm2,SEM,NA,NA,6.3,NA,1.212435565,None,NA,NA,NA,NA,NA,NA,No,Yes
Trieu_1999,"Trieu, V. N.",1999,In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke,b,Mouse,BALB/c,Male,None,NA,NR,9,NR,NR,NR,NR,2,81,22,15,11,7.363636364,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,1.6,5,EA (ellagic acid),Anti-oxidants,40,mg/kg,-24,Before stroke,24,Other histology (ex vivo),14.6,0.7,13.8,5.8,NA,NA,mm2,SEM,NA,NA,6.3,NA,22.46330341,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1999,"Trieu, V. N.",1999,In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke,c,Mouse,BALB/c,Male,None,NA,NR,9,NR,NR,NR,NR,2,81,22,14,11,7.363636364,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,1.6,5,Propyl gallate,Anti-oxidants,40,mg/kg,-24,Before stroke,24,Other histology (ex vivo),14.6,0.7,15.5,1.1,NA,NA,mm2,SEM,NA,NA,6.3,NA,4.115823125,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1999,"Trieu, V. N.",1999,In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke,d,Mouse,BALB/c,Male,None,NA,NR,9,NR,NR,NR,NR,2,81,22,23,11,7.363636364,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,1.6,5,Quinazoline,Anti-oxidants,40,mg/kg,-24,Before stroke,24,Other histology (ex vivo),14.6,0.7,20.7,1.8,NA,NA,mm2,SEM,NA,NA,6.3,NA,8.632496742,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1999,"Trieu, V. N.",1999,In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke,e,Mouse,BALB/c,Male,None,NA,NR,9,NR,NR,NR,NR,2,81,22,13,11,7.363636364,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,1.6,5,Anti-Ox2,Anti-oxidants,40,mg/kg,-24,Before stroke,24,Other histology (ex vivo),14.6,0.7,13.6,1.6,NA,NA,mm2,SEM,NA,NA,6.3,NA,5.768882041,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1999,"Trieu, V. N.",1999,In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke,f,Mouse,BALB/c,Male,None,NA,NR,9,NR,NR,NR,NR,2,81,22,5,11,7.363636364,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,1.6,5,Anti-Ox4,Anti-oxidants,40,mg/kg,-24,Before stroke,24,Other histology (ex vivo),14.6,0.7,11.9,2.4,NA,NA,mm2,SEM,NA,NA,6.3,NA,5.366563146,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1999,"Trieu, V. N.",1999,In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke,g,Mouse,BALB/c,Male,None,NA,NR,9,NR,NR,NR,NR,2,81,22,19,11,7.363636364,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,1.6,5,Anti-Ox5,Anti-oxidants,40,mg/kg,-24,Before stroke,24,Other histology (ex vivo),14.6,0.7,10.3,0.8,NA,NA,mm2,SEM,NA,NA,6.3,NA,3.487119155,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1999,"Trieu, V. N.",1999,In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke,h,Mouse,BALB/c,Male,None,NA,NR,9,NR,NR,NR,NR,2,81,22,14,11,7.363636364,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,1.6,5,Anti-Ox6,Anti-oxidants,40,mg/kg,-24,Before stroke,24,Other histology (ex vivo),14.6,0.7,14.5,1.6,NA,NA,mm2,SEM,NA,NA,6.3,NA,5.986651819,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1998,"Trieu, V. N.",1998,Male-associated hypertension in LDL-R deficient mice,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,NR,NR,NR,6,23,0,NA,NA,NA,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,3.2,5,None,NA,NA,NA,NA,NA,0.5,Other histology (ex vivo),6.3,1.1,NA,NA,NA,NA,mm2,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1998,"Trieu, V. N.",1998,Male-associated hypertension in LDL-R deficient mice,b,Mouse,Apo(a) transgenic,Male,None,NA,NR,NR,NR,NR,NR,NR,6,7,0,NA,NA,NA,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,3.2,5,None,NA,NA,NA,NA,NA,0.5,Other histology (ex vivo),7.2,2.6,NA,NA,NA,NA,mm2,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1998,"Trieu, V. N.",1998,Male-associated hypertension in LDL-R deficient mice,c,Mouse,ApoE deficient,Male,None,NA,NR,NR,NR,NR,NR,NR,6,6,0,NA,NA,NA,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,3.2,5,None,NA,NA,NA,NA,NA,0.5,Other histology (ex vivo),7.6,2.4,NA,NA,NA,NA,mm2,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1998,"Trieu, V. N.",1998,Male-associated hypertension in LDL-R deficient mice,d,Mouse,LDL-R deficient,Male,Hypertension,Genetic,NR,NR,NR,NR,NR,NR,6,12,0,NA,NA,NA,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,3.2,5,None,NA,NA,NA,NA,NA,0.5,Other histology (ex vivo),10.7,1.5,NA,NA,NA,NA,mm2,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1998,"Trieu, V. N.",1998,Male-associated hypertension in LDL-R deficient mice,e,Mouse,ApoE deficient,Female,None,NA,NR,NR,NR,NR,NR,NR,6,6,0,NA,NA,NA,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,3.2,5,None,NA,NA,NA,NA,NA,0.5,Other histology (ex vivo),9.7,1.8,NA,NA,NA,NA,mm2,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Trieu_1998,"Trieu, V. N.",1998,Male-associated hypertension in LDL-R deficient mice,f,Mouse,LDL-R deficient,Female,None,NA,NR,NR,NR,NR,NR,NR,6,7,0,NA,NA,NA,Ketamine,Xylazine,Scalp and skull intact,NR,3,mg/ml,NA,300,W,NA,Xenon lamp,Xenon,550,3.2,5,None,NA,NA,NA,NA,NA,0.5,Other histology (ex vivo),9.4,2.1,NA,NA,NA,NA,mm2,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Tuor_2016_a,"Tuor, U. I.",2016,Model of minor stroke with mild peri-infarct ischemic injury,a,Rat,Wistar,Male,None,NA,NR,NR,NR,226,310.5,395,1,14,0,NA,NA,NA,Isoflurane,NA,Skull thinned,Cerebral cortex,10,mg/kg,10,150,W,NA,Halogen lamp,Halogen,555,3,5,None,NA,NA,NA,NA,NA,24,MRI (in vivo),1.7,0.8,NA,NA,NA,NA,mm3,SD,0.086250634,NA,0.8,0.040588534,NA,None,NA,NA,NA,NA,NA,NA,No,No
Tuor_2016_b,"Tuor, U. I.",2016,Magnetic resonance imaging of ischemic injury produced by varying severities of photothrombosis differs in neonatal and adult brain,a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,274,308,1,6,0,NA,NA,NA,Isoflurane,NA,Skull thinned,Cerebral cortex,10,mg/kg,10,41,mW/cm2,0.041,Halogen lamp,Halogen,555,3,5,None,NA,NA,NA,NA,NA,24,MRI (in vivo),5.25,1.17,NA,NA,NA,NA,mm2,SD,NA,NA,1.17,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Tuor_2016_b,"Tuor, U. I.",2016,Magnetic resonance imaging of ischemic injury produced by varying severities of photothrombosis differs in neonatal and adult brain,b,Rat,Wistar,Mixed,None,NA,NR,1,NR,10,15,20,1,6,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Cerebral cortex,60,mg/kg,60,41,mW/cm2,0.041,Halogen lamp,Halogen,555,2,15,None,NA,NA,NA,NA,NA,24,MRI (in vivo),4.97,1.25,NA,NA,NA,NA,mm2,SD,NA,NA,1.25,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Uemura_2016,"Uemura, T.",2016,Aggravation of brain infarction through an increase in acrolein production and a decrease in glutathione with aging,a,Mouse,C57BL/6,Female,None,NA,NR,9,NR,NR,22,NR,1,7,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),28.08,6.53,NA,NA,NA,NA,mm3,SE,5.517675031,NA,17.27675606,3.394854898,NA,None,NA,NA,NA,NA,NA,NA,No,No
Uemura_2016,"Uemura, T.",2016,Aggravation of brain infarction through an increase in acrolein production and a decrease in glutathione with aging,b,Mouse,C57BL/6,Female,None,NA,NR,26,NR,NR,NR,NR,1,7,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),46.18,11.27,NA,NA,NA,NA,mm3,SE,9.074296044,NA,29.81761728,5.859114043,NA,None,NA,NA,NA,NA,NA,NA,No,No
Uemura_2016,"Uemura, T.",2016,Aggravation of brain infarction through an increase in acrolein production and a decrease in glutathione with aging,c,Mouse,C57BL/6,Female,Aged,NA,NR,52,NR,NR,40,NR,1,7,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),59.33,9.89,NA,NA,NA,NA,mm3,SE,11.65824999,NA,26.16648047,5.141671507,NA,None,NA,NA,NA,NA,NA,NA,No,No
Uemura_2016,"Uemura, T.",2016,Aggravation of brain infarction through an increase in acrolein production and a decrease in glutathione with aging,d,Mouse,C57BL/6,Female,None,NA,NR,9,NR,NR,22,NR,1,7,1,7,1,7,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,N-acetylcysteine,Anti-oxidants,250,mg/kg,NR,After stroke,24,TTC (ex vivo),37.3,6.04,29.07,3.85,NA,NA,mm3,SE,7.329390265,5.712208446,15.98033792,3.140110809,10.18614255,None,NA,NA,NA,NA,NA,NA,No,No
Uemura_2016,"Uemura, T.",2016,Aggravation of brain infarction through an increase in acrolein production and a decrease in glutathione with aging,e,Mouse,C57BL/6,Female,Aged,NA,NR,52,NR,NR,40,NR,1,7,1,7,1,7,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,N-acetylcysteine,Anti-oxidants,250,mg/kg,NR,After stroke,24,TTC (ex vivo),69.32,3.48,41.16,4.11,NA,NA,mm3,SE,13.62126899,8.087874084,9.207214563,1.809202917,10.87403789,None,NA,NA,NA,NA,NA,NA,No,No
Uemura_2018,"Uemura, T.",2018,Protective Effects of Brain Infarction by N-Acetylcysteine Derivatives,a,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,1,10,3,10,3,3.333333333,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,N-acetylcysteine,Anti-oxidants,150,mg/kg,0,During stroke,24,TTC (ex vivo),NR,NR,NR,NR,NA,NA,mm3,SD,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Uemura_2018,"Uemura, T.",2018,Protective Effects of Brain Infarction by N-Acetylcysteine Derivatives,b,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,1,10,3,10,3,3.333333333,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,N-acetylcysteine ethyl ester,Anti-oxidants,150,mg/kg,0,During stroke,24,TTC (ex vivo),NR,NR,NR,NR,NA,NA,mm3,SD,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Uemura_2018,"Uemura, T.",2018,Protective Effects of Brain Infarction by N-Acetylcysteine Derivatives,c,Mouse,C57BL/6,Male,None,NA,NR,8,NR,22,24,26,1,10,3,10,3,3.333333333,Isoflurane,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,NR,10,N-acetylcysteine benzyl ester,Anti-oxidants,150,mg/kg,0,During stroke,24,TTC (ex vivo),NR,NR,NR,NR,NA,NA,mm3,SD,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Umemura_1996,"Umemura, K.",1996,Inhibitory effect of MS-153 on elevated brain glutamate level induced by rat middle cerebral artery occlusion,a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,250,260,1,8,3,8,3,2.666666667,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.62,W/cm2,0.62,Xenon lamp,Xenon,540,3,10,MS-153,Energy substrates,12.5,mg/kg/h,1,After stroke,24,TTC (ex vivo),15.36,0.96,8.93,0.77,NA,NA,Direct rLV % hemisphere,SE,7.68,4.465,2.71529004,1.35764502,2.177888886,None,NA,NA,NA,NA,NA,NA,No,Yes
Umemura_2008,"Umemura, K.",2008,"Effects of alteplase, a thrombolytic agent, in a rat photothrombotic middle cerebral artery occlusion model",a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,279,289.5,300,1,22.5,1,22.5,1,22.5,Halothane,NA,Skull breached,Middle cerebral artery (MCA),12,mg/kg,12,NR,NA,NA,Xenon lamp,Xenon,540,3,10,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,3,mg/kg,0,During stroke,24,TTC (ex vivo),173.46,13.69,111.35,11.15,NA,NA,mm3,SE,8.800608828,5.64941654,64.93737175,3.29464088,52.88909387,Bederson Scale,2.91,0.05,2,0.2,SE,24,No,No
Umemura_1995,"Umemura, K.",1995,"Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model",a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,250,260,1,14,4,5,4,3.5,Sodium Pentobarbital,NA,Skull breached,Middle cerebral artery (MCA),NR,NA,NA,0.62,W/cm2,0.62,Xenon lamp,Xenon,540,3,NR,SUN9216,Thrombolytics,1,mg/kg,0.5,After stroke,24,TTC (ex vivo),16.96,0.46,11.84,1.46,NA,NA,% (not specified percentage of),SEM,NA,NA,1.721162398,NA,3.264659247,None,NA,NA,NA,NA,NA,NA,No,Yes
Umemura_1997,"Umemura, K.",1997,"Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia",a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,250,260,2,8,6,8,3,2.666666667,Halothane,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,0.62,W/cm2,0.62,Xenon lamp,Xenon,540,3,10,YM90K,Nootropics/cognition,20,mg/kg,1,After stroke,24,TTC (ex vivo),19.53,5.16,10.66,4.85,NA,NA,Direct rLV % hemisphere,SD,9.765,5.33,5.16,2.58,4.85,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Umemura_1994_a,"Umemura, K.",1994,"Thrombolytic efficacy of a modified tissue-type plasminogen activator, SUN9216, in the rat middle cerebral artery thrombosis model",a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,250,260,1,10,6,7,6,1.666666667,Sodium Pentobarbital,NA,Skull breached,Middle cerebral artery (MCA),NR,NA,NA,0.62,W/cm2,0.62,Xenon lamp,Xenon,540,3,NR,SUN9216,Thrombolytics,20,mg/kg,0.5,After stroke,24,TTC (ex vivo),16.71,0.5,10.79,0.62,NA,NA,Direct rLV % hemisphere,SE,8.355,5.395,1.58113883,0.790569415,1.640365813,None,NA,NA,NA,NA,NA,NA,No,Yes
Umemura_1994_a,"Umemura, K.",1994,"Thrombolytic efficacy of a modified tissue-type plasminogen activator, SUN9216, in the rat middle cerebral artery thrombosis model",b,Rat,Wistar,Male,None,NA,NR,NR,NR,240,250,260,1,10,6,5,6,1.666666667,Sodium Pentobarbital,NA,Skull breached,Middle cerebral artery (MCA),NR,NA,NA,0.62,W/cm2,0.62,Xenon lamp,Xenon,540,3,NR,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,30,mg/kg,0.5,After stroke,24,TTC (ex vivo),16.71,0.5,15.96,1.53,NA,NA,Direct rLV % hemisphere,SE,8.355,7.98,1.58113883,0.790569415,3.421184006,None,NA,NA,NA,NA,NA,NA,No,Yes
Umemura_1993,"Umemura, K.",1993,"Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model",a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,250,260,1,10,2,6,2,5,Sodium Pentobarbital,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,10,SUN9216,Thrombolytics,1,mg/kg,0.5,After stroke,24,TTC (ex vivo),16.72,0.53,11.26,1.36,NA,NA,Direct rLV % hemisphere,SE,8.36,5.63,1.67600716,0.83800358,3.33130605,None,NA,NA,NA,NA,NA,NA,No,Yes
Umemura_1994_b,"Umemura, K.",1994,"Effect of 21-aminosteroid lipid peroxidation inhibitor, U74006F, in the rat middle cerebral artery occlusion model",a,Rat,Wistar,Male,None,NA,NR,NR,NR,240,250,260,1,5,1,5,1,5,Sodium Pentobarbital,NA,Skull breached,Middle cerebral artery (MCA),20,mg/kg,20,NR,NA,NA,Xenon lamp,Xenon,540,3,10,U74006F,Anti-oxidants,1,mg/kg,0.17,After stroke,24,MRI (in vivo),32.84,0.86,25.1,1.49,NA,NA,% (not specified percentage of),SEM,NA,NA,1.923018461,NA,3.331741286,None,NA,NA,NA,NA,NA,NA,No,No
Van Hoecke_2005,"Van Hoecke, M.",2005,"Apoptotic cell death progression after photothrombotic focal cerebral ischaemia: effects of the lipophilic iron chelator 2,2'-dipyridyl",a,Rat,Wistar,Male,None,NA,NR,NR,NR,330,340,350,1,6,1,6,1,6,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,90,mW,NA,Diode-pumped solid state laser,Diode-pumped solid state laser,532,1,5,"2,2'-Dipyridyl (2,2'-Bipyridine)",Anti-oxidants,20,mg/kg,-0.25,Before stroke,24,Other histology (ex vivo),68.9,3.6,40.8,4.5,NA,NA,mm3,SEM,3.495687468,2.070015221,8.818163074,0.447395387,11.02270384,None,NA,NA,NA,NA,NA,NA,Yes,No
Van Reempts_1987,"Van Reempts, J.",1987,Flunarizine reduces cerebral infarct size after photochemically induced thrombosis in spontaneously hypertensive rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,NR,NR,NR,250,260,270,1,13,1,13,1,13,Nitrous oxide,Halothane,"Scalp retracted, skull intact",NR,10,mg/kg,10,150,W,NA,Fibre-optic,NR,NR,1,20,Flunarizine,Blood flow,40,mg/kg,-3,Before stroke,4,Other histology (ex vivo),10.04,4.45,6.03,3.35,NA,NA,mm3,SD,0.509425126,0.305936073,4.446510732,0.225596689,3.348143764,None,NA,NA,NA,NA,NA,NA,No,No
van Rossem_1996,"van Rossem, K.",1996,The role of PAF and the effect of a specific PAF antagonist on local tissue PO2 and neuronal integrity during and after photothrombotic brain infarction in unanesthetised rabbits,a,Rabbit,Dutch,Male,None,NA,NR,NR,NR,1700,2200,2700,1,6,1,6,1,6,Sodium Pentobarbital,NA,NR,Forelimb motor cortex,10,mg/kg,10,110,W/cm2,110,Green laser,Diode-pumped solid state laser,525,NR,20,RP 48740 (platelet activating factor),Multiple mechanisms,10,mg/kg,-0.17,Before stroke,4,Other histology (ex vivo),18.61,5.08,15.69,3.32,NA,NA,mm3,SD,NA,NA,5.08,NA,3.32,None,NA,NA,NA,NA,NA,NA,No,No
Vandeputte_2012,"Vandeputte, C.",2012,Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model,a,Rat,Wistar,Male,None,NA,NR,10,NR,NR,NR,NR,2,9,0,NA,NA,NA,Isoflurane,NA,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,20,None,NA,NA,NA,NA,NA,NR,MRI (in vivo),18.5,9,NA,NA,NA,NA,mm3,SD,0.938609843,NA,9,0.456621005,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Vandeputte_2010,"Vandeputte, C.",2010,Automated quantitative gait analysis in animal models of movement disorders,a,Rat,Wistar,Male,None,NA,NR,8,NR,NR,NR,NR,1,5,0,NA,NA,NA,Ketamine,Medetomidine,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,0.68,W/cm2,0.68,Xenon lamp,Xenon,540,3,20,None,NA,NA,NA,NA,NA,NR,Other histology (ex vivo),NR,NR,NA,NA,NA,NA,NR,SEM,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Wajima_2010,"Wajima, D.",2010,Enhanced cerebral ischemic lesions after two-vein occlusion in diabetic rats,a,Rat,"LETO (Long-Evans Tokushima Otsuka, control for diabetic OLETF)",Male,None,NA,NR,20,NR,NR,NR,NR,1,10,0,NA,NA,NA,Chloral hydrate,Atropine,Skull breached,Cerebral cortex,50,mg/kg,50,7000,lux,0.00102487,Fibre-optic,NR,540,NR,20,None,NA,NA,NA,NA,NA,48,Other histology (ex vivo),2.4,0.4,NA,NA,NA,NA,Direct rLV % hemisphere,SEM,1.2,NA,1.264911064,0.632455532,NA,None,NA,NA,NA,NA,NA,NA,No,No
Wajima_2010,"Wajima, D.",2010,Enhanced cerebral ischemic lesions after two-vein occlusion in diabetic rats,b,Rat,OLETF (Otsuka Long-Evans Tokushima Fatty),Male,Diabetes,Genetic,NR,20,NR,NR,NR,NR,1,10,0,NA,NA,NA,Chloral hydrate,Atropine,Skull breached,Cerebral cortex,50,mg/kg,50,7000,lux,0.00102487,Fibre-optic,NR,540,NR,20,None,NA,NA,NA,NA,NA,48,Other histology (ex vivo),7.7,0.5,NA,NA,NA,NA,Direct rLV % hemisphere,SEM,3.85,NA,1.58113883,0.790569415,NA,None,NA,NA,NA,NA,NA,NA,No,No
Wajima_2011,"Wajima, D.",2011,Cilostazol minimizes venous ischemic injury in diabetic and normal rats,a,Rat,"LETO (Long-Evans Tokushima Otsuka, control for diabetic OLETF)",Male,None,NA,NR,30,NR,337,352,367,4,5,4,5,1,5,Nitrous oxide,Halothane,Skull breached,Cerebral cortex,50,mg/kg,50,7000,lux,0.00102487,Fibre-optic,NR,540,NR,20,Cilostazol,Thrombolytics,60,mg/kg/day,1,After stroke,168,Other histology (ex vivo),5.5,0.6,3.7,0.4,NA,NA,Direct rLV % hemisphere,SEM,2.75,1.85,1.341640786,0.670820393,0.894427191,None,NA,NA,NA,NA,NA,NA,Yes,No
Wajima_2011,"Wajima, D.",2011,Cilostazol minimizes venous ischemic injury in diabetic and normal rats,b,Rat,OLETF (Otsuka Long-Evans Tokushima Fatty),Male,Diabetes,Genetic,NR,30,NR,575,587,602,4,5,4,5,1,5,Nitrous oxide,Halothane,Skull breached,Cerebral cortex,50,mg/kg,50,7000,lux,0.00102487,Fibre-optic,NR,540,NR,20,Cilostazol,Thrombolytics,60,mg/kg/day,1,After stroke,168,Other histology (ex vivo),13.7,0.6,11.3,0.5,NA,NA,Direct rLV % hemisphere,SEM,6.85,5.65,1.341640786,0.670820393,1.118033989,None,NA,NA,NA,NA,NA,NA,Yes,No
Walter_2015,"Walter, H. L.",2015,Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke,a,Mouse,C57BL/6,Male,None,NA,12,14,16,28,31.5,35,1,9,1,9,1,9,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,10,mg/ml,31.74603175,NR,NA,NA,LCD,NR,NR,2.5,20,AMD3100 (CXCR4 inhibitor),Anti-inflammation,1,mg/kg/day,48,After stroke,336,Other histology (ex vivo),NR,NR,NR,NR,NA,NA,mm3,SEM,NA,NA,NA,NA,NA,Other,NR,NR,NR,NR,NR,NR,Yes,No
Walter_2015,"Walter, H. L.",2015,Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke,b,Mouse,Cx3CR1-GFP,Male,None,NA,30,35,40,25,30,35,1,8,1,10,1,8,Nitrous oxide,Isoflurane,Skull thinned,NR,10,mg/ml,33.33333333,NR,NA,NA,LCD,NR,NR,1.5,15,AMD3100 (CXCR4 inhibitor),Anti-inflammation,1,mg/kg/day,48,After stroke,336,Other histology (ex vivo),5.35,0.81,5.56,0.65,NA,NA,mm3,SEM,1.051266432,1.092531096,2.291025971,0.450182934,2.055480479,Other,NR,NR,NR,NR,NR,NR,Yes,No
Wang_2017,"Wang, C.",2017,Nicotinamide Administration Improves Remyelination after Stroke,a,Mouse,C57BL/6,Male,None,NA,8,9,10,20,22.5,25,1,6,3,6,3,2,Sodium Pentobarbital,NA,Skull breached,Proximal middle cerebral artery (pMCA),0.025,mmol/kg,24.34175,NR,NA,NA,NR,NR,532,0.1,NR,Nicotinamide,Anti-apoptosis/regeneration,200,mg/kg,1,After stroke,168,MRI (in vivo),27.8,5.42,17.06,2.3,NA,NA,Indirect rLV % hemisphere,SD,13.9,8.53,5.42,2.71,2.3,mNSS,4.28,1.12,2.39,0.87,SD,336,Yes,Yes
Wang_2016_a,"Wang, H.",2016,Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus,a,Mouse,C57BL/6,Female,None,NA,NR,42,NR,NR,NR,NR,1,8,1,8,1,8,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),50,mg/kg,50,1.5,mW,NA,Green laser,Diode-pumped solid state laser,540,NR,30,"Pristane (2,6,10,14-tetramethylpentadecane)",Harm induction,0.5,ml,-5376,Before stroke,72,TTC (ex vivo),4.71,0.81,10.08,1.44,NA,NA,Direct rLV % hemisphere,SE,2.355,5.04,2.291025971,1.145512986,4.07293506,None,NA,NA,NA,NA,NA,NA,No,No
Wang_2016_a,"Wang, H.",2016,Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus,b,Mouse,Psgl-1-/-,Female,Lupus,Genetic,NR,42,NR,NR,NR,NR,1,8,1,8,1,8,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Middle cerebral artery (MCA),50,mg/kg,50,1.5,mW,NA,Green laser,Diode-pumped solid state laser,540,NR,30,"Pristane (2,6,10,14-tetramethylpentadecane)",Harm induction,0.5,ml,-5376,Before stroke,72,TTC (ex vivo),5.59,0.92,5.41,0.51,NA,NA,Direct rLV % hemisphere,SE,2.795,2.705,2.602152955,1.301076477,1.442497834,None,NA,NA,NA,NA,NA,NA,No,No
Wang_2013,"Wang, J.",2013,Combination treatment with progesterone and rehabilitation training further promotes behavioral recovery after acute ischemic stroke in mice,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,22,23.5,25,1,6,3,6,3,2,Ketamine,Xylazine,Skull thinned,Sensorimotor cortex,24,mg/kg,24,NR,NA,NA,Green laser,Diode-pumped solid state laser,NR,NR,4.25,Progesterone,Other,2,mg/kg,4,After stroke,72,TTC (ex vivo),28.73,1.05,16.7,0.93,NA,NA,mm3,SEM,5.64539899,3.281523256,2.57196423,0.505386852,2.278025461,Bederson Scale,NR,NR,NR,NR,NR,4,Yes,Yes
Wang_2013,"Wang, J.",2013,Combination treatment with progesterone and rehabilitation training further promotes behavioral recovery after acute ischemic stroke in mice,b,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,22,23.5,25,1,6,3,6,3,2,Ketamine,Xylazine,Skull thinned,Sensorimotor cortex,24,mg/kg,24,NR,NA,NA,Green laser,Diode-pumped solid state laser,NR,NR,4.25,Task-specific training (TST),Other,NA,NA,24,After stroke,72,TTC (ex vivo),28.73,1.05,22.19,0.93,NA,NA,mm3,SEM,5.64539899,4.360299464,2.57196423,0.505386852,2.278025461,Bederson Scale,NR,NR,NR,NR,NR,4,Yes,Yes
Wang_2016_b,"Wang, X.",2016,Enriched environment improves post-stroke cognitive impairment in mice by potential regulation of acetylation homeostasis in cholinergic circuits,a,Mouse,Kunming,Male,None,NA,NR,8,NR,25,27.5,30,1,5,0,NA,NA,NA,Sodium Pentobarbital,NA,Skull thinned,NR,100,mg/kg,100,50,mW,NA,Cold light,NR,561,3,15,None,NA,NA,NA,NA,NA,24,MRI (in vivo),5.5,0.18,NA,NA,NA,NA,mm2,SD,NA,NA,0.18,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Watson_2002,"Watson, B. D.",2002,Cerebral blood flow restoration and reperfusion injury after ultraviolet laser-facilitated middle cerebral artery recanalization in rat thrombotic stroke,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,250,300,350,1,7,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,5,mW,NA,NR,NR,562,0.25,5,None,NA,NA,NA,NA,NA,72,Other histology (ex vivo),11.68,2.98,NA,NA,NA,NA,mm3,SD,0.592592593,NA,2.98,0.151192288,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Weise_2011,"Weise, G.",2011,In vivo imaging of stepwise vessel occlusion in cerebral photothrombosis of mice by 19F MRI,a,Mouse,C57BL/6,NR,None,NA,NR,NR,NR,25,27.5,30,1,8,0,NA,NA,NA,Enflurane,NA,"Scalp retracted, skull intact",NR,0.2,mL,NA,NR,NA,NA,NR,NR,NR,NR,20,None,NA,NA,NA,NA,NA,2,MRI (in vivo),0.59,0.03,NA,NA,NA,NA,NR,NR,NA,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Wiessner_2003,"Wiessner, C.",2003,Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats,a,Rat,Fischer 344,Male,None,NA,NR,NR,NR,NR,300,NR,1,13,1,14,1,13,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,80,mg/kg,80,150,W,NA,NR,NR,NR,NR,7,Anti-Nogo-A,Anti-apoptosis/regeneration,15,ug/hour,24,After stroke,1512,MRI (in vivo),91.8,35.6,90.5,31.5,NA,NA,ul,SD,4.657534247,4.591577879,35.6,1.806189751,31.5,None,NA,NA,NA,NA,NA,NA,Yes,No
Wood_1997,"Wood, N. I.",1997,"The effects of SB 206284A, a novel neuronal calcium-channel antagonist, in models of cerebral ischemia",a,Rat,Lister Hooded Rat,Male,None,NA,NR,NR,NR,250,265,280,3,9,3,9,1,9,Halothane,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,300,W,NA,Xenon lamp,Xenon,NR,3,5,SB 206284-A,Blood flow,10,mg/kg,-0.17,After stroke,168,Other histology (ex vivo),5.87,3.93,1.93,2.1,NA,NA,mm3,SD,0.297818366,0.097919838,3.93,0.199391172,2.1,None,NA,NA,NA,NA,NA,NA,No,Yes
Wood_1997,"Wood, N. I.",1997,"The effects of SB 206284A, a novel neuronal calcium-channel antagonist, in models of cerebral ischemia",b,Primate,Marmoset,Mixed,None,NA,NR,NR,NR,300,400,500,1,6,1,6,1,6,Alfaxolone/Alfadolone,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,300,W,NA,Xenon lamp,Xenon,NR,3,10,SB 206284-A,Blood flow,10,mg/kg,-0.17,After stroke,168,Other histology (ex vivo),38.83,7.98,31.41,4.09,NA,NA,mm3,SD,NA,NA,7.98,NA,4.09,None,NA,NA,NA,NA,NA,NA,No,No
Wood_1996,"Wood, N. I.",1996,Motor dysfunction in a photothrombotic focal ischaemia model,a,Rat,Lister Hooded Rat,Male,None,NA,NR,NR,NR,250,265,280,8,5,0,NA,NA,NA,Halothane,NA,"Scalp retracted, skull intact",NR,20,mg/kg,20,300,W,NA,Xenon lamp,Xenon,NR,3,5,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),55.88,8.04,NA,NA,NA,NA,mm3,NR,2.835109082,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Wurm_2007,"Wurm, F.",2007,Effects of skilled forelimb training on hippocampal neurogenesis and spatial learning after focal cortical infarcts in the adult rat brain,a,Rat,Wistar,Male,None,NA,10,11,12,250,260,270,1,6,2,7,2,3,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,1.3,mg/100mg,NA,NR,NA,NA,Cold light,NR,NR,NR,20,Enriched cage environment,Other,NA,NA,24,After stroke,240,Other histology (ex vivo),4,0.5,4.9,0.6,NA,NA,Direct rLV % whole brain,SD,4,4.9,0.5,0.5,0.6,None,NA,NA,NA,NA,NA,NA,Yes,No
Wurm_2007,"Wurm, F.",2007,Effects of skilled forelimb training on hippocampal neurogenesis and spatial learning after focal cortical infarcts in the adult rat brain,b,Rat,Wistar,Male,None,NA,10,11,12,250,260,270,1,6,2,10,2,3,Nitrous oxide,Enflurane,"Scalp retracted, skull intact",Forelimb sensorimotor cortex,1.3,mg/100mg,NA,NR,NA,NA,Cold light,NR,NR,NR,20,Task-specific training (TST),Other,NA,NA,24,After stroke,240,Other histology (ex vivo),4,0.5,4.9,0.8,NA,NA,Direct rLV % whole brain,SD,4,4.9,0.5,0.5,0.8,None,NA,NA,NA,NA,NA,NA,Yes,No
Yan_2018_a,"Yan, T.",2018,Inflammatory responses mediate brain-heart interaction after ischemic stroke in adult mice,a,Mouse,C57BL/6,Male,None,NA,35,37,39,NR,NR,NR,2,6,0,NA,NA,NA,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,10,mg/ml,NA,NR,NA,NA,LED,LED,NR,NR,15,None,NA,NA,NA,NA,NA,72,Other histology (ex vivo),12.59,3.22,NA,NA,NA,NA,Direct rLV % hemisphere,SD,6.295,NA,3.22,1.61,NA,mNSS,3.54,0.44,NA,NA,SD,168,Yes,No
Yan_2018_a,"Yan, T.",2018,Inflammatory responses mediate brain-heart interaction after ischemic stroke in adult mice,b,Mouse,C57BL/6,Male,Immunodeficiency,Splenectomy,35,37,39,NR,NR,NR,2,6,0,NA,NA,NA,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,10,mg/ml,NA,NR,NA,NA,LED,LED,NR,NR,15,None,NA,NA,NA,NA,NA,72,Other histology (ex vivo),8.87,1.58,NA,NA,NA,NA,Direct rLV % hemisphere,SD,4.435,NA,1.58,0.79,NA,mNSS,0.98,0.4,NA,NA,SD,168,Yes,No
Yan_1998,"Yan, Y. P.",1998,Effect of glutamate transporter on neuronal damage induced by photochemical thrombotic brain ischemia,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,253.3,261,268.7,1,3,3,3,3,1,Chloral hydrate,NA,Other,Parietal sensorimotor neocortex,80,mg/kg,80,150,W,NA,Halogen lamp,Halogen,750,NR,10,"L-trans-2,4-PDC",Harm induction,5,ug,-0.25,Before stroke,72,Other histology (ex vivo),1.03,0.21,2.24,0.36,NA,NA,mm3,SEM,0.052257737,0.113647894,0.36373067,0.018454118,0.623538291,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Yan_2018_b,"Yan, Y. T.",2018,Panax notoginsenoside saponins Rb1 regulates the expressions of Akt/ mTOR/PTEN signals in the hippocampus after focal cerebral ischemia in rats,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,280,305,330,1,15,3,15,3,5,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",Cerebral cortex,0.2,mg/100g,2,50,mW,NA,Diode laser,Diode laser,560,NR,20,PNS-Rb1,Anti-apoptosis/regeneration,100,mg/kg,4,After stroke,24,Other histology (ex vivo),NR,NR,NR,NR,NA,NA,NR,SD,NA,NA,NA,NA,NA,Bederson Scale,NR,NR,NR,NR,SD,24,No,Yes
Yanev_2019,"Yanev, P.",2019,Impaired meningeal lymphatic vessel development worsens stroke outcome,a,Mouse,C57BL/6,Male,None,NA,6,8,10,NR,NR,NR,1,6,0,NA,NA,NA,Nitrous oxide,Isoflurane,"Scalp retracted, skull intact",NR,40,mg/kg,40,45,mW,NA,Green laser,Diode-pumped solid state laser,561,2.7,15,None,NA,NA,NA,NA,NA,336,Other histology (ex vivo),6.1,2.7,NA,NA,NA,NA,mm3,SD,1.198640231,NA,2.7,0.530545676,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yang_2018,"Yang, L.",2018,Photobiomodulation therapy promotes neurogenesis by improving post-stroke local microenvironment and stimulating neuroprogenitor cells,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,200,225,250,1,4.5,1,4.5,1,4.5,Sodium Pentobarbital,NA,"Scalp retracted, skull intact",NR,0.1,mg/g,100,NR,NA,NA,Cold light,NR,NR,6,15,LLLT (Low-level light therapy),Anti-inflammation,808,nm,24,After stroke,336,Other histology (ex vivo),3.12,0.23,1.9,0.05,NA,NA,Direct rLV % hemisphere,SE,1.56,0.95,0.487903679,0.24395184,0.106066017,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2015,"Yao, H.",2015,Focal Ischemic Injury with Complex Middle Cerebral Artery in Stroke-Prone Spontaneously Hypertensive Rats with Loss-Of-Function in NADPH Oxidases,a,Rat,Stroke-prone SHR (Spontaneously Hypertensive Rat),Male,Hypertension,Genetic,11,15.5,20,244,269,294,2,14,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Diode laser,Diode laser,561,NR,NR,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),83,35,NA,NA,NA,NA,mm3,SD,4.211060375,NA,35,1.775748351,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2015,"Yao, H.",2015,Focal Ischemic Injury with Complex Middle Cerebral Artery in Stroke-Prone Spontaneously Hypertensive Rats with Loss-Of-Function in NADPH Oxidases,b,Rat,SP.MES,Male,Hypertension,Genetic,11,15.5,20,244,269,294,2,11,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Diode laser,Diode laser,561,NR,NR,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),89,39,NA,NA,NA,NA,mm3,SD,4.515474378,NA,39,1.97869102,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_1996,"Yao, H.",1996,Simplified model of krypton laser-induced thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,22,24,26,300,375,450,1,6,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,64,mW/mm2,6.4,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),84.8,17.4,NA,NA,NA,NA,mm3,SD,4.302384576,NA,17.4,0.882800609,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_1997,"Yao, H.",1997,"AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats",a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,22,26,30,300,375,450,1,8,1,8,1,8,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,3,4,YM90K,Nootropics/cognition,5,mg/kg/h,0,During stroke,72,TTC (ex vivo),93,23,61,25,NA,NA,mm3,SD,4.718417047,3.094875698,23,1.166920345,25,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2009_a,"Yao, H.",2009,Regional and temporal changes in proteomic profile after middle cerebral artery occlusion with or without reperfusion in rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,22,26,30,340,352,364,1,NR,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,NR,6,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),30.2,5.7,NA,NA,NA,NA,mm3,SD,1.532217149,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Yao_2011,"Yao, H.",2011,Characterizing photothrombotic distal middle cerebral artery occlusion and YAG laser-induced reperfusion model in the Izumo strain of spontaneously hypertensive rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,22,26,30,340,357,374,2,NR,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,15.9,W/cm2,15.9,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),39,17,NA,NA,NA,NA,mm3,SD,1.97869102,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Yao_2011,"Yao, H.",2011,Characterizing photothrombotic distal middle cerebral artery occlusion and YAG laser-induced reperfusion model in the Izumo strain of spontaneously hypertensive rats,b,Rat,Stroke-prone SHR (Spontaneously Hypertensive Rat),Male,Hypertension,Genetic,NR,22,NR,293,311,329,2,10,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,15.9,W/cm2,15.9,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),124,34.8,NA,NA,NA,NA,mm3,SD,6.29122273,NA,34.8,1.765601218,NA,None,NA,NA,NA,NA,NA,NA,Yes,No
Yao_2014,"Yao, H.",2014,Excess salt increases infarct size produced by photothrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,NR,13,NR,NR,NR,NR,1,19,1,24,1,19,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,15.9,W/cm2,15.9,Krypton laser,Krypton laser,568,3,4,Saline drinking water,Multiple mechanisms,0.9,% in diet,-336,Before stroke,48,TTC (ex vivo),77,12,112,27,NA,NA,mm3,SD,3.906646372,5.682394723,12,0.608828006,27,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2014,"Yao, H.",2014,Excess salt increases infarct size produced by photothrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats,b,Rat,Wistar-Kyoto,Male,None,NA,NR,13,NR,NR,NR,NR,1,5.5,1,5.5,1,5.5,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,15.9,W/cm2,15.9,Krypton laser,Krypton laser,568,3,4,Saline drinking water,Multiple mechanisms,0.9,% in diet,-336,Before stroke,48,TTC (ex vivo),38,9,45,19,NA,NA,mm3,SD,1.927955353,2.283105023,9,0.456621005,19,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2002,"Yao, H.",2002,Therapeutic time window for YAG laser-induced reperfusion of thrombotic stroke in hypertensive rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,22,26,30,346,395,444,1,6.5,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),81.6,18.3,NA,NA,NA,NA,mm3,SD,4.140030441,NA,18.3,0.928462709,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2003,"Yao, H.",2003,Photothrombotic middle cerebral artery occlusion and reperfusion laser system in spontaneously hypertensive rats,a,Rat,SHR/Kyushu,Male,Hypertension,Genetic,22,26,30,NR,NR,NR,23,6,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,NR,NA,NA,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),85,17,NA,NA,NA,NA,mm3,SD,4.31253171,NA,17,0.862506342,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2003,"Yao, H.",2003,Photothrombotic middle cerebral artery occlusion and reperfusion laser system in spontaneously hypertensive rats,b,Rat,Sprague-Dawley,Male,None,NA,22,26,30,NR,NR,NR,23,4,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,NR,NA,NA,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),12,2,NA,NA,NA,NA,mm3,SD,0.608828006,NA,2,0.101471334,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2003,"Yao, H.",2003,Photothrombotic middle cerebral artery occlusion and reperfusion laser system in spontaneously hypertensive rats,c,Rat,SHR/Kyushu,Female,Hypertension,Genetic,22,26,30,NR,NR,NR,23,8,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,NR,NA,NA,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),58,14,NA,NA,NA,NA,mm3,SD,2.942668696,NA,14,0.71029934,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2003,"Yao, H.",2003,Photothrombotic middle cerebral artery occlusion and reperfusion laser system in spontaneously hypertensive rats,d,Rat,SHR/Izm,Male,Hypertension,Genetic,22,26,30,NR,NR,NR,23,10,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,NR,NA,NA,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),62,11,NA,NA,NA,NA,mm3,SD,3.145611365,NA,11,0.558092339,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2003,"Yao, H.",2003,Photothrombotic middle cerebral artery occlusion and reperfusion laser system in spontaneously hypertensive rats,e,Rat,SHR/Izm,Female,Hypertension,Genetic,22,26,30,NR,NR,NR,23,5,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,NR,NA,NA,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),35,8,NA,NA,NA,NA,mm3,SD,1.775748351,NA,8,0.405885337,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2003,"Yao, H.",2003,Photothrombotic middle cerebral artery occlusion and reperfusion laser system in spontaneously hypertensive rats,f,Rat,Wistar-Kyoto/Izm,Male,None,NA,22,26,30,NR,NR,NR,23,6,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,NR,NA,NA,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),23,4,NA,NA,NA,NA,mm3,SD,1.166920345,NA,4,0.202942669,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2003,"Yao, H.",2003,Photothrombotic middle cerebral artery occlusion and reperfusion laser system in spontaneously hypertensive rats,g,Rat,SHR-SP/Izm,Male,None,NA,22,26,30,NR,NR,NR,23,6,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,NR,NA,NA,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),97,25,NA,NA,NA,NA,mm3,SD,4.921359716,NA,25,1.268391679,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2001,"Yao, H.",2001,DNA fragmentation in ischemic core and penumbra in focal cerebral ischemia in rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,22,26,30,350,394,438,1,6,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),84.3,9.9,NA,NA,NA,NA,mm3,SD,4.277016743,NA,9.9,0.502283105,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yao_2009_b,"Yao, H.",2009,Reperfusion-induced temporary appearance of therapeutic window in penumbra after 2 h of photothrombotic middle cerebral artery occlusion in rats,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,22,26,30,NR,NR,NR,1,NR,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Krypton laser,Krypton laser,568,3,4,None,NA,NA,NA,NA,NA,72,TTC (ex vivo),70.95,19.61,NA,NA,NA,NA,mm3,SD,3.599695586,NA,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Ye_2018,"Ye, X. C.",2018,Astrocytic Lrp4 (Low-Density Lipoprotein Receptor-Related Protein 4) Contributes to Ischemia-Induced Brain Injury by Regulating ATP Release and Adenosine-A2AR (Adenosine A2A Receptor) Signaling,a,Mouse,Lrp4 f/f,Male,None,NA,9,11,13,24,27,30,1,6,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",Sensorimotor cortex,100,mg/kg,100,150,W,NA,Cold light,NR,NR,2,15,None,NA,NA,NA,NA,NA,336,TTC (ex vivo),14.3,0.61,NA,NA,NA,NA,Indirect rLV % hemisphere,SEM,7.15,NA,1.494188743,0.747094372,NA,mNSS,8.24,0.24,NA,NA,SEM,24,Yes,No
Ye_2018,"Ye, X. C.",2018,Astrocytic Lrp4 (Low-Density Lipoprotein Receptor-Related Protein 4) Contributes to Ischemia-Induced Brain Injury by Regulating ATP Release and Adenosine-A2AR (Adenosine A2A Receptor) Signaling,b,Mouse,Lrp4 GFAP-Cre,Male,None,NA,9,11,13,24,27,30,1,6,0,NA,NA,NA,Ketamine,Xylazine,"Scalp retracted, skull intact",Sensorimotor cortex,100,mg/kg,100,150,W,NA,Cold light,NR,NR,2,15,None,NA,NA,NA,NA,NA,336,TTC (ex vivo),11,0.49,NA,NA,NA,NA,Indirect rLV % hemisphere,SEM,5.5,NA,1.200249974,0.600124987,NA,mNSS,7,0.43,NA,NA,SEM,24,Yes,No
Yew_2019,"Yew, W. P.",2019,Early treatment with minocycline following stroke in rats improves functional recovery and differentially modifies responses of peri-infarct microglia and astrocytes,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,270,305,340,3,6,3,6,1,6,Ketamine,Xylazine,"Scalp retracted, skull intact",Forelimb motor cortex,13,mg/kg,13,140000,lux,0.0204974,NR,NR,560,6,15,Minocycline,Anti-inflammation,50,mg/kg,1,After stroke,72,Other histology (ex vivo),19.3,4.03,16.13,3.47,NA,NA,mm3,SD,0.979198376,0.818366312,4.03,0.204464739,3.47,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Yin_1998,"Yin, K. J.",1998,Neuroprotective action of dextromethorphan in rat photochemically-induced focal cerebral ischemia,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,230,250,270,1,7,3,7,3,2.333333333,Chloral hydrate,NA,"Scalp retracted, skull intact",NR,80,mg/kg,80,NR,NA,NA,Cold light,NR,775,NR,10,Dextromethorphan,Excitotoxicity,50,mg/kg,-0.25,Before stroke,12,Other histology (ex vivo),6,0.5,3,0.4,NA,NA,mm3,SD,0.304414003,0.152207002,0.5,0.025367834,0.4,None,NA,NA,NA,NA,NA,NA,No,Yes
Yoshida_2012,"Yoshida, H.",2012,"K-134, a phosphodiesterase 3 inhibitor, prevents brain damage by inhibiting thrombus formation in a rat cerebral infarction model",a,Rat,Sprague-Dawley,Male,None,NA,5,6.5,8,NR,NR,NR,1,12,3,12,3,4,Sodium Pentobarbital,NA,Skull breached,Middle cerebral artery (MCA),25,mg/kg/ml,NA,800000,lux,0.117128,Xenon lamp,Xenon,540,NR,8,K-134,Thrombolytics,30,mg/kg,-2,Before stroke,24,TTC (ex vivo),131.4,18.9,62.1,12.9,NA,NA,mm3,SEM,6.666666667,3.150684932,65.47152053,3.321741275,44.68691084,None,NA,NA,NA,NA,NA,NA,No,Yes
Yoshida_2012,"Yoshida, H.",2012,"K-134, a phosphodiesterase 3 inhibitor, prevents brain damage by inhibiting thrombus formation in a rat cerebral infarction model",b,Rat,Sprague-Dawley,Male,None,NA,5,6.5,8,NR,NR,NR,1,12,3,12,3,4,Sodium Pentobarbital,NA,Skull breached,Middle cerebral artery (MCA),25,mg/kg/ml,NA,800000,lux,0.117128,Xenon lamp,Xenon,540,NR,8,Cilostazol,Thrombolytics,300,mg/kg,-3,Before stroke,24,TTC (ex vivo),131.4,18.9,95.8,14.8,NA,NA,mm3,SEM,6.666666667,4.860476915,65.47152053,3.321741275,51.2687039,None,NA,NA,NA,NA,NA,NA,No,No
Yu_2015,"Yu, C. L.",2015,Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice,a,Mouse,Kunming,Male,None,NA,8,9,10,20,22.5,25,1,3,0,NA,NA,NA,None,NA,Other,Motor cortex,100,mg/kg,100,18.5,mW,NA,Diode laser,Diode laser,473,0.2,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),29.45,4.67,NA,NA,NA,NA,Direct rLV % whole brain,SEM,29.45,NA,8.088677271,8.088677271,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yu_2015,"Yu, C. L.",2015,Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice,b,Mouse,Kunming,Male,None,NA,8,9,10,20,22.5,25,1,3,0,NA,NA,NA,None,NA,Other,Motor cortex,100,mg/kg,100,18.5,mW,NA,Diode laser,Diode laser,593,0.2,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),2.37,0.96,NA,NA,NA,NA,Direct rLV % whole brain,SEM,2.37,NA,1.662768775,1.662768775,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yu_2015,"Yu, C. L.",2015,Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice,c,Mouse,Kunming,Male,None,NA,8,9,10,20,22.5,25,1,3,0,NA,NA,NA,None,NA,Other,Motor cortex,100,mg/kg,100,11,mW,NA,LED,LED,565,0.2,30,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),0.79,0.68,NA,NA,NA,NA,Direct rLV % whole brain,SEM,0.79,NA,1.177794549,1.177794549,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yu_2015,"Yu, C. L.",2015,Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice,d,Mouse,Kunming,Male,None,NA,8,9,10,20,22.5,25,1,3,1,3,1,3,None,NA,Other,Motor cortex,100,mg/kg,100,18.5,mW,NA,Diode laser,Diode laser,473,0.2,30,Nimodipine,Blood flow,15,mg/kg,-0.17,Before stroke,24,TTC (ex vivo),29.6,3.14,13.63,2.9,NA,NA,Direct rLV % whole brain,SEM,29.6,13.63,5.438639536,5.438639536,5.022947342,None,NA,NA,NA,NA,NA,NA,Yes,No
Yu_2016,"Yu, X.",2016,Zebrafish (Danio rerio) Developed as an Alternative Animal Model for Focal Ischemic Stroke,a,Zebrafish,NA,NR,None,NA,NR,NR,NR,NA,NA,NA,1,7,0,NA,NA,NA,MS-222,NA,Other,Optic tectum (Zebrafish),100,ug/g,100,800,uW/cm2,0.0008,Cold light,NR,NR,NR,20,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),33,20,NA,NA,NA,NA,Direct rLV % whole brain,SD,33,NA,20,20,NA,None,NA,NA,NA,NA,NA,NA,No,No
Yu_2016,"Yu, X.",2016,Zebrafish (Danio rerio) Developed as an Alternative Animal Model for Focal Ischemic Stroke,b,Zebrafish,NA,NR,None,NA,NR,NR,NR,NA,NA,NA,1,7,1,7,1,7,MS-222,NA,Other,Optic tectum (Zebrafish),100,ug/g,100,800,uW/cm2,0.0008,Cold light,NR,NR,NR,30,rTPA (Recombinant tissue plasminogen activator),Thrombolytics,NR,NA,NR,After stroke,24,TTC (ex vivo),44,7,11,20,NA,NA,Direct rLV % whole brain,SD,44,11,7,7,20,None,NA,NA,NA,NA,NA,NA,No,No
Zhan_2013,"Zhan, H.",2013,The effect of an NgR1 antagonist on the neuroprotection of cortical axons after cortical infarction in rats,a,Rat,Sprague-Dawley,Male,None,NA,NR,NR,NR,NR,250,NR,1,3,1,3,1,3,Ketamine,Xylazine,"Scalp retracted, skull intact",Parietal cortex,40,mg/kg,40,150,W,NA,Cold light,NR,NR,10,8,sNgR-Fc (soluble Nogo66 receptor),Multiple mechanisms,400,ug/kg,24,After stroke,24,TTC (ex vivo),297.1,23.4,285.4,19.7,NA,NA,ul,SD,15.07356672,14.47995941,23.4,1.187214612,19.7,None,NA,NA,NA,NA,NA,NA,No,No
Zhang_2010,"Zhang, W.",2010,Neuronal protective role of PBEF in a mouse model of cerebral ischemia,a,Mouse,C57BL/6,NR,None,NA,10,11.5,13,NR,NR,NR,1,9,0,NA,NA,NA,NR,NA,Skull breached,Somatosensory cortex,30,mg/kg,30,NR,NA,NA,Green laser,Diode-pumped solid state laser,NR,1,2,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),1.09,0.16,NA,NA,NA,NA,mm3,SEM,0.214183254,NA,0.48,0.094319231,NA,None,NA,NA,NA,NA,NA,NA,No,No
Zhang_2010,"Zhang, W.",2010,Neuronal protective role of PBEF in a mouse model of cerebral ischemia,b,Mouse,Pbef+/-,NR,None,NA,10,11.5,13,NR,NR,NR,1,10,0,NA,NA,NA,NR,NA,Skull breached,Somatosensory cortex,30,mg/kg,30,NR,NA,NA,Green laser,Diode-pumped solid state laser,NR,1,2,None,NA,NA,NA,NA,NA,24,Other histology (ex vivo),1.68,0.25,NA,NA,NA,NA,mm3,SEM,0.33011731,NA,0.790569415,0.155345624,NA,None,NA,NA,NA,NA,NA,NA,No,No
Zhao_2004,"Zhao, B. Q.",2004,Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice,a,Mouse,Wild type (WT),NR,None,NA,9,10.5,12,NR,NR,NR,1,6,1,6,1,6,NR,NA,Skull breached,Middle cerebral artery (MCA),NR,NA,NA,3.16,W/cm2,3.16,Green laser,Diode-pumped solid state laser,540,1,30,Heparin,Thrombolytics,150,U/kg/h,3,After stroke,48,TTC (ex vivo),29.14,24.75,27.65,18.49,NA,NA,mm3,SD,5.725963333,5.43318072,24.75,4.863335364,18.49,None,NA,NA,NA,NA,NA,NA,No,No
Zhao_2004,"Zhao, B. Q.",2004,Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice,b,Mouse,tPA-/-,NR,None,NA,9,10.5,12,NR,NR,NR,1,6,1,6,1,6,NR,NA,Skull breached,Middle cerebral artery (MCA),NR,NA,NA,3.16,W/cm2,3.16,Green laser,Diode-pumped solid state laser,540,1,30,Heparin,Thrombolytics,150,U/kg/h,3,After stroke,48,TTC (ex vivo),22.14,21.61,18.71,18.71,NA,NA,mm3,SD,4.350474544,3.676485037,21.61,4.246330392,18.71,None,NA,NA,NA,NA,NA,NA,No,No
Zhao_2001_a,"Zhao, B. Q.",2001,Combination of a free radical scavenger and heparin reduces cerebral hemorrhage after heparin treatment in a rabbit middle cerebral artery occlusion model,a,Rabbit,Japanese White,Male,None,NA,NR,NR,NR,2000,2500,3000,1,10,3,8,3,3.333333333,Nitrous oxide,Isoflurane,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,0.17,W/cm2,0.17,Xenon lamp,Xenon,540,3,60,Heparin,Thrombolytics,100,IU/kg/h,3,After stroke,48,TTC (ex vivo),261.8,40.1,304.5,64.9,NA,NA,mm3,SD,NA,NA,40.1,NA,64.9,Other,NR,NR,NR,NR,NR,48,No,Yes
Zhao_2001_a,"Zhao, B. Q.",2001,Combination of a free radical scavenger and heparin reduces cerebral hemorrhage after heparin treatment in a rabbit middle cerebral artery occlusion model,b,Rabbit,Japanese White,Male,None,NA,NR,NR,NR,2000,2500,3000,1,10,3,8,3,3.333333333,Nitrous oxide,Isoflurane,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,0.17,W/cm2,0.17,Xenon lamp,Xenon,540,3,60,EPC-K1,Anti-oxidants,10,mg/kg,3,After stroke,48,TTC (ex vivo),261.8,40.1,184.69,45.93,NA,NA,mm3,SD,NA,NA,40.1,NA,45.93,Other,NR,NR,NR,NR,NR,48,No,Yes
Zhao_2001_b,"Zhao, B. Q.",2001,Cerebral hemorrhage due to heparin limits its neuroprotective effects: studies in a rabbit model of photothrombotic middle cerebral artery occlusion,a,Rabbit,Japanese White,Male,None,NA,NR,NR,NR,2000,2500,3000,1,14,3,10,3,4.666666667,Nitrous oxide,Isoflurane,Skull breached,Middle cerebral artery (MCA),10,mg/kg,10,0.17,W/cm2,0.17,Xenon lamp,Xenon,540,3,60,Heparin,Thrombolytics,100,IU/kg,0.5,After stroke,24,TTC (ex vivo),220.59,12.6,128.15,14.29,NA,NA,mm3,SEM,NA,NA,47.14488307,NA,45.18894776,Other,NR,NR,NR,NR,NR,24,No,Yes
Zhao_2005_a,"Zhao, C. S.",2005,Behavioral effects of photothrombotic ischemic cortical injury in aged rats treated with the sedative-hypnotic GABAergic drug zopiclone,a,Rat,Wistar,Male,Aged,NA,NR,104,NR,424,584,744,1,9,1,9,1,9,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,4,10,Zopiclone,Nootropics/cognition,3,mg/kg,-96,Before stroke,696,Other histology (ex vivo),9.4,1.3,9.1,1.8,NA,NA,mm3,SEM,0.476915271,0.461694571,3.9,0.197869102,5.4,None,NA,NA,NA,NA,NA,NA,No,No
Zhao_2005_b,"Zhao, C. S.",2005,Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury,a,Rat,Wistar,Male,Aged,NA,NR,104,NR,NR,NR,NR,1,9,3,9,3,3,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,4,10,Risperidone,Nootropics/cognition,1,mg/kg,-168,Before stroke,480,Other histology (ex vivo),5,1,4.3,0.6,NA,NA,mm3,SEM,0.253678336,0.218163369,3,0.152207002,1.8,None,NA,NA,NA,NA,NA,NA,No,Yes
Zhao_2005_b,"Zhao, C. S.",2005,Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury,b,Rat,Wistar,Male,Aged,NA,NR,104,NR,NR,NR,NR,1,9,3,9,3,3,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,4,10,Fluoxetine,Blood flow,5,mg/kg,-168,Before stroke,480,Other histology (ex vivo),5,1,6.7,1.1,NA,NA,mm3,SEM,0.253678336,0.33992897,3,0.152207002,3.3,None,NA,NA,NA,NA,NA,NA,No,Yes
Zhao_2005_c,"Zhao, C. S.",2005,"Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats",a,Rat,Wistar,Male,None,NA,NR,22,NR,385,444,503,1,10,1,10,1,10,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,4,10,Galanthamine,Nootropics/cognition,2.5,mg/kg,-96,Before stroke,480,Other histology (ex vivo),15.4,0.9,16.6,1.5,NA,NA,mm3,SEM,0.781329274,0.842212075,2.846049894,0.14439624,4.74341649,None,NA,NA,NA,NA,NA,NA,No,No
Zhao_2005_c,"Zhao, C. S.",2005,"Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats",b,Rat,Wistar,Male,Aged,NA,NR,104,NR,468,580,692,1,7,1,7,1,7,Nitrous oxide,Halothane,"Scalp retracted, skull intact",Sensorimotor cortex,20,mg/kg,20,NR,NA,NA,Cold light,NR,NR,4,10,Galanthamine,Nootropics/cognition,2.5,mg/kg,-96,Before stroke,480,Other histology (ex vivo),11.7,1.1,12.6,1.4,NA,NA,mm3,SEM,0.593607306,0.639269406,2.910326442,0.147657354,3.704051835,None,NA,NA,NA,NA,NA,NA,No,No
Zhao_1996,"Zhao, W.",1996,Depiction of infarct frequency distribution by computer-assisted image mapping in rat brains with middle cerebral artery occlusion. Comparison of photothrombotic and intraluminal suture models,a,Rat,Spontaneously Hypertensive Rat (SHR),Male,Hypertension,Genetic,NR,NR,NR,270,307.5,345,1,8,0,NA,NA,NA,Nitrous oxide,Halothane,Skull breached,Distal middle cerebral artery (dMCA),20,mg/kg,20,20,mW,NA,Argon laser,Argon laser,562,NR,NR,None,NA,NA,NA,NA,NA,72,Other histology (ex vivo),37,9.7,NA,NA,NA,NA,mm3,SD,1.877219685,NA,9.7,0.492135972,NA,None,NA,NA,NA,NA,NA,NA,No,No
Zhao_2018,"Zhao, X. M.",2018,Plasma Phospholipid Transfer Protein Promotes Platelet Aggregation,a,Mouse,C57BL/6,NR,None,NA,10,11.5,13,NR,NR,NR,1,5,0,NA,NA,NA,NR,NA,"Scalp retracted, skull intact",NR,50,mg/kg,50,NR,NA,NA,Fibre-optic,NR,NR,NR,3,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),8.12,0.87,NA,NA,NA,NA,Direct rLV % whole brain,SD,8.12,NA,0.87,0.87,NA,None,NA,NA,NA,NA,NA,NA,No,No
Zhao_2018,"Zhao, X. M.",2018,Plasma Phospholipid Transfer Protein Promotes Platelet Aggregation,b,Mouse,PLTP transgenic,NR,None,NA,10,11.5,13,NR,NR,NR,1,5,0,NA,NA,NA,NR,NA,"Scalp retracted, skull intact",NR,50,mg/kg,50,NR,NA,NA,Fibre-optic,NR,NR,NR,3,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),11.76,0.97,NA,NA,NA,NA,Direct rLV % whole brain,SD,11.76,NA,0.97,0.97,NA,None,NA,NA,NA,NA,NA,NA,No,No
Zhao_2018,"Zhao, X. M.",2018,Plasma Phospholipid Transfer Protein Promotes Platelet Aggregation,c,Mouse,PLTP knockout,NR,None,NA,10,11.5,13,NR,NR,NR,1,5,0,NA,NA,NA,NR,NA,"Scalp retracted, skull intact",NR,50,mg/kg,50,NR,NA,NA,Fibre-optic,NR,NR,NR,3,None,NA,NA,NA,NA,NA,24,TTC (ex vivo),5.8,0.82,NA,NA,NA,NA,Direct rLV % whole brain,SD,5.8,NA,0.82,0.82,NA,None,NA,NA,NA,NA,NA,NA,No,No
Zhao_2017,"Zhao, Z.",2017,Chronic stress induced disruption of the peri-infarct neurovascular unit following experimentally induced photothrombotic stroke,a,Mouse,C57BL/6,Male,None,NA,NR,NR,NR,NR,NR,NR,1,10,1,12,1,10,Isoflurane,NA,"Scalp retracted, skull intact",Somatosensory cortex,10,mg/ml,NA,NR,NA,NA,Cold light,NR,NR,4.5,15,Stress (restraint),Other,NA,NA,NR,Before stroke,1008,Other histology (ex vivo),5.83,0.99,6.83,0.76,NA,NA,mm3,SEM,1.145585663,1.342084062,3.130654884,0.615168671,2.632717228,None,NA,NA,NA,NA,NA,NA,No,No
Zheng_2013,"Zheng, W.",2013,"P2Y1R-initiated, IP3R-dependent stimulation of astrocyte mitochondrial metabolism reduces and partially reverses ischemic neuronal damage in mouse",a,Mouse,NR,Male,None,NA,17,21.5,26,NR,NR,NR,1,4,1,4,1,4,Isoflurane,NA,Skull breached,Somatosensory cortex,10,mg/ml,NA,5,mW,NA,Green laser,Diode-pumped solid state laser,543,NR,10,2MeSADP,Anti-inflammation,0.25,mg/kg,0,During stroke,24,TTC (ex vivo),170496,9600,69700,3300,NA,NA,um2,SEM,NA,NA,19200,NA,6600,None,NA,NA,NA,NA,NA,NA,No,No
Zheng_2010,"Zheng, W.",2010,Purinergic receptor stimulation reduces cytotoxic edema and brain infarcts in mouse induced by photothrombosis by energizing glial mitochondria,a,Mouse,FVB/NJ,Male,None,NA,17,21.5,26,NR,NR,NR,1,5,7,5,7,0.714285714,Isoflurane,NA,Skull breached,Somatosensory cortex,20,mg/ml,NA,5,mW,NA,Green laser,Diode-pumped solid state laser,543,NR,NR,2MeSADP,Anti-inflammation,100,uM,0,During stroke,120,TTC (ex vivo),2.38,0.07,0.8,0.14,NA,NA,mm2,SEM,NA,NA,0.156524758,NA,0.313049517,None,NA,NA,NA,NA,NA,NA,Yes,Yes
Zou_2006,"Zou, L. Y.",2006,Melatonin reduces infarction volume in a photothrombotic stroke model in the wild-type but not cyclooxygenase-1-gene knockout mice,a,Mouse,C57BL/6,NR,None,NA,10,11,12,22,22.5,23,2,6,2,6,1,6,Ketamine,Xylazine,"Scalp retracted, skull intact",Sensorimotor cortex,1,mg,44.44444444,150,W,NA,Halogen lamp,Halogen,NR,1.5,15,Melatonin,Anti-oxidants,15,mg/kg,-0.5,Before stroke,72,Other histology (ex vivo),8.4,0.3,6.3,0.3,NA,NA,Direct rLV % hemisphere,SEM,4.2,3.15,0.734846923,0.367423461,0.734846923,None,NA,NA,NA,NA,NA,NA,No,No
Zou_2006,"Zou, L. Y.",2006,Melatonin reduces infarction volume in a photothrombotic stroke model in the wild-type but not cyclooxygenase-1-gene knockout mice,b,Mouse,COX-1 -/-,NR,None,NA,10,11,12,22,22.5,23,2,6,2,6,1,6,Ketamine,Xylazine,"Scalp retracted, skull intact",Sensorimotor cortex,1,mg,44.44444444,150,W,NA,Halogen lamp,Halogen,NR,1.5,15,Melatonin,Anti-oxidants,15,mg/kg,-0.5,Before stroke,72,Other histology (ex vivo),8.1,0.3,8.2,0.2,NA,NA,Direct rLV % hemisphere,SEM,4.05,4.1,0.734846923,0.367423461,0.489897949,None,NA,NA,NA,NA,NA,NA,No,No
Zou_2004,"Zou, L. Y.",2004,"Melatonin reduced volume of cerebral infarct induced by photothrombosis in wild-type mice, not in Cyclooxygenase-1 gene knockout mice",a,Mouse,Wild type (WT),NR,None,NA,NR,NR,NR,NR,NR,NR,2,6,2,6,1,6,NR,NA,NR,NR,NR,NA,NA,NR,NA,NA,Cold light,NR,NR,NR,15,Melatonin,Anti-oxidants,15,mg/kg,-0.5,Before stroke,72,TTC (ex vivo),16.09,1.46,14.9,1.3,NA,NA,Direct rLV % hemisphere,NR,8.045,7.45,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Zou_2004,"Zou, L. Y.",2004,"Melatonin reduced volume of cerebral infarct induced by photothrombosis in wild-type mice, not in Cyclooxygenase-1 gene knockout mice",b,Mouse,COX-1 -/-,NR,None,NA,NR,NR,NR,NR,NR,NR,2,6,2,6,1,6,NR,NA,NR,NR,NR,NA,NA,NR,NA,NA,Cold light,NR,NR,NR,15,Melatonin,Anti-oxidants,15,mg/kg,-0.5,Before stroke,72,TTC (ex vivo),15.65,2.46,10.54,2.85,NA,NA,Direct rLV % hemisphere,NR,7.825,5.27,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Zou_2004,"Zou, L. Y.",2004,"Melatonin reduced volume of cerebral infarct induced by photothrombosis in wild-type mice, not in Cyclooxygenase-1 gene knockout mice",c,Mouse,COX-1 +/-,NR,None,NA,NR,NR,NR,NR,NR,NR,2,6,2,6,1,6,NR,NA,NR,NR,NR,NA,NA,NR,NA,NA,Cold light,NR,NR,NR,15,Melatonin,Anti-oxidants,15,mg/kg,-0.5,Before stroke,72,TTC (ex vivo),16.68,3.84,15.33,2.38,NA,NA,Direct rLV % hemisphere,NR,8.34,7.665,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,No
Gudasheva_2012,"Gudasheva, T. A.",2012,[Neuroprotective and antiamnesic effects of GK-2h dipeptide HNGF mimetic on a model of experimental ischemic stroke of brain cortex prefrontal areas],a,Rat,Other,Male,None,NA,NR,NR,NR,180,NR,200,1,7,2,7,2,3.5,Chloral hydrate,NA,"Scalp retracted, skull intact",Frontal cortex,40,mg/kg,40,250,W,NA,Xenon lamp,Xenon,NR,3,15,GK-2h (hexamethylenediamine),Anti-apoptosis/regeneration,0.1,mg/kg,4,After stroke,216,Other histology (ex vivo),14,3.16,4.19,1.3,NA,NA,mm3,NR,0.71029934,0.212582445,NA,NA,NA,None,NA,NA,NA,NA,NA,NA,No,Yes
Mitagvariia_1996,"Mitagvariia, N. P.",1996,[The role of preparation LB in forming a thrombotic infarct of the cerebral cortex],a,Rat,NR,NR,None,NA,NR,NR,NR,150,NR,200,1,14,1,14,1,14,Urethane,NA,"Scalp retracted, skull intact",NR,10,mg/100g,100,250,W,NA,Halogen lamp,Halogen,NR,2,30,Plaferon-LB,Anti-oxidants,0.1,mg/kg,-0.25,Before stroke,4,Other histology (ex vivo),22,3,3.3,0.8,NA,NA,mm3,SEM,1.116184678,0.167427702,11.22497216,0.569506452,2.993325909,None,NA,NA,NA,NA,NA,NA,No,No
